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Abstract  
Aim: People with diabetes have visual problems and often these are the first 
symptoms at the time of diagnosis. In many respects the optics of diabetic 
eyes make them appear as older eyes than those of people of the same age 
without diabetes. The overall aim of this thesis was to test this as a 
hypothesis. While there have been studies that have considered larger 
numbers of people, this thesis builds on previous work by way of a 
comprehensive study of a large range of biometric and optical parameters in 
diabetes. 
Methods: Biometric and other parameters of 74 people with type 1 diabetes 
and an age matched control group were assessed. Most of the people were 
part of the Longitudinal Assessment of Neuropathy in Diabetes using novel 
ophthalmic Markers (LANDMark) study at the Institute of Health and 
Biomedical Innovation. In order to facilitate a longitudinal evaluation of the 
progression of severity of neuropathy with type 1 diabetes with no or mild 
diabetic neuropathy, nearly all of these participants had low levels of 
neuropathy, retinopathy and nephropathy. 
Some testing involved common clinical tests, but novel methods were 
developed to measure lens parameters such as yellowing, surface radii of 
curvature, diameter, refraction index distribution and equivalent refractive 
index. 
Results:  Marginal or no significant differences were found between groups 
for corneal shape, corneal thickness, pupil size, pupil decentrations and most 
higher-order aberrations (total, corneal and internal) for 4.5 mm pupils. 
Relative to the control group, the diabetes group demonstrated smaller 
anterior chamber depths, more curved lenses, thicker lenses, lower lens 
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equivalent refractive index, greater straylight, lower amplitudes of 
accommodation, greater lens yellowing, and different ocular aberration 
coefficients for horizontal coma and vertical coma. While the hypothesis has 
been supported, most of these differences did not increase significantly with 
age. A novel finding was the lower lens diameter in diabetic eyes than in 
non-diabetic eyes. 
Conclusion: As nearly all of the diabetes participants had low levels of 
neuropathy, retinopathy and nephropathy, it is concluded that age-related 
changes in the optics of the eyes of people with diabetes need not be 
accelerated if the diabetes is well controlled. 
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Chapter 1:  Introduction 
Diabetes mellitus is a group of metabolic diseases characterised by chronic 
hyperglycaemia. Its main classifications are Type 1 diabetes mellitus (DM1), 
which is characterised by auto-immune destruction of pancreatic beta-cells 
that leads to loss of insulin secretion, and Type 2 diabetes mellitus (DM2) 
which is the most common form. Diabetes affects all parts of the human eye 
with its most important ocular complication being diabetic retinopathy. In 
addition, it affects the eye’s optics and biometry of the human eye. In many 
optical respects, diabetic eyes act like older normal eyes.  
 
Greater central corneal thickness has been reported in people with diabetes 
than in people without diabetes in some studies (Busted, Olsen, & Schmitz, 
1981; Lee, Oum, Choi, Lee, & Cho, 2005) but not in others (Inoue, Kato, 
Inoue, Amano, & Oshika, 2002; Keoleian, Pach, Hodge, Trocme, & Bourne, 
1992; Wiemer, Dubbelman, Kostense, Ringens, & Polak, 2007; Ziadi et al., 
2002).  
 
Wiemer et al. (2007) found smaller posterior cornea radii of curvature in 
people with diabetes than in people without diabetes without significant 
differences in the anterior cornea radii of curvature, but this did not affect the 
overall corneal power. 
 
Age-related lenticular changes are more pronounced in people with diabetes 
than in people without diabetes (Bron, Sparrow, Brown, Harding, & 
Blakytny, 1993; Brown & Hungerford, 1982; Fledelius & Miyamoto, 1987; 
Løgstrup, Sjølie, Kyvik, & Green, 1996; Løgstrup, Sjølie, Kyvik, & Green, 
1997; Pierro, Brancato, Zaganelli, Guarisco, & Calori, 1996; Saw, Wong, Ting, 
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Foong, & Foster, 2007; Sparrow, Bron, Brown, & Neil, 1992; Wiemer, 
Dubbelman, Kostense, Ringens, & Polak, 2008d). These changes are 
dependent on the duration of diabetes (Løgstrup, et al., 1996; Sparrow, Bron, 
Brown, & Neil, 1990; Wiemer, Dubbelman, Hermans, Ringens, & Polak, 
2008c; Wiemer, et al., 2008d). 
 
With increasing age anterior chamber depth decreases, lens thickness 
increases, lens surface curvatures increases, and lens equivalent refractive 
index decreases (Atchison et al., 2008). The intraocular distance changes are 
greater in people with diabetes than in people without diabetes (Braun, 
Benson, Remaley, Chew, & Ferris III, 1995; Pierro, et al., 1996; Saw, et al., 
2007; Wiemer, et al., 2008d). People with diabetes, at least for DM1, have 
greater lens surface curvatures than people without diabetes. 
 
Similarly, nearly twice the rate of change in equivalent refractive index for 
DM1 (0.0007/year) occurs than for people without diabetes (Wiemer, et al., 
2008d). Equatorial diameter increases with ageing according to 
Kasthurirangan et al. (2011), but not Strenk et al. (1999); no information is 
available on diameters in diabetes. 
 
Wiemer et al. (2008c) found different impacts of DM1 and DM2 on lens 
biometry. They found thicker lens nuclei, anterior cortices and posterior 
cortices in DM1 than in non-diabetic people. In DM2, they found significant 
thicker nuclei than non-diabetic people but thinner posterior cortices than in 
non-diabetic people. 
 
Lenticular refractive index distribution changes with ageing and 
accommodation. Kasthurirangan et al. (2008) found alterations of gradient 
refractive index, but with the central and edge refractive indices remaining 
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unaffected. Refractive index variation occurred over a large portion of the 
lens during accommodation, but with ageing the variation was restricted to 
the peripheral part of the lens. These changes with ageing explain the lens 
paradox, which is that despite the lens curvatures increasing with age, most 
eyes do not become more myopic. The study showed a contribution of the 
gradient index distribution to accommodation as proposed by Gullstrand 
and incorporated in his No. 1 schematic eye. 
 
Diabetic people have lower lens light transmission than non-diabetic people 
(Davies & Morland, 2002; Lutze & Bresnick, 1991; Van Best, Vrij, & 
Oosterhuis, 1985; Zagers, Pot, & van Norren, 2005). In vivo (Lutze & Bresnick, 
1991) and in vitro (Kessel, Lundeman, Herbst, Andersen, & Larsen, 2010) 
studies have found that diabetic lenses are yellower than non-diabetic lenses. 
 
Lower subjective amplitudes of accommodation have been found for people 
with diabetes than for age-matched controls (Cavallerano, 1990; Moss, Klein, 
& Klein, 1987; Yamamoto, Adachi-Usami, & Kuroda, 1989). Moss et al. (1987) 
and Braun et al. (1995) found that duration of diabetes was approximately 
60% and 40% as important, respectively, as age in reducing amplitude. Most 
studies used a narrow age range for which decline in the amplitude of 
accommodation with age was not investigated. Also, subjective techniques 
are unreliable due to depth-of-focus. There appears to have been only one 
objective measurement of amplitude of accommodation for people with 
diabetes, an electrophysiological study by Yamamoto et al. (1989) who found 
reduced amplitudes in people with diabetes.  
 
The decrease in equivalent gradient index in diabetes (Wiemer, et al., 2008d) 
might be due to a change in refractive index distribution such as occurs in 
ageing or to an overall decrease in refractive index throughout the lens. If the 
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change in lens shape during accommodation is not affected then either of 
these could explain the reduction in accommodation with age. Should the 
change in lens shape be reduced during accommodation, it is possible that 
there may be a neural component, although there may also be contributions 
due to the changed architecture of the lens and its supporting structures.  
 
One aspect that is not known well is how the lens refractive index 
distribution differs between people with and without diabetes. It is 
important to know this to understand the accommodation mechanism and to 
predict effects of acute hyperglycaemic attacks on refraction and visual 
acuity. 
 
With increasing age, higher order aberrations increase. This is attributable to 
the lens as there is little age-related change in corneal optics. When 
monochromatic higher order aberrations are corrected with large pupils, 
visual acuity improves by approximately 0.1 to 0.15 log minutes of arc 
resolution (1.2-1.4X) (Guo, Atchison, & Birt, 2008) and contrast sensitivity 
improves up to 6 times (Liang, Williams, & Miller, 1997). Therefore, it is 
expected that any increased higher order aberrations in people with diabetes 
could reduce visual acuity and other visual functions. 
 
Shahidi et al. (2004) found approximately 33% greater higher-order 
aberrations with 6 mm pupils in people with diabetic retinopathy than in 
non-diabetic people. Wiemer et al. (2009) examined higher-order aberrations 
with 5 mm pupils in 25 people with diabetes presenting with acute 
hyperglycaemia and blurred vision. They found 18% lesser higher-order 
aberrations in four of their people with diabetes when they brought 
hyperglycaemia under control, but no changes in the others. There has been 
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no similar study between non-diabetic people and people with diabetes but 
without retinopathy. 
 
Several studies have shown that long term diabetes is associated with 
increased retinal thickness (Goebel & Kretzchmar-Gross, 2002) but some 
studies have found thinner retinas in people with diabetes or without 
minimal retinopathy (Biallosterski et al., 2007; Van Dijk et al., 2010). Choroids 
are thinner in people with diabetes than in age-matched controls 
(Esmaeelpour et al., 2011). Lima et al. (2010) compared age matched controls 
with DM2 and found that macular pigment density decreased as HbA1c 
(glycated haemoglobin) levels increased. 
 
It is thought that hyperglycaemia results in myopia (Fledelius & Miyamoto, 
1987; Furushima, Imaizumi, & Nakatsuka, 1999; Mäntyjärvi, 1988) and 
hyperopia has been reported during reduction of hyperglycaemia 
hyperglycaemia (Giusti, 2003; Lin, Lin, Chang, & Tsai, 2009; Okamoto, Sone, 
Nonoyama, & Hommura, 2000; Saito et al., 1993). In contrast to the above 
studies, some investigators have observed both myopic and hyperopic shifts 
during hyperglycaemia (Sonmez et al., 2005; Wiemer, et al., 2009). The 
mechanisms of long term and short term hyperglycaemic changes on 
refractive status of the eye are poorly understood (Cavallerano, 1990). 
 
Wiemer et al. (2008b) studied refractive changes in 5 healthy young 
participants during acute hyperglycaemia. For one participant, they observed 
a hyperopic shift with increased anterior lens curvature and decreased lens 
equivalent refractive index. They concluded that refraction changes during 
hyperglycaemia may be explained on the basis of change in lens shape and 
refractive index. 
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In previous studies involving intraocular distance measurements by 
techniques such as ultrasonography, optical pachymetry, and optical 
coherence tomography, a fixed refractive index was assumed within one or 
more elements. In partial coherence interferometry, a fixed index has been 
assumed to be adequate for the whole eye (e.g. IOLMaster) or fixed indices 
are assigned to each medium (e.g. Lenstar). A non-optical technique of value 
here is magnetic resonance imaging as no such assumptions are made.  
 
Investigation of the optics of the diabetic eye is a relatively new area of 
research, especially for objective measurements of amplitude of 
accommodation, intra-ocular aberrations, straylight, lens diameter and the 
lenticular refractive index distribution. The causes of amplitude of 
accommodative loss are not known. This research will utilise state-of-the-art 
ocular measurement techniques to examine the changes in optics of diabetic 
eyes, and investigate a range of potential ocular factors (such as lens 
thickness, shape and refractive index distribution) that may contribute to loss 
of amplitude of accommodation.  
 
The findings from this research will add to our understanding of the 
underlying causes of optical changes in diabetic ocular components, but will 
not provide information regarding histological or biochemical changes. This 
research will provide insights into the visual problems faced by people with 
diabetes. 
 
The over-riding hypothesis of this study is that eyes of people with diabetes 
act as older eyes than those of people of the same age without diabetes. The 
aims are as follows:  
1) To determine whether people with diabetes have greater higher-order 
aberrations than people without diabetes of the same age. 
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2) To identify whether loss of accommodation with diabetes can be attributed 
to changes in the lens to which the refractive index distribution 
contributes. 
3) To determine whether diabetic lenses become yellower at greater rates 
than aged-matched normal lenses. 
4) To determine whether refractive index distribution of the diabetic lens is 
different from that of the non-diabetic lens. 
5) To determine whether corrections to assumed refractive index are needed 
in biometric measurements of diabetic eyes. 
6) To determine whether people with diabetes have more straylight than 
people without diabetes. 
 
The contents of this thesis are as follows. Chapter 2 is a literature review 
about diabetes, what is known about the relationship between diabetes and 
the optics of the human eye, and how visual functions are affected by 
diabetes. Chapter 3 describes the participants and techniques used in the 
study. The latter include both standard clinical and specialised techniques. 
The background of the techniques is included, and as appropriate, full details 
of development of some specialised techniques such as phakometry are 
included. Chapter 4 gives results of the various optics and biometric 
measurements for people with DM1 and for age-matched controls. 
Discussion and summary of the study are given in Chapter 5. 
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Chapter 2:  Literature Review 
2.1 Diabetes: Overview  
Diabetes mellitus is a group of metabolic diseases characterised by chronic 
hyperglycaemia. It has multiple complications and premature morbidity and 
mortality. It is reaching epidemic levels throughout the world, producing 
cardiovascular complications, eye and kidney diseases and limb 
amputations. Reducing morbidity and mortality, and improving quality of 
life are major public health goals, which can be achieved by earlier disease 
diagnosis and improved screening for associated complications. Diabetes 
affects the refractive components of the eye, so blurriness of vision is often 
the first sign. 
 
2.1.1 Definition and Classification  
Diabetes results from defects in insulin secretion, insulin action or both. It 
has been classified on the basis of the level of hyperglycaemia (Gries, 2003). 
 
Type 1 diabetes mellitus (DM1), which was known previously as insulin-
dependent diabetes, is juvenile in its onset and is characterised by auto-
immune destruction of pancreatic beta-cells, leading to loss of insulin 
secretion. Its cause is not well known and it is not preventable with current 
knowledge. Excessive excretion of urine (polyuria), thirst (polydipsia), 
constant hunger (polyphagia), weight loss, vision changes and fatigue are 
symptoms of DM1 which may occur suddenly (WHO, 2011a). 
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Type 2 diabetes mellitus (DM2) is the most common form of the disease, 
being responsible for over 90% of diabetics in the world. It includes insulin 
resistance and impaired insulin secretion conditions. Excess body weight and 
physical inactivity are contributing factors for DM2. It has similar but not as 
severe symptoms as DM1. It may be diagnosed several years after its onset 
when the complications have already occurred. It was thought that DM2 
occurs only in adults, but it has also been found in children (WHO, 2011a). 
 
Gestational diabetes is hyperglycaemia of variable severity due to 
carbohydrate intolerance with onset or first recognition during pregnancy. It 
affects approximately 7% of all pregnant women and is considered to be a 
major risk for later development of diabetes mellitus (American Diabetes 
Association, 2004).  
 
Latent Autoimmune Diabetes in Adults comprises up to 10 – 15% adults 
diagnosed with DM2. It is a form of diabetes which is diagnosed in 
individuals who are older than the usual age of onset of type 1 diabetes. 
Maturity onset diabetes of the young is a monogenic form of diabetes with 
an autosomal dominance inheritance characterised by non-ketotic 
hyperglycaemia in adolescents of young adults in conjuction with a family 
history of diabetes (Patel & Macerollo, 2010). 
 
2.1.2 Criteria of Diagnosis  
According to the World Health Organization (WHO, 2011b), glycosylated 
haemoglobin (HbA1c) can be used as a diagnostic test with HbA1c of 6.5% as 
the cut off point for diagnosing diabetes, with the normal range being 4-6%. 
The previous WHO diagnostic criterion for diabetes was fasting plasma 
glucose ≥ 7.0 mmol/l or 2 - h plasma glucose ≥ 11.1 mmol/l (National Health 
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and Medical Research Council, 2008). The diagnosis should be confirmed 
with a repeat HbA1c test, unless clinical symptoms and plasma glucose levels 
≥ 11.1 mmol/l are present (WHO, 2011b). 
 
Haemoglobin is found in red blood cells, which carry oxygen from the lungs 
to the body cells and remove waste carbon dioxide from them. A small 
percentage of haemoglobin has glucose attached to it, forming haemoglobin 
A. High levels of serum glucose sustained over a long period of time will 
increase haemoglobin A. The red blood cells circulate for 60-120 days in the 
body, so the blood level of haemoglobin A provides an average of blood 
glucose levels for a period of 2-3 months (Cavallerano, 1990). It is a useful 
measure as, unlike plasma glucose levels, it is not subject to within hour 
fluctuations  but indicates the chronic  elevated blood glucose level. 
 
2.1.3 Prevalence of Diabetes  
Diabetes is known as the epidemic of the 21st century. It is estimated that 366 
million of the world’s population suffer from diabetes and predicted that it 
will increase to 552 million by 2030 (Whiting, Guariguata, Weil, & Shaw, 
2011). The prevalence of diabetes increases with age and it is high in certain 
racial groups. 
 
Approximately 80% of people with diabetes are in developing countries. 
Prevalence estimates of diabetes and impaired glucose tolerance are high in 
Asian countries, and are expected to increase during the next two decades. It 
is expected that diabetes in adults in developing countries and developed 
countries will increase by 69% and 20%, respectively, between 2010 and 2030 
(Shaw & Chisholm, 2003). Diabetes develops at younger ages in Asian 
populations than in white populations, and hence the morbidity and 
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mortality associated with the disease and its complications are more common 
in young Asian people than in young white people (Ramachandran, Wan 
Ma, & Snehalatha, 2010). 
 
Around one million Australians (7.5% aged 25 years or over) have diabetes 
and the number is expected to increase over the coming decades. 
Approximately 275 adults develop diabetes each day (Barr et al., 2006). Its 
prevalence increases with age, and more than 20% of the population aged 
over 60 years have DM2. The prevalence of DM2 has more than doubled in 
Australia since 1981 (Shaw & Chisholm, 2003). In some Aboriginal and 
Torres Strait islander communities as many as one-third of the people have 
diabetes, and DM2 may be among the highest in the world. For this reason, 
Federal state and territory governments have included diabetes as one of the 
National Health Priority Areas (Dunstan et al., 2000).  
 
By world standards, Australia provides excellent opportunities for healthy 
lifestyles (WHO, 2000). However with the modernisation and 
industrialisation of society, diseases such as diabetes and heart disease have 
great impact. Lifestyle changes have also had an unfavourable influence on 
diet, as the consumption of energy-rich foods has increased. Together with a 
reduction in physical activity, this is contributing to an increase in obesity 
which in return is contributing to the increase in diabetes (Barr, et al., 2006).  
 
Measures such as avoiding tobacco usage, doing physical activity, 
maintaining healthy body weight, and eating vegetables and fruits are 
helpful in preventing or delaying DM2 (WHO, 2011a). 
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2.1.4 Complications of Diabetes  
Diabetes can cause a range of complications that lead to disabilities, 
shortened life expectancy and reduced quality of life. As well as personal 
health costs, the disease inflicts a large public health burden (Barr, et al., 
2006). People with diabetes often develop diverse microvascular, 
macrovascular, and neuropathic complications. It has a number of systemic 
effects, including skin disorders, peripheral vascular disease, increased bone 
fragility, diabetic nephropathy, diabetic cardiomyopathy, coronary artery 
disease, cerebrovascular disease and diabetic neuropathy. As raised blood 
glucose concentrations diminish the ability of the body to combat infection, 
infections of the skin are particularly common (Ariffin, Hill, & Leigh, 1992; 
Williams & Pickup, 2004) . 
 
Mortality caused by diabetes is predominantly due to cardiovascular disease. 
Long term microvascular complications lead to increase in morbidity: 
diabetic retinopathy is the leading cause of premature blindness worldwide 
(Centres for Disease Control and Prevention, 1993), diabetic nephropathy is 
the most common cause of end stage renal failure (Bergrem & Leivestad, 
2001) and diabetic neuropathy is the leading cause of non-traumatic lower 
limb amputation (Patout, Birke, Horswell, Williams, & Cerise, 2000). These 
changes are related to age of the patients and to duration of the disease. 
 
Diabetes affects all parts of the eye. It has important ocular complications, 
including diabetic keratopathy, diabetic retinopathy, glaucoma, diabetic 
cataract, anterior ischemic optic neuropathy, iridopathy, recurrent styes and 
ocular motor nerve palsies (Ariffin, et al., 1992; Howells, 1953; Williams & 
Pickup, 2004). Variations in blood glucose level change refractive 
components and thus lead to unstable refraction (Okamoto, et al., 2000). 
Diabetic keratopathy includes recurrent erosions, delayed wound healing, 
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ulcers and oedema of the cornea. The cornea suffers from neuropathy with 
loss of corneal sensation and innervation (Lutty, 2013). Diabetic retinopathy 
is one of the leading causes of blindness in the world. It is generally regarded 
as a vascular disease. Classically, it presents with micro-aneurysms and small 
haemorrhages in the early stages. Several studies have indicated that neural 
loss may occur before any sign of vasculopathy can be observed (Barber et 
al., 1998; Bearse, 2006; Biallosterski, et al., 2007; Van Dijk, et al., 2010).  
 
2.2 Overview of the Eye 
The human eye consists of outer, middle and inner layers (Figure 2:1). The 
outer layer consists of the anterior cornea and posterior sclera. The cornea is 
transparent and approximately spherical with a radius of curvature of about 
8 mm. It has a tear film in front of its outer surface, and has distinctive parts 
from the outer surface: the epithelium, Bowman’s membrane, the stroma, 
Dua’s layer, Descemet’s membrane and endothelium. The middle layer is the 
uveal tract composed of anteriorly iris, posteriorly choroid, and 
intermediately ciliary body which has the ciliary muscle. Behind the iris is a 
transparent, biconvex structure covered with a capsule called the lens. The 
inner layer is the light-sensitive retina which is connected to the brain by the 
optic nerve. The thickness of the retina varies from about 166 µm at the 
foveal centre to about 277 µm in the nasal area (Grover, Murthy, Brar, & 
Chalam, 2010). The retina consists of a number of cellular and pigmented 
layers and a nerve fibre layer. The light-sensitive cells (rods and cones) are at 
the back of the retina and the light must pass through the rest of the retina to 
reach them.  
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The inside of the eye is divided into three chambers: the anterior chamber 
between cornea and iris which contains the fluid known as the aqueous 
humour, the posterior chamber between iris, ciliary body and lens, and the 
vitreous chamber between lens and retina which contains the vitreous 
humour.  
 
Image forming light enters the eye through the cornea, and is refracted by 
the cornea and the lens to be focussed at the retina. The diameter of the 
incoming beam of light is controlled by the iris, which forms the aperture 
stop of the eye. The image of the aperture stop in the cornea is the entrance 
pupil, usually called the pupil. 
 
 
Figure 2:1 The horizontal section of the right eye as seen from above. [Adapted from 
Atchison & Smith (2000d)]. 
 
The power of the lens can be changed when the eye needs to focus at 
different distances. This process is called accommodation. Various theories 
have been proposed for the mechanism of accommodation but Helmholtz’s 
theory is widely accepted (Atchison, 1995). According to Helmholtz’s theory, 
during accommodation when the eye changes focus from a far to near object, 
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the multiunit ciliary muscle contracts, and the tension on the zonules is 
released. The crystalline lens takes a more rounded shape because of the 
elastic properties of the lens capsule. In the unaccommodated form, when the 
focus of the eye at its far point, the ciliary muscle is relaxed and the lens is 
flattened due to tension of the zonules (Atchison & Smith, 2000a). 
 
 
Figure 2:2 Typical accommodative stimulus-response function of a young adult. 
 
Usually an accommodation stimulus-response curve shows a lead of 
accommodation response for distance vision, a linear portion with a slope of 
less than one and a saturation point corresponding to the amplitude of 
accommodation (Figure 2:2). 
 
The age related optical changes in the human eye increase monochromatic 
aberrations (Artal, Berrio, Guirao, & Piers, 2002), increase intraocular light 
scattering and reduce light transmission (Cavallotti & Cerulli, 2010). These 
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contribute to losses in visual acuity and contrast sensitivity with age, 
although neural factors also play a role (Elliott et al., 2009). 
 
Some studies have found increase in anterior corneal radius of curvature 
with increasing age (Hayashi, Hayashi, & Hayashi, 1995) but other have not 
found this (Atchison, et al., 2008; Douthwaite, Hough, Edwards, & Notay, 
1999). The average anterior cornea is slightly prolate (negative asphericity) 
(Atchison & Smith, 2000a). Dubbelman et al. (2006) found a decrease in 
negative asphericity with age but Atchison et al. (2008) found no change. 
 
The human lens grows throughout life with considerable changes in size, 
shape,  mass and stiffness (loss of elasticity). The young lens is soft and easy 
to deform, while the old lens is stiffer and unable to be deformed (Heys, 
Cram, & Truscott, 2004). The equivalent refractive index, the constant index 
that gives the same lens power as the gradient index distribution, decreases 
with age (Atchison, et al., 2008). In the unaccommodated state, lens thickness 
increases (Brown, 1974; Dubbelman & Van der Heijde, 2001a) and anterior 
chamber depth decreases (Brown, 1974; Dubbelman & Van der Heijde, 2001b; 
Koretz, Strenk, Strenk, & Semmlow, 2004) with age at rates of approximately 
0.024 mm/year and 0.011 mm/year, respectively (Atchison, et al., 2008).  
 
The lens has a non-uniform refractive index distribution that increases from 
the lens surface to the nucleus (Atchison & Smith, 2000b). The refractive 
index contributes to the optical power of the lens so that the power of the 
lens is greater than it would be if the lens were homogeneous and had a 
uniform refractive index equal to its peak value in the nucleus. 
Kasthurirangan et al. (2008) showed changes in refractive index distribution 
with age and accommodation such that the gradient is altered while the 
central and edge refractive indices are unaffected. With increasing age, 
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refractive index change is restricted to smaller regions of the peripheral lens 
while with accommodation the change of index occurs over a larger part of 
the lens. These changes explain the lens paradox, which is that despite the 
lens curvatures increasing with age, most eyes do not become more myopic. 
The study showed a contribution of the gradient index distribution to 
accommodation as proposed by Gullstrand and incorporated in his No. 1 
schematic eye (Gullstrand, 1909). 
 
The human lens gradually loses its ability to accommodate with age. 
Presbyopia results when the loss is sufficient to interfere with close tasks 
such as reading. Total loss is complete around 55 years of age. Ramsdale and 
Charman (1989) found linear decrease of accommodation in individuals with 
age. Several studies have measured loss of accommodation with age 
(Atchison & Smith, 2000a) been proposed to explain loss of accommodation 
with age. These can be divided into lenticular and extralenticular theories. In 
the former, the loss is due to decreasing ability of the lens and/or capsule to 
deform or to the lens’ changing geometrical relationship with the zonules 
and ciliary body. In the latter there are changes in the supporting structures, 
such as weakening ciliary muscle, increase in connective tissue preventing 
the muscle from moving, or loss of tissue elasticity. The  preferred theory 
remains the lenticular theory of the lens becoming less deformable with age 
(Atchison, 1995).  
2.3 Influence of Diabetes on Biometry and Optics of the Human Eye 
Diabetes mellitus has considerable consequences for the biometry of the eye. 
In patients with DM, the lenses are more convex, thicker and have decreased 
equivalent refractive index as compared to the lenses of non-diabetic eyes. 
Amplitude of accommodation is reduced in diabetic eyes. 
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Some people with diabetes complain of blurred vision during 
hyperglycaemia; the mechanism of these symptoms is unclear. Some authors 
(Huggert, 1953; Saito, et al., 1993; Wiemer, et al., 2008b), but not others 
(Giusti, 2003; Okamoto, et al., 2000; Planten, Kooyman, Vries, & Wolderingh, 
1979), have found biometrical changes during hyperglycaemia. Some authors 
have suggested that transient refractive changes occur due to changes in 
lenticular refractive index including its gradient (Duke-Elder, 1925; Giusti, 
2003; Mäntyjärvi, 1988; Planten, 1981). Transient changes might result from 
some combination of change in lenticular refractive index, change in aqueous 
and/or vitreous indices, choroidal thickness changes, and tonus of ciliary 
muscle. 
 
An accurate knowledge about the influence of long-term diabetes mellitus on 
the refractive components of the eye is very important. Furthermore, the 
mechanisms underlying blurred vision, refractive changes and reduced 
accommodation may be clarified with an accurate description of the changes 
in the refractive properties of the eye and refractive index distribution in the 
lens during hyperglycaemia in people with diabetes.  
 
2.3.1 Cornea 
Diabetes mellitus has considerable effects on morphology, physiology and 
clinical appearance of the cornea (Sánchez-Thorin, 1998), leading to increased 
corneal fluorescence (Ishiko et al., 2000; Van Schaik, Coppens, van den Berg, 
& Van Best, 1999), impaired epithelial barrier function (Gekka et al., 2004), 
decreased corneal sensitivity (Cousen, Cackett, Bennett, Swa, & Dhillon, 
2007), and altered corneal endothelial morphology (Roszkowska, Tringali, 
Colosi, Squeri, & Ferreri, 2000; Schultz, Matsuda, Yee, Edelhauser, & Schultz, 
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1984) and permeability (Sánchez-Thorin, 1998). Diabetes mellitus causes 
changes in corneal endothelial cell morphology similar to those induced by 
ageing (Busted, et al., 1981; Carlson, Bourne, McLaren, & Brubaker, 1988; 
Chang & Hu, 1993). Using confocal biomicroscopy, Morishige et al. (2001) 
and Takahashi et al. (2007) found greater light scattering in the corneal 
epithelial basement membrane zones of people with diabetes than those of 
non-diabetic people.  
 
Several studies have reported greater central corneal thickness in adults and 
children with diabetes than in non-diabetic adults and children (Busted, et 
al., 1981; Larsson, Bourne, Pach, & Brubaker, 1996; Lee, et al., 2005; Ozdamar 
et al., 2010; Roszkowska, et al., 2000; Storr-Paulsen, Singh, Jeppesen, 
Norregaard, & Thulesen, 2014; Su et al., 2008) but some have not (Inoue, et 
al., 2002; Keoleian, et al., 1992; Wiemer, et al., 2007; Ziadi, et al., 2002). Some 
authors (Su, et al., 2008; Zengin, Özbek, Arikan, Durak, & Saatci, 2010), but 
not all (Pierro, Brancato, & Zaganelli, 1993) have found a positive correlation 
between corneal thickness and HbA1c levels in people with diabetes. Zengin 
et al. (2010) found people with diabetes having HbA1c levels > 7% had higher 
central corneal thickness than those with with HbA1c levels < 7%.  
 
Wiemer et al. (2007) found smaller posterior radii of curvature in people with 
diabetes than in people without diabetes without significant differences in 
the anterior radius of curvature, but this did not affect the overall corneal 
power. 
 
2.3.2 Aqueous Humour 
With ageing, there is no change in spectral transmission and scattering in 
aqueous humour (Atchison & Smith, 2000c). Aqueous humour flow 
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decreases with age (Toris, Yablonski, Wang, & Camras, 1999) and this is 
more prononuced in people with diabetes than in people without diabetes 
(Lane et al., 2010; Lane et al., 2001). 
 
2.3.3 Pupil 
The natural pupil becomes smaller with increase in age (Watson & Yellott, 
2012; Winn, Whitaker, Elliott, & Phillips, 1994), and is smaller in people with 
diabetes than those without diabetes, particularly at low light levels 
(Bahrami & Goncharov, 2014; Cahill, Eustace, & de Jesus, 2001; Hreidarsson, 
1982; Lei et al., 2011; Yang, Yu, & Yao, 2006; Zaczek & Zetterström, 1998).  
 
2.3.4 Lens 
Age related changes in the lens and to the depth of the anterior chamber are 
more pronounced in people with diabetes than in non-diabetic people (Bron, 
et al., 1993; Brown & Hungerford, 1982; Fledelius & Miyamoto, 1987; 
Løgstrup, et al., 1996; Løgstrup, et al., 1997; Pierro, et al., 1996; Saw, et al., 
2007; Sparrow, et al., 1992; Wiemer, et al., 2008d). These changes are 
dependent on diabetes duration (Løgstrup, et al., 1996; Sparrow, et al., 1990; 
Wiemer, et al., 2008c).  
 
With increasing age, the lens becomes thicker and the anterior chamber 
depth decreases (Atchison, et al., 2008; Dubbelman & Van der Heijde, 2001b). 
Wiemer et al. (2008c) found different impacts of DM1 and DM2 on lens 
biometry. They found significantly thicker nuclei, anterior cortices and 
posterior cortices in DM1 than in non-diabetic people. In DM2, they found 
significant thicker nuclei than non-diabetic people but thinner posterior 
cortices than in non-diabetic people. 
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Surface curvatures are greater in people with diabetes than in people without 
diabetes (Sparrow, et al., 1992; Wiemer, et al., 2008d) although Wiemer et al. 
found that this occurred in DM1 only. Equivalent refractive index of the lens 
is lower in DM1 than without diabetes, and compensates for the steeper 
surface curvatures so that there is no significant change in lens power 
(Wiemer, et al., 2008d). For DM1, the age related change in equivalent 
refractive index is nearly twice that of controls at −0.0007/year (Wiemer, et 
al., 2008d), but no information is available about changes in refractive index 
distribution that cause the reduction in equivalent refractive index. In this 
case, the magnetic resonance imaging techniques employed by Jones et al. 
(2005) and Kasthurirangan et al. (2008) can be useful. Also, equatorial 
diameter increases with ageing according to Kasthurirangan et al. (2011), but 
not by Strenk et al. (1999); no information is available on diameters in 
diabetes.  
 
People with diabetes have lower lens light transmission than people without 
diabetes (Davies & Morland, 2002; Sparrow, et al., 1990; Van Best, et al., 1985; 
Zagers, et al., 2005). Van Best et al. (1985) reported an average 0.5% decrease 
of lens light transmission in the people with diabetes for each year of 
diabetes measured with fluorophotometry. The decrease occurred 15 years 
earlier in diabetic people with more than 10 years of diabetic duration than in 
non-diabetic people.  
 
Both in vivo (Davies & Morland, 2002; Lutze & Bresnick, 1991) and in vitro 
(Kessel, et al., 2010) studies have reported that lenses of people with diabetes 
are yellower than those of people without diabetes.  
 
People with diabetes have lower amplitudes of accommodation than non-
diabetic people (Moss, et al., 1987; Yamamoto, et al., 1989). This might be due 
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to a change in refractive index distribution such as occurs in ageing, or to an 
overall decrease in refractive index throughout the lens. Either could explain 
the reduction in accommodation with age if the change in lens shape upon 
accommodation is not affected. 
 
2.3.5 Vitreous 
In an in vitro study Sebag (1993) found accelerated age related changes in 
diabetic vitreous compared with that of aged-matched non-diabetic vitreous, 
with more fibrous tissue and liquefaction in the former. A nine years old 
vitreous with five years of diabetes duration was morphologically similar to 
that of fifty six years old non-diabetic vitreous.  
 
2.3.6 Retina and Choroid 
Generally, an increase in retinal thickness has been reported in people with 
long-term DM and advanced stages of retinopathy (Esmaeelpour, et al., 2011; 
Goebel & Kretzchmar-Gross, 2002). Esmaeelpour et al. (2011), but not 
Asefzadeh et al. (2008), observed retinal thinning in people with diabetes 
without diabetic retinopathy. 
 
Hernández et al. (2010) found an increase in macular thickness during 
reduction of hyperglycaemia in 18 out of 24 eyes of people with diabetes and 
blurred vision. However, Prakash et al. (2011) found macular thinning 
during reduction of hyperglycaemia. Jeppesen et al. (2007) and Wiemer et al. 
(2008a) induced hyperglycaemia in non-diabetic people and found no 
difference in retinal thickness between hyperglycaemic and euglycaemic 
states.  
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Davies & Morland (2002) and Lima et al., (2010) found lower macular 
pigment optical density in people with diabetes than in people without 
diabetes. However, Zagers et al., (2005) did not find reduced macular optical 
pigment density in DM than in aged matched normals. Esmaeelpour (2011), 
but not Xu et al. (2013), found lower choroidal thickness in people with 
diabetes than in age-matched people without diabetes.  
 
2.3.7 Axial Length  
Pierro et al., (1999) found no difference in axial lengths of people with 
diabetes, but without retinopathy, and of non-diabetic people. They found a 
negative correlation between diabetic retinopathy and axial length. To 
reduce the effect of myopia, they selected non-myopic diabetic and non-
myopic non-diabetic people with axial lengths less than 24 mm. As there was 
no information about the refractive status, this study provides little useful 
information.  
 
2.3.8 Refraction 
People with diabetes have both long term (chronic) and short term (acute) 
alterations in their refractive status, but the mechanisms are poorly 
understood (Cavallerano, 1990). Long term refractive changes occur over 
years and short term changes occur from a few minutes to months. 
 
2.3.8.1 Long Term Refractive Changes 
Higher prevalence of myopia has been observed in people with diabetes than 
in people without diabetes (Fledelius, 1983, 1986; Jacobsen, Jensen, Lund-
Andersen, & Goldschmidt, 2008; Mäntyjärvi, 1988). Fledelius (1983) found 
38% myopia in 381 people with diabetes and 27.5% myopia in 1035 non-
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diabetic people. Higher prevalence of low order late onset (≤ 1D , ≥ 20 years) 
myopia has been reported in people with diabetes than in people without 
diabetes (Fledelius, 1986). Poor glycaemic control has been considered a risk 
factor for higher prevalence of myopia in people with diabetes (Jacobsen, et 
al., 2008; Morgan, Ohno-Matsui, & Saw, 2012).  
 
Many etiological factors are involved in myopia development (Morgan, et al., 
2012). Age related lens changes are more pronounced in people with diabetes 
than in people without diabetes, which may also contribute to development 
of myopia. These biometrical changes are more evident in DM1 people 
(Wiemer, et al., 2008c) than in DM2 people and this might be the reason for 
more myopic refractions in the former group (Jacobsen, et al., 2008).  
 
2.3.8.2 Short Term Refractive Changes 
It is thought that in people with diabetes, hyperglycaemia results in myopia 
(Fledelius & Miyamoto, 1987; Mäntyjärvi, 1988) and hyperopia has been 
reported during reduction of hyperglycaemia (Giusti, 2003; Lin, et al., 2009; 
Okamoto, et al., 2000; Saito, et al., 1993), but some investigators have 
observed both myopic and hyperopic shift during hyperglycaemia (Sonmez, 
et al., 2005; Wiemer, et al., 2009). Studies and case reports showing these 
short term refractive changes have been summarised in Table 2:1.  
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Table 2:1 Summary of short-term refractive changes in people with diabetes  
 
Author (year) Number of 
participants, 
age range 
(years) 
Measurement techniques Refractive shift 
O’ Brien (1942) 12, 8-28 Retinoscopy Hyperopia during hyperglycaemia reduction 
Huggert (1954) 23, not 
reported 
not reported Myopia with hyperglycaemia and hyperopia 
during hyperglycaemia reduction  
Rosen (1956) 1, 42 Retinoscopy Hyperopia during hyperglycaemia 
Turtz & Turtz 
(1958) 
1, 22 Retinoscopy Myopia and weakness of accommodation 
during hyperglycaemia 
Nauheim (1962) 1, 21 Retinoscopy Myopia during hyperglycaemia 
Marmor (1973) 1, 7 Retinoscopy Hyperopia during hyperglycaemia reduction 
Fledelius et 
al.(1990) 
15, 19-53 Subjective refraction, 
keratometer, ultrasound 
Hyperopia (nine participants), myopia (two 
participants) and four remain stable during 
reduction of hyperglycaemia 
Imai & Matsuda 
(1992) 
10, 48-64 not reported Hyperopia during hyperglycaemia reduction 
Saito et al. (1993) 5, not 
reported 
Auto-refractokeratometer, 
ultrasound 
Hyperopia during hyperglycaemia reduction 
Willi (1996) 1, 48 not reported Hyperopia during hyperglycaemia reduction 
Okamoto et al. 
(2000) 
14, 27-72 ultrasound Hyperopia during hyperglycaemia reduction 
Giusti (2003) 20, 15-19 Auto-Refractokeratometer, 
ultrasound 
Hyperopia during hyperglycaemia reduction 
Srivastava (2003) 1, 40 not reported Hyperopia during hyperglycaemia reduction  
Sonmez et al. 
(2005) 
18, 44-67 Auto-refraction, c-scan 
corneal topography, 
keratometry, corneal 
pachymetry, ultrasound 
Hyperopia (nine participants) and myopia 
(two participants) during reduction of 
hyperglycaemia 
Tai et al. (2006) 24, 38-69 Auto-refractokeratometer, 
Ultrasound, Orbscan II 
Hyperopia (eight participants) during 
hyperglycaemia reduction 
Wiemer (2009) 25, 18-80 Aberrometry, Scheimpflug 
imaging 
Both hyperopia (four participants) and 
Myopia (five participants) during 
hyperglycaemia 
Lin et al. (2009) 5, 39-58 
 
Auto-refractokeratometer, 
ultrasound 
Myopia with hyperglycaemia and hyperopia 
during hyperglycaemia reduction 
Li et al. (2010) 5, 36-57 ultrasound Hyperopia during hyperglycaemia reduction 
Hernández et al. 
(2010) 
26, 24-61 Auto-Refractor, OCT Myopia (seven participants) during 
hyperglycaemia 
Agardh et al. 
(2011) 
53, 42-56 Auto-Refractor 0.4 D mean intraindividual variability in 
spherical equivalent refraction in 10 
participants at 4 different visits in a month 
and stable in th other 43 participants 
Huntjens et al. 
(2012)   
21 DM1, 21 
DM2, not 
reported 
 
Autorefraction None - fluctuations in glucose levels over 12 
hours not associated with refraction changes 
Sekeroglu et al. 
(2013) 
1, 55 not reported Hyperopia during hyperglycaemia reduction 
 
Most of these studies showed positive correlation between the maximum 
hyperopic change and HbA1c level on admission. The hyperopic change 
started within few days or weeks of hyperglycaemia treatment and reverted 
to the baseline within months (Giusti, 2003; Li, et al., 2010; Lin, et al., 2009; 
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Okamoto, et al., 2000). Okamato et al. (2000) found that time taken by the 
hyperopic change to reach the peak and recover during hyperglycaemia 
depends upon the maximum hyperopic change (and initial plasma glucose 
concentration). Saito et al. (1993) found that these effects are similar in both 
eyes of the same individual at high and low fasting plasma glucose levels. 
Larger refractive changes have been observed in people with diabetes having 
considerable myopia (Lin, et al., 2009; Okamoto, et al., 2000) with Lin et al. 
(2009) reporting a participant with high myopia showing a hyperopic change 
of 6.25 D in both eyes. 
 
Small but significant biometrical changes have been found by some authors 
during hyperglycaemia (Fledelius, et al., 1990; Saito, et al., 1993; Tai, et al., 
2006) and during reduction of hyperglycaemia (Sonmez, et al., 2005). Sonmez 
et al. (2005) found increase in power of the flatter corneal meridian through 
c-scan corneal topography. They also observed a negative correlation 
between anterior chamber depth and change in refraction. Saito et al. (1993) 
observed an increase in lens thickness through photography and 
ultrasonography, and decrease in anterior chamber depth through 
photography but not through ultrasonography. Tai et al. (2006) found a 
decrease in anterior chamber depth with Orbscan II but not through 
ultrasonography and Wiemer et al. (2009) found a decrease in anterior 
chamber depth with Scheimpflug camera  only in eight of their 25 
participants. Fledelius et al. (1990) observed an increase in lens thickness and 
a decrease in anterior chamber depth through ultrasonography. Contrary to 
these findings, others found no biometrical changes (Giusti, 2003; Li, et al., 
2010; Lin, et al., 2009; Okamoto, et al., 2000). Several of the authors inferred 
that changes in refractive index, particularly lens refractive index, might be 
responsible for refractive changes in people with diabetes.  
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Huntjens et al. (2012) investigated how short-term changes in blood glucose 
levels affected refractive and ocular biometry (central corneal thickness, 
anterior chamber depth, lens thickness, axial length and ocular aberrations) 
during the day. While “minor changes of marginal statistical or optical 
significance were observed for some parameters”, they concluded that the 
normal short-term fluctuations in blood glucose level of people with diabetes 
are not usually associated with acute changes in refraction or ocular 
aberrations.  
 
In a theoretical study, Charman et al. (2012) considered the possible 
lenticular origin of transient hyperopic refractive shifts. Refractive shifts of 
up to a few diopters could be explained by reduction in refractive index near 
the lens centre and alteration in the rate of change between centre and 
surface, so that most of the index change occurred closer to the lens surface. 
Restoration of the original refraction depended on further change in the 
refractive index distribution with more gradual changes in refractive index 
from the lens center to its surface. 
 
Table 2:2 is a summary of studies in which hypoglycaemia or 
hyperglycaemia were induced. The studies were conducted on people with 
different types of diabetes, with large variations of glucose level, variable 
durations of diabetes, different methods of treatment and different systemic 
diseases which affect the refractive components. They did not consider very 
short term variations (e.g. within a day or from day to day) in blood glucose 
level.  
 
To find the effects of glucose fluctuations on refraction in people with 
diabetes, hyperglycaemia and hypoglycaemia were induced in people with 
diabetes (Gwinup & Villarreal, 1976; Steffes, 1999)(Table 2:2). Gwinup & 
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Villarreal (1976) induced hyperglycaemia in ten people with diabetes, four 
having monocular aphakia. The aphakic eyes showed hyperopic shifts and 
phakic eyes showed myopic shifts (maximum 0.65 D) within 15 minutes. 
They supposed that retinal swelling reducing the distance between cornea 
and retina may be responsible for hyperopic shift, and lens swelling may be 
responsible for myopic shift. Steffes (1999) induced hypoglycaemia in a 
diabetic participant from 5.3 mmol/l (95 mg/dl) to 2.8 mmol/l (50 mg/dl), and 
observed maximum reduction in myopia of 0.25 D myopia within 40 mins 
from initiation of hypoglycaemia. This participant took a similar time to 
regain the base line refraction when glucose was administered. It was 
supposed that decrease of glucose in aqueous caused this refractive shift.  
 
Furushima et al. (1999) and Wiemer et al. (2008b) investigated the short term 
effects of hyperglycaemia on biometry of healthy individuals. Myopic shift 
was found by Furushima et al. (1999) with increase in lens thickness and 
decrease in anterior chamber depth while Wiemer et al. (2008b) found 
hyperopic shift in one participant and no changes for four other participants. 
The participant with hyperopic shift showed 1.96 mm decrease in anterior 
lens radius of curvature and 0.014 decrease in lens equivalent refractive 
index. This participant received twice the oral glucose dose (150 mg glucose) 
compared with the others because of a delayed rise in glucose level.   
  
Wiemer et al. (2008b) proposed that equivalent refractive index and radius of 
curvature changes are responsible for hyperopic shift while Furushima et al. 
(1999) argued that lens thickness is responsible for myopic shift.  
 
Summary 
The above studies do not show a clear picture about the mechanism of the 
short term refractive changes in people with diabetes. The sensitivity of the 
     29 | P a g e |  
Chapter 2: Literature Review 
instruments is important in these measurements. Many of the authors 
believed that change in refractive index, probably alteration in lens gradient 
refractive index, plays a major role. 
 
Table 2:2 Summary of the refractive changes after induction of hyperglycaemia or 
hypoglycaemia in people with and without diabetes. 
Author (Year) Number of 
participants, age 
range (years) 
Glucose changes Mean change in 
refraction 
Participants 
Biometrical changes 
Gwinup & 
Villarreal (1976) 
10, not reported Hyperglycaemia Four aphakic diabetic 
participants showed 
hyperopic shifts, six 
phakic diabetic 
participants showed 
myopic shifts 
not reported 
Furushima et al. 
(1999) 
7, 18-29 Hyperglycaemia −1.9 D (1.9 ± 0.39 D) 
Non-diabetic participants  
Increase in lens 
thickness (1.14 ± 0.41 
mm) and decrease in 
anterior chamber 
depth (1.21 ± 0.50 mm) 
Steffs (1999) 1, not reported Hypoglycaemia 0.25 D less myopic 
Diabetic participant 
not reported 
 
Wiemer et al. 
(2008b) 
5, 21-33 Hyperglycaemia One participant showed 
0.4 D hyperopic shift 
Non-diabetic participants 
Decrease in anterior 
lens radius of 
curvature (1.96 mm) 
and decrease in 
equivalent refractive 
index (0.014) 
 
2.3.9 Higher-order Aberrations 
With increasing age, higher-order aberrations increase. This is attributable to 
the lens as there is little age-related change in corneal optics. Shahidi et al. 
(2004) found approximately 33% greater higher-order aberrations with 6 mm 
pupils in people with diabetes mellitus than in non-diabetic people. 
Valeshabad et al. (2014) found greater higher order root-mean square 
aberrations and overall 4th-order aberrations in a group of people with 
diabetes than in a control group for 5 mm pupils. Wiemer et al. (2009) 
examined higher-order aberrations with 5 mm pupils during hyperglycaemia 
and the normal glucose state in 25 people with diabetes. In four people 
(18%), they found an increase in higher-order aberrations during 
hyperglycaemia. In only one of five normal participants, hyperglycaemia 
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induction increased spherical aberration (change +0.08 µm, 5.7 mm pupils) 
(Wiemer, et al., 2008b).  
 
Calvo-Maroto et al. (2014) reported total ocular, corneal and internal higher-
order aberrations in small groups of type 1 and type 2 diabetes, but without a 
control group. Internal aberrations were determined as the differences 
between ocular and corneal aberrations. There were no significant 
differences between the groups. The aberrations were very high for 5mm 
pupils, with ocular higher-order root-mean-squared aberrations of  0.63 ± 
0.23 μm and 0.53 ± 0.25 μm for DM1 and DM2, but there was no control 
group . In addition, it is not clear whether the ocular and corneal aberrations 
used the same reference axis. 
  
When monochromatic higher-order aberrations are corrected with large 
pupils, visual acuity improves by approximately 0.1 to 0.15 log minutes of 
arc resolution (1.2-1.4x)(Guo, et al., 2008) and contrast sensitivity can 
improve up to 6 times (Liang, et al., 1997). If there are greater higher-order 
aberrations in people with diabetes than in people without diabetes, it is 
expected that correcting higher-order aberrations would improve visual 
performance more in the former than in the latter. 
 
2.3.10 Straylight 
People with diabetes complain of visual disturbances but the mechanisms are 
not well understood (Huntjens, et al., 2012; Wiemer, et al., 2009). Having 
visual acuity of 6/6 or better is not enough to ensure good vision (De Wit, 
Franssen, Coppens, & van den Berg, 2006; Michael et al., 2009; Van Der 
Meulen et al., 2012). Real-world visual scenarios with bright distant light 
sources and low contrast surroundings cannot be represented by visual 
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acuity and contrast sensitivity measurements. These assess vision due to 
small details of point spread function (from 1 to 10 min arc) and do not 
account for point spread function information beyond 60 min arc produced 
by straylight (van den Berg, Franssen, & Coppens, 2010). Straylight is 
responsible for glare while driving at night, perception of halos around 
bright lights, facial recognition problems, hazy vision and lowered contrast 
(Elliott & Bullimore, 1993).  
 
Straylight in healthy young people is due to physiological imperfections in 
ocular structures. The cornea and lens contribute 2/3 of the straylight with 
the other 1/3 contributed by the iris, sclera, vitreous and fundus (van den 
Berg, 1995). Straylight is approximately constant until 45 years of age and 
then increases. According to van den Berg (1995), it can be described 
according to the formula 
 
    log(s) = P + log [1 + (age/65)4]...... (2.1) 
 
where P = 0.90 is the asymptomatic value for log(s)  at lower ages, and 65 
years is the age at which the straylight doubles relative to that of healthy 
young people. Greater straylight occurs when cataract is present than when 
it is not (Bal, Coeckelbergh, Van Looveren, Rozema, & Tassignon, 2010; Van 
Der Meulen, et al., 2012) and straylight reduces after cataract surgery 
(Rozema, Coeckelbergh, Caals, Bila, & Tassignon, 2013). Conditions such as 
corneal oedema, keratoconus, Fuchs’ corneal dystrophy, and vitreous floaters 
are also responsible for increasing straylight (Jinabhai, O’Donnell, 
Radhakrishnan, & Nourrit, 2012; Mura et al., 2011). 
 
Morishige et al. (2001) and Takahashi et al. (2007) found greater light 
scattering in the corneal epithelial basement membrane in people with 
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diabetes than in people without diabetes when measured objectively through 
confocal microscopy. As greater age related optical changes seem to be found 
in people with diabetes than in people without diabetes, we expect greater 
straylight in people with diabetes than in people without diabetes. 
 
2.4 Influence of Diabetes on Retinal Functions and Amplitude of 
Accommodation 
Abnormal retinal functions have been found in people with diabetes 
(Fortune, Schneck, & Adams, 1999; Holm & Adrian, 2012; Lecleire-Collet et 
al., 2011; Shimada, Li, Bearse, Sutter, & Fung, 2001; Tyrberg, Ponjavic, & 
Lövestam-Adrian, 2005). Multifocal electroretinograms have delays in 
implicit time (Fortune, et al., 1999; Holm & Adrian, 2012) and absence of the 
3rd position waveform in the second order component (Palmowski, Sutter, 
Bearse, & Fung, 1997; Tyrberg, et al., 2005).  
 
 Amplitude of Accommodation 
 
Several studies have reported lower amplitudes of accommodation in people 
with diabetes than in age matched controls (Cavallerano, 1990; Moss, et al., 
1987; Spafford & Lovasik, 1986; Yamamoto, et al., 1989). Most of these studies 
used narrow age ranges, and thus did not investigate the rate of change with 
age. Apart from the study of Yamamoto et al. (1989), these were all subjective 
techniques and were thus affected by depth-of-focus which overestimates 
amplitude.  
 
Spafford & Lovasik (1986) used a Lovasik-Woodruff dynamic 
accommodation meter to determine the monocular amplitude of 
accommodation subjectively via a push-up method in thirty DM1 and thirty 
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age-matched non-diabetics and found significant lower amplitudes of 
accommodation in the former. Using a monocular push-up method, 
Mantyaryi & Nousiainen (1988) found 9.9 D mean amplitude of 
accommodation in children with diabetes, approximately 1.9 D less than for 
non-diabetic children. Moss et al. (1987) indicated that subjective amplitude 
loss in diabetes could be accounted for by adding the duration of diabetes to 
the age of the participants. Pawelski & Gliem (1971), and Braun et al. (1995) 
found that duration of diabetes was approximately 60%,  46%, and 40% as 
important, respectively, as age in reducing amplitude. Yamamoto et al. 
(1989) found smaller accommodative amplitudes in people with diabetes 
than in non-diabetics using an indirect method based on pattern reversal 
visually evoked cortical potentials. 
 
Related to reduction in amplitude of accommodation with diabetes, Leffler et 
al. (2008) found that the preferred reading addition in a 43-71 year 
population was significantly related to the duration of diabetes, although not 
the presence of diabetes, such that the addition was predicted to increase by 
0.06 D/year of diabetes duration.  
 
Accommodative spasm has been reported during hyperglycaemia in people 
with diabetes, and it disappeared after recovery (Marmor, 1973; Melani & 
Battistini, 1963; Rosen, 1956; Turtz & Turtz, 1958).  
 
2.5 Techniques 
A variety of techniques has been used for measuring ocular biometry in 
association with diabetes. These include ultrasound, Scheimpflug imaging 
and (recently) partial coherence interferometry for intra-ocular distances, 
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Placido disk imaging and Scheimpflug imaging for anterior corneal 
topography and Scheimpflug imaging for posterior corneal topography, and 
Scheimpflug imaging for lenticular shape and equivalent refractive index. 
Scheimpflug imaging is versatile in its application and will be described in 
section 3.4.5.2. I will use the method of phakometry instead of Scheimpflug 
imaging to determine lenticular shape and equivalent refractive index 
(section 3.5.5).  
 
There are assumptions involved in the different techniques, including the 
refractive indices of different media and particularly that of the lens. This 
suggests that determination of the refractive index distribution of the 
diabetic lens is of considerable importance, and a magnetic resonance 
imaging method of doing this will be described in section 3.5.6.  
 
Lens yellowing has been determined by fluorophotometry and flicker 
photometry, and an application of the latter will be described in section 3.5.4. 
Aberrometry has been used recently in people with diabetes (section 2.3.9). 
In combination with corneal topography, it will be used to determine corneal 
and internal aberration components (section 3.5.2). The aberrometer will also 
be adapted to providing objective amplitude of accommodation 
measurement (section 3.5.3). An easy-to-use instrument, the C-Quant, has 
recently become available for straylight estimates (section 3.5.1). 
 
2.6 Summary 
Most of the previous studies on the influence of diabetes on the optics of the 
eye included participants with a considerable range of severity of 
complications including diabetic retinopathy. Aberrations were measured 
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with dilated pupils, and there is no information about intra-ocular 
contributions to these aberrations. Subjective measures of amplitude of 
accommodation in previous studies were affected by depth of focus and 
relative distance magnification, and there is need for objective measurements 
of amplitude of accommodation. Ocular scattering has been studied in the 
cornea with confocal microscopy, but no information is available about 
whole eye straylight. There is no information about lens diameter and the 
lens refractive index distribution in people with diabetes. 
 
Lower amplitudes of accommodation in people with diabetes might be due 
to a change in refractive index distribution such as occurs in ageing, or to an 
overall decrease in refractive index throughout the lens. Either could explain 
the reduction in accommodation with age if the change in lens shape upon 
accommodation is not affected. 
 
The hypothesis of this thesis is that eyes of people with diabetes act as older 
eyes than those of people of the same ages without diabetes. For this 
purpose, the thesis has the following aims, as already presented in chapter 1:  
1) To determine whether people with diabetes have greater higher-order 
aberrations than people without diabetes of the same age. 
2) To identify whether loss of accommodation with diabetes can be attributed 
to changes in the lens to which the refractive index distribution 
contributes. 
3) To determine whether diabetic lenses become yellower at greater rates 
than aged-matched normal lenses. 
4) To determine whether refractive index distribution of the diabetic lens is 
different from that of the non-diabetic lens. 
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5) To determine whether corrections to assumed refractive index are needed 
in biometric measurements of diabetic eyes. 
6) To determine whether people with diabetes have more straylight than 
people without diabetes 
Investigating a range of potential ocular factors (such as lens thickness, 
shape, diameter and refractive index distribution) that may contribute to loss 
of amplitude of accommodation will add to our understanding of the 
underlying causes of optical changes in diabetic ocular components. This 
research will also provide insights into the visual problems faced by people 
with diabetes. 
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Chapter 3:  Methodology 
 
Section 3.1 covers participant recruitment, including inclusion and exclusion 
criteria. Section 3.2 gives a statistical justification of the number of 
participants. Section 3.3 presents the data analysis methods. Section 3.4 
includes the standard clinical techniques that were used including visual 
function assessments of colour vision (visual acuity, letter contrast sensitivity 
and subjective amplitude of accommodation), refraction, pupil diameter, slit-
lamp and fundus photography, corneal topography, and partial coherence 
interferometry. Section 3.5 includes specialised techniques of straylight, 
ocular aberrations and their component aberrations, objective amplitude of 
accommodation, flicker photometry for lens yellowing, phakometry, and 
magnetic resonance imaging. Table 3:1 is a list of biometric parameters and 
the techniques by which they were investigated. 
  
This was a controlled, cross sectional observational study. Magnetic 
resonance imaging procedures were conducted by radiographers Aiman Al 
Najjar and Anita Burns at the Centre for Advanced Imaging of the University 
of Queensland. Blood was collected from participants by an experienced 
nurse at the Institute of Health and Biomedical Innovation. Fundus 
photography screening was conducted by fellow graduate student Cirous 
Dehghani. All other procedures were performed by the author at the 
Ophthalmic & Visual Optics and Anterior Eye laboratories at the Institute of 
Health & Biomedical Innovation of Queensland University of Technology. 
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Ethical approval was obtained from the Queensland University of 
Technology and the University of Queensland before the commencement of 
the study (QUT ethics number 1100001182, UQ ethics number 2012000172), 
and written informed consent was obtained from participants after 
explanation of the nature and possible consequences of the study. All 
participants were treated in accordance with the Declaration of Helsinki. 
3.1 Participants  
The majority of participants were recruited from the Longitudinal 
Assessment of Neuropathy in Diabetes using novel ophthalmic Markers 
(LANDMark) study at the Institute of Health and Biomedical Innovation 
(54/74 diabetes, 19/64 non diabetes), and others were recruited through 
advertisement in media, advertisement in university websites and from the 
QUT health clinics. A key strategy of the LANDMark study was to recruit 
participants with type 1 diabetes with no or mild diabetic neuropathy, in 
order to facilitate a longitudinal evaluation of the progression of severity of 
neuropathy. This is essential for the establishment of the predictive validity 
of novel ophthalmic markers of diabetic neuropathy – especially corneal 
confocal microscopy. Consequently, nearly all of the participants recruited 
through LANDMark had low levels of the classic triad of diabetic 
complications – neuropathy, retinopathy and nephropathy.   
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Table 3:1 Biometric parameters and their determination  
Biometric parameter Method or instrument, section 
Spherical equivalent refraction Aberrometer (for screening), 3.4.2 
Anterior corneal radius of curvature Medmont E-300 corneal topographer, 
3.4.5.1 
Pentacam, 3.4.5.2 
Anterior corneal asphericity Medmont E-300 topographer, 3.4.5.1 
Corneal decentration and tilt Medmont E-300 corneal topographer, 
COAS aberrometer, 3.5.2 
Cornea central thickness Lenstar, 3.4.6 
Pentacam, 3.4.5.2 
Posterior corneal radius of curvature Pentacam, 3.4.5.2 
Anterior chamber depth Lenstar, 3.4.6 
Pentacam, 3.4.5.2 
Pupil diameter COAS aberrometer, 3.4.3 
Anterior lens radius of curvature  
Lens equivalent refractive index 
Posterior lens radius of curvature 
Phakometry, 3.5.5.4 
Lens central thickness  Lenstar, 3.4.6 
Lens refractive index distribution 
Lens diameter  
Magnetic resonance imaging, 3.5.6 
Lens equivalent power Phakometry, 3.5.5.4 
Anterior segment length, Lenstar Lenstar, 3.4.6 
Vitreous chamber depth Lenstar, 3.4.6 
Axial length Lenstar, 3.4.6 
 
Participants with a physician diagnosis of type 1 diabetes and using insulin 
were recruited with ages between 19 and 63 years, with mean ages 41 ± 13 
and 42 ± 13 years in people without diabetes and with DM1, respectively. 
Visual functions testing and ocular health assessment included case history 
(including self-reported duration of diabetes), slit lamp biomicroscopy, 
intraocular pressure (I-Care) and colour vision assessment (Lanthony 
desaturated 15). Blood was collected from participants and was sent to 
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laboratory for a HbA1c assay. HbA1c (glycated haemoglobin) provides 
average plasma glucose for the preceding two to three months. Capillary 
blood glucose was measured with an Accu-Chek glucometer through finger 
prick in people with DM1 only. 
 
Participants with corrected visual acuities ≤ 0.1 log minimum angle of 
resolution (logMAR), Pelli-Robson contrast sensitivity scores ≥ 1.65, 
equivalent spherical refraction ≤ ±3.5 D, and normal colour vision were 
included. Participants with mild diabetic retinopathy were included e.g. 
micro-aneurysms, hard exudates, cotton-wool spots, and/or mild retinal 
haemorrhages. For the MRI component of the study, participants were also 
screened according to the standard MRI clinical checklist. The stringent 
criteria were adopted to ensure exclusion of people with cataract and 
moderate to severe diabetic retinopathies, and to minimise the influence of 
refraction on ocular parameters. 
 
For participants recruited directly by me, the right eye was selected where it 
fulfilled the criteria; otherwise the left eye was selected. In the LANDMark 
study, people were examined for the eye on the side of hand dominance; as 
this testing involved contact with the cornea, the other eye was examined on 
the same day where possible. If this eye did not fulfil the criteria and the 
participant was able to return on another day, I tested the better eye. 
 
Participants were excluded from the study with more than mild diabetic 
retinopathy (e.g. soft exudates, venous beading and/or severe retinal 
haemorrhage), retinal diseases, glaucoma, uveitis, ocular trauma or surgery, 
epilepsy, endocrine disorders (except DM1), hypertension, neurological or 
psychiatric disorders, anaemia, contact lens wear and cataract (posterior sub-
capsular, cortical and nuclear of grades higher than 1). Slit lamp photographs 
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and C-Quant values (straylight > 1.60 log(s) was excluded) were used to 
classify participants with and without cataract. For amplitude of 
accommodation measurements (section 3.5.3.), participants using systemic 
medications with known accommodation effects or central nervous system 
effects were excluded.  
 
The anticipated time for standard clinical and specialised testing was 2 - 4 
hours, with an extra hour (and transport time) required for those undergoing 
magnetic resonance imaging. 
 
There were different numbers of participants for different tests due to 
participant time availability, financial considerations and criteria for some 
tests (e.g. amplitude of accommodation). Some participants were recruited 
on the day of participation in the LANDMark study, but were not able to 
devote the full 2 - 4 hours to our study on the same day and were not also 
able to come again.  
 
Magnetic resonance imaging was performed in a limited number of 
participants due to financial limitations. An additional twenty people, 
mainly young adults, performed most tests (including magnetic resonance 
imaging). While it is most likely that they did not have diabetes, they were 
excluded because HbA1c assays were not able to be performed.  
 
All potential participants performing MRI underwent a checklist. This 
checklist included pacemaker or artificial heart valve, syringe driver, brain or 
aortic clip or neurostimulators, metal mesh implants/clips/wire sutures, 
medicated skin patches, hearing aid/implant, dental bridge or dentures with 
wires, glass eye, joint replacement, bullet/shrapnel wound, metal fragments 
in eye/head/skin, artificial limb, people working with metals, suffering from 
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claustrophobia, using mascara, pregnant, intra-uterine device, fractures 
bones treated with metal, major surgery, tattoos and history of kidney 
disease/disorder. People having any of these conditions were excluded. 
3.2 Statistical Justification of Participant Numbers  
Statistical justification of the number of participants was based on power 
analysis using the freeware program G*Power version 3.1.7 and using prior 
data. The calculations were done for α (type 1 error) of 0.05 and power (1 − 
type 2 error) of 0.80, and equal numbers of participants were considered for 
control (no diabetes) and experimental (DM1) groups. For regressions 
against age, inputs required were difference in regression slopes (│ slope│) 
standard deviations σx1 and σx2 of the independent variable of age for the two 
groups, standard deviations σy1 and σy2 of the dependent variable, and 
correlation coefficients 1 and 2. For comparisons of means of two groups, 
inputs were differences in means (│ mean│) and standard deviations σx1 
and σx2. 
 
Estimate of numbers for lens shape and equivalent lens refractive index were 
based on Wiemer et al. (2008d). For example, their Figure 3 provided 
equivalent refractive index data. Inputs were │ slope│0.000365/year, σx1 
12.225 years, σx2 9.352 years, σy1 0.007444, σy2 0.009234, 1 –0.5775 and 2 –
0.7255 to give an estimated 34 participants/group. Other results from Wiemer 
et al. were 78 participants/group and 71 participants/group for anterior 
radius of curvature and lens thickness, respectively. Lens yellowing numbers 
were based on data from figure 2 of Lutze & Bresnick (1991) for groups of 
under 51 years age (control 35 ± 9 years and DM1 32 ± 10 years). Inputs were 
│ slope│0.013484/year, σx1 10.0 years, σx2 9.5 years, σy1 0.30, σy2 0.16, 1 0.82 
and 2 0.66 to give an estimated 17 participants/group. 
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Root-mean squared higher order aberrations were estimated from figure 4 of 
Shahidi et al. (2004) for groups of similar age (control 47 ± 9 years and DM1 
52 ± 12 years). Inputs were │ mean│0.11 μm, σx1 0.14 μm, and σx2 0.18 µm to 
give an estimate of 28 participants in each group. 
 
On the basis of these power analyses, I considered that 70 participants (eyes) 
in each of the diabetes and non-diabetes groups should give sufficient 
statistical power to provide significant age-related effects of diabetes for 
most, if not all, ocular parameters. Accordingly, I aimed to get this number 
(see section 4.1 for numbers of participants and reasons for non-inclusion in 
each test). 
 
3.3 Data Analysis 
Analyses were performed with IBM SPSS Statistics 21 version. Statistical 
significance was set at p < 0.05 for all tests. The normality of data was 
checked by both mathematical and graphical methods. Kolmogorov-Smirnov 
and Shapiro-Wilk tests were applied to determine the significance level of 
Standardised residuals while Standardised residual plots were used to judge 
the normality of the data by visual inspection (Section 4.1).  
 
The Student unpaired t-test and the chi-square test determined significance 
of differences between the two groups for non-categorical data (e.g. lens 
thickness) and categorical data (e.g. proportions of males and females), 
respectively. Analysis of variance (ANOVA) was performed to determine the 
difference in lens dimensions and refractive index between different 
participant groups. 
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Simple linear regressions were applied to find the effects of ocular (spherical 
equivalent refractive error, lens thickness, axial length) and systemic 
parameters (age, diabetes duration, HbA1c, gender) on various parameters 
e.g. straylight. Multiple regression analysis was used to determine the 
combined effects of age and diabetes duration on parameters. We note that 
different approaches have been used previously. Sparrow et al. (1990) 
determined the linear regression for the non-diabetic group, superimposed 
this fit upon their diabetes group and then determined the additional effect 
due to the diabetes duration. Wiemer et al. (2008d) made a multiple 
regression analysis in type 1 diabetes participants with diabetes duration and 
age as factors. Our multiple regression analysis was performed in “Enter” 
fashion with age and diabetes duration as factors, but with gender and/or 
axial length as additional factors where these were significant according to 
simple linear regression. This analysis was done both for the whole group, 
with duration for the participants without diabetes given as zero, and for 
only the participants with diabetes. 
 
ANCOVA analysis [between-participants factor: group (diabetes, non-
diabetes); covariate: age] was performed to determine the interaction 
between group (diabetes, non-diabetes) and age. Also, it showed the 
significance of difference in slopes for each parameter (e.g. lens thickness) 
with age between people with and without diabetes. 
3.4 Clinical Techniques 
This section includes the standard clinical techniques performed on all 
participants. Visual function assessment, slit lamp and fundus photography 
were performed to screen the participants.  
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3.4.1 Visual Function Assessment 
All measurements were undertaken monocularly without use of dilating or 
cycloplegic drugs.  
 
Colour vision (Lanthony desaturated D15) was performed in a dark room 
with a custom built white illumination box; the source was a 20 W, 600 mm 
Duro-test True-Lite fluorescent tube (correlated colour temperature 5500"K, 
colour rending index > 90) to give illuminance at the centre of the floor of  
approximately 1600 lux. Corrected distant visual acuity at 6 metres was 
measured using the Early Treatment Diabetic Retinopathy Study chart 
(ETDRS) with a log-MAR scale using a termination rule of four mistakes (or 
more) on a line (Carkeet, 2001); chart luminance was 150 cd/m2 as measured 
with a Topcon BM-7A luminance-colorimeter. Photopic letter contrast 
sensitivity was tested using the Pelli-Robson contrast sensitivity chart 
(Clement Clark, UK) at one metre and 134 cd/m2 luminance. This consists of 
letters of constant size, with lines of 6 characters, 3 of a particular contrast. 
Contrast reduces in 0.15 log steps per triplet from left to right and 
downwards. The participant was rested in the room for at least 5 minutes to 
adapt to room luminance, and encouraged to identify and guess each 
character in the chart for up to 20 seconds when the letters were difficult to 
identify. Contrast sensitivity was scored by characters and noted as log (CS). 
When “C” was called “O” it was marked to be correct (Elliott, Bullimore, & 
Bailey, 1991). The measurement was finalised when the participant was 
unable to identify any of the three letters of the same contrast.  
 
Subjective amplitude of accommodation was measured with a hand held 
Redenstock Badal optometer (Schober, 1958) at approximately 500 cd/m2 
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luminance. The lens power is approximately +12.0 D. The target was placed 
at the far end of the optometer. The participant was instructed to move the 
target towards the eye and stop where the bottom line of 6/12 characters first 
became clear. This was noted as the far point. The participant was instructed 
to bring the target towards eye, and when the bottom line became blurred 
and could not be cleared this point was noted as near point of 
accommodation. Three sets of measurements were taken for each participant. 
The amplitude of accommodation was taken as the difference between the 
mean scale readings for the near and far points.  
 
3.4.2 Refraction 
Refraction is usually done using standard clinical techniques of subjective 
refraction, retinoscopy and autorefraction. However, for this study objective 
refraction was determined from aberrometry (section 3.5.3.1). At least three 
aberrometer readings, taken with the COAS-HD aberrometer under the 
unaccommodated state with room lights turned off, were averaged. This has 
been found to be a reliable, accurate instrument for determining refraction 
(Salmon, West, Gasser, & Kenmore, 2003). All readings were taken with 
reference to the corneal plane and refraction was measured using 2nd and 4th 
order Zernike polynomial coefficients for a 4 mm pupil at 555 nm 
wavelength. 
 
3.4.3 Pupil Diameter 
Pupil diameter can be determined with pupillometers of varying 
sophistication, but in this study it was determined from at least three 
aberrometer readings taken with the COAS-HD aberrometer under the 
unaccommodated state with room lighting turned off (section 3.5.3.1). 
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3.4.4 Slit-lamp and Fundus Photography 
A Topcon SL-D digital slit lamp was used to take lens images. The images 
were graded for cataract classification using the LOCS III (lens opacity 
classification system) protocol. Fundus photographs were taken through a 
non-mydriatic camera (Visucampro-Carl Zeiss) for diabetic retinopathy 
detection according to NHMRC guidelines (NHMRC, 2008). The images 
were graded for cataract and diabetic retinopathy by two Optometrists and 
the gradings were confirmed by an Ophthalmologist. 
 
3.4.5 Corneal Topography 
Computer-aided videokeratoscopes provide comprehensive descriptions of 
corneal surface shape, either for the anterior surface or for both surfaces. 
There are several types of videokeratoscopes including Placido 
videokeratoscopes, Scheimpflug instruments, Raster-stereogrammetry, Slit-
profiling and Moire fringing (Seitz, Behrens, & Langenbucher, 1997). 
 
3.4.5.1 Corneal Topographer 
The Medmont E-300 Corneal topographer is an example of a Placido 
videokeratoscope. It contains 32 dark and light Placido rings fitted into a 
cone and illuminated by red light-emitting diodes (Medmont, 2010). The 
anterior cornea acts as a convex mirror and images are captured by a camera. 
Positions, sizes and spacings of these rings in the images are used to 
determine the corneal shape. Closer rings indicate steeper corneas, and hence 
larger refractive power. An arc-step algorithm is used for image 
reconstruction to allow accurate corneal height interpretation (Medmont, 
2010).  
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There are four different maps of corneal topography, axial, tangential, 
elevation and refractive, that provide a comprehensive description of the 
anterior corneal surface (Roberts, 1998; Salmon & Horner, 1995). The axial 
maps display corneal curvature and power of the surface with respect to the 
keratoscope axis. The tangential maps display the local curvature and power 
of the surface. The elevation maps display the distance from a specified best-
fit sphere to the surface in microns. The refractive map displays the true 
refractive power of the surfaces in dioptres (Medmont, 2010). 
 
The accuracy of the Medmont instrument is good for spherical and aspheric 
test surfaces (Tang, Collins, Carney, & Davis, 2000) and it exhibits highly 
repeatable results (Cho, Lam, Mountford, & Ng, 2002; Chui & Cho, 2005). It 
has been used to derive corneal shape (Atchison, et al., 2008) and anterior 
corneal contribution to aberrations (Mathur, Atchison, & Tabernero, 2012) 
and was used for this purpose in this study (section 3.5.2). At least two 
anterior corneal topography images with the instrument’s quality 
specification of 95% for alignment or better were analysed. 
 
To estimate anterior corneal radius of curvature R and asphericity Q in the 
conicoid equation 
 02)1( 222  ZRZQYX ...... (3.1) 
for 6 mm diameter corneas, files with suffices .axl, .dst, .hgt, .slp, and .tgl. 
were exported from the topographer into a Matlab program which gave a 
least squares solution. To do this, the data were referenced from the corneal 
topographic centre to the position on the cornea corresponding to the centre 
of the pupil during aberration measurements (section 3.5.2.2).  
 
Files with the suffix .mxf (having anterior height data) and .ptd were 
exported into the custom built Matlab program and then into the optical 
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design package Zemax so that the corneal tilt and decentration, and corneal 
contribution to aberrations could be determined (section 3.5.2.2). 
 
3.4.5.2  Scheimpflug Camera 
The Scheimpflug camera is a modified form of a slit-lamp camera to improve 
depth of focus.  
 
 
Figure 3:1 Scheimpflug principle. a) tilted image plane; b) tilted lens plane [Adapted from 
Dubbelman thesis, (2002)]. 
 
In a Scheimpflug camera, the slit beam, camera lens plane and CCD sensor 
plane intersect at one point and the image of an obliquely positioned object is 
captured. This can be performed by tilting the lens plane, image plane or a 
combination, so that the plane of focus becomes parallel with the slit beam 
(Figure 3:1).  
 
The high depth-of-focus and the high resolution of the Scheimpflug image 
make it possible to detect small changes in the shape of the cornea and the 
lens (Rosales & Marcos, 2009). There are two types of image distortions in the 
Scheimpflug imaging system. The first type of distortion arises from the 
geometry of the camera, which introduces a variation of the magnification 
along the image plane, since the image and object planes are not parallel. The 
second type of distortion arises because the posterior corneal, anterior lens 
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and posterior lens surfaces are viewed through the ocular surfaces in front of 
them.  
 
Dubbelman et el. (2001b; 2005; 2003) corrected geometrical distortions and 
retrieved real coordinates of the anterior cornea surface image captured on 
the CCD camera chip by ray tracing backwards from the image plane (i.e., 
CCD chip) through the optics of the camera, to the object plane (slit beam). 
Similarly, the posterior corneal surface was traced through the optics of the 
camera and anterior corneal surface to get the real coordinates of the 
posterior corneal surface. The anterior surface of the lens was then traced 
through the optics of the camera and the cornea. Finally, the posterior surface 
of the lens was traced through the optics of the camera, the cornea and the 
anterior lens.  
 
The Oculus Pentacam is a 2-dimensional imaging system using the 
Scheimpflug principle. It does not correct any distortion on the crystalline 
lens surfaces but it gives optical distortions-corrected data of the posterior 
corneal surface (Rosales & Marcos, 2009).  
 
By using a rotating Scheimpflug camera system, the Pentacam performs 12 to 
50 single captures of the anterior segment of the eye, which can be converted 
to a three-dimensional model for analysis. It can perform five types of 
evaluation: Scheimpflug tomography, three-dimensional chamber analysis 
(volume, angle and depth), pachymetry, densitometry of the lens, and 
corneal topography).  
 
The Pentacam has excellent repeatability for measuring central corneal 
thickness (Barkana et al., 2005; Lackner, Schmidinger, Pieh, Funovics, & 
Skorpik, 2005; O'Donnell & Maldonado-Codina, 2005), corneal curvature 
     51 | P a g e |  
Chapter 3: Methodology 
(Shankar, Taranath, Santhirathelagan, & Pesudovs, 2008), lens densitometry 
(Kirkwood, Hendicott, Read, & Pesudovs, 2009) and anterior chamber depth 
(Rabsilber, Khoramnia, & Auffarth, 2006; Shankar, et al., 2008). In this study, 
the Pentacam was used to measure the cornea anterior and posterior radii of 
curvature, which were used in calculation of lens radii of curvature and lens 
equivalent refractive index (section 3.5.5.4). 
 
The Pentacam indicates the position of the pupil centre with respect to the 
corneal apex. There were insufficient information to determine the geometric 
centre of the cornea limbus, and thus I was unable to reference the corneal 
data to the aberrometer pupil centre. Therefore, I used the Medmont E300 
corneal topography for determining anterior corneal asphericity and corneal 
contribution to aberrations. However the Pentacam was preferred for 
Phakometry because it provides radii of curvature for both corneal surfaces 
(section 3.5.2.2). 
 
3.4.6 Partial Coherence Interferometry  
Partial coherence interferometry is a non-invasive optical technique to 
measure distances. It depends on a laser Doppler to measure the echo delay 
and intensity of infrared light reflected back from tissue interfaces 
(Rosenfield & Logan, 2009). It removes any influence of longitudinal eye 
motions during measurement by using the cornea as a reference surface. It 
emits radiation from a low power diode laser. A short coherence length beam 
splits into two parallel beams. When these beams are reflected from cornea 
and retina, they produce interference patterns from which the optical path 
length can be determined (Rabbetts & Mallen, 2007a). The instrument 
provides longitudinal resolution of 0.3 to 10 µm (Drexler, Baumgartner, 
Findl, Hitzenberger, & Fercher, 1997). 
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The Zeiss IOLMaster 500 measures axial length (cornea to retinal pigment 
epithelium) to a precision of 0.01 mm (Rabbetts & Mallen, 2007a). It has been 
used for axial length measurements with good repeatability (Hussin, Spry, 
Majid, & Gouws, 2005; Lam, Chan, & Pang, 2001). It does not recognise 
individual interfaces and applies an average group index of 1.3549 to the eye 
at 780 nm. 
 
The Haag–Streit Lenstar LS 900 uses a broadband source. It can measure 
central corneal thickness, anterior chamber depth, lens thickness, axial 
thickness, corneal diameter, pupil size, eccentricity of the visual line (visual 
axis with respect to the pupil centre), retinal thickness and choroidal 
thickness. Several studies have reported excellent repeatability (Liampa, 
Kynigopoulos, Pallas, & Gerding, 2010; Rabsilber, Jepsen, Auffarth, & 
Holzer, 2010; Rohrer et al., 2009). Read et al. (2011) compared the Lenstar (LS 
900) and spectral domain optical coherence tomographer (Copernicus SOCT 
HR) for choroidal and retinal thickness, and found excellent agreement 
between the two instruments.  
 
The Lenstar was used in the present study for measurements of corneal 
thickness, anterior chamber depth, lens thickness and axial length. Because 
the Lenstar gives all the intraocular distances in the eye, but the Pentacam 
does not, the former was used for phakometer calculations of lens radii of 
curvature and lens equivalent refractive index (section 3.5.5.4) which need all 
the distances.  
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3.5 Specialised Techniques  
This section describes the specialised techniques used to find the straylight, 
amplitude of accommodation, aberrations, lens yellowing, lens radii of 
curvatures, lens equivalent refractive index and lens refractive index 
distribution. 
 
3.5.1 Straylight 
3.5.1.1 Introduction 
Retinal image quality depends upon ocular scattering, aberrations and 
diffraction. There are two types of scattering: forward scattering (retinal 
straylight), which is responsible for a veiling light over retina and reduction 
of retinal contrast, and backward scattering, responsible for reduction in the 
amount of light reaching the retina. There is more forward scattering than 
backward scattering (Atchison & Smith, 2000a). 
 
Retinal straylight is responsible for the outer skirt of the point spread 
function beyond approximately 60 min arc, and affects visual function tests 
such as contrast sensitivity, visual field and the pattern electro-retinogram 
(van den Berg, Franssen, Kruijt, & Coppens, 2013).  
 
Both psychophysical and optical methods are used to measure forward 
scattering, but psychophysical methods are more meaningful because of their 
dependency on participant perception (Piñero, Ortiz, & Alio, 2010). 
 
3.5.1.2 Instrument Principle 
The C-Quant (Oculus Optikgeräte, Wetzler, Germany) is a commercial 
instrument using a compensation comparison to measure straylight. It has a 
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central test field which is divided into two halves (right and left half fields) 
and an outer circular ring (acting as a straylight source) at an average 7 
degree eccentricity (Figure 3:2). When the outer ring flashes ON, due to eye 
imperfections some of the light reaches the fovea. This light is perceived as a 
weak flickering in the central test field. In only one of the two half fields a 
variable counterphase compensated flicker is introduced. This results in two 
types of flicker with different depth modulation in the central test field. One 
flicker is a combination of straylight and compensated light in one half field, 
and the other flicker is due to straylight in other half field. The amount of 
light in the compensated half field can be varied. In a series of trials the 
participant decides which half field has the stronger flicker. The instrument 
determines the amount of light at which no flickering is observed in the 
compensated field, and this is the measure of ocular straylight. 
 
 
Figure 3:2 Layout of stimulus in compensation comparison method for C-Quant. The 
outer ring flashes, the left half field has compensated flicker and right half field is 
without compensation. The participant has to decide which of the two half fields has the 
stronger flicker.  
 
To give some more detail, in measuring straylight a series of 1 or 2 seconds 
straylight stimuli are introduced and variable amount of compensated light 
is presented. The instrument has a two-alternative-force-choice 
Outer flickering ring 
(straylight source) 
Left test half 
field 
Right test half 
field 
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psychophysical measurement algorithm to decide the field with stronger 
flicker. The responses are recorded as either 0 or 1 by two push buttons 
representing the two half fields. The selection of the compensated half field is 
scored as 1 while the non-compensated half field is scored as 0. A 
psychometric curve is fitted to the participant’s responses using a maximum 
likelihood technique. The logarithm of straylight parameter log(s) and two 
reliability parameters, expected standard deviation ESD and quality 
parameter Q, are deduced from the psychometric curve (Figure 3:3). A 
measurement is considered reliable when ESD ≤ 0.08 and Q > 1.0 (Coppens, 
Franssen, & van den Berg, 2006).  
 
 
Figure 3:3 The operator screen of the C-Quant instrument with upper graph showing the 
straylight value and age (red dot) of the participant compared with the range of normal 
values at different ages. The lower graph shows the participant responses as a function of 
straylight compensation level. The red curve is the psychometric curve fitted to the 
participant responses with the red dot being the straylight value. The grey bands show 
the normal range for the participant’s age. The blue filled circles represent the initial 
phase of stimuli while the red filled circles show the final phase of stimuli.  
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To reduce the number of stimuli presentations and to obtain accurate 
measurements there is an option for selecting age ranges (A, B, C, D, E) and 
there is an option (F, G) for cataract or corneal disturbances. In order to 
familiarise the participant with the instrument, five stimuli with obvious 
flicker differences between the two halves are presented, and then 25 more 
stimuli (12 stimuli in initial phase and 13 stimuli in final phase) are presented 
to obtain the straylight parameters. In initial phase stimuli, the outer ring 
flicker increases from low intensity to high intensity while the compensation 
flicker is kept constant, while in the final phase the outer ring flicker is 
constant and amount of light in the compensation flicker varies as described 
above. Changing the compensation light alters the luminance balance of the 
two half fields, but this is prevented by additional light being added to the 
non-compensated half field (C-Quant Guide; Coppens, Franssen, van Rijn, & 
van den Berg, 2006; Franssen & Coppens, 2007; Franssen, Coppens, & van 
den Berg, 2006, 2007; Van Den Berg, Coppens, & Franssen, 2005).  
 
3.5.1.3 Procedure 
All participants were briefed about the experiment and a flicker stimulus was 
shown on the screen using “simulate” option before starting the actual 
experiment. Room lights were turn off except light from the computer 
monitor. One eye was tested for each participant and the non-tested eye was 
patched. Spherical equivalent refractive correction was provided, and five 
measurements were taken and averaged.  
 
3.5.2 Ocular Aberrations and their Component Aberrations 
Objective aberrometers use light propagating out of the eye, after reflection 
at a point on the retina, to measure aberration. Objective sequential 
aberrometers include laser ray-tracers (Navarro & Losada, 1997) and 
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objective simultaneous aberrometers include the Hartmann-Shack 
aberrometer (Liang, Grimm, Goelz, & Bille, 1994), the objective Tscherning 
aberroscope and the objective crossed-cylinder aberroscope (Walsh, 
Charman, & Howland, 1984).  
 
There are three major parts of a Hartmann-Shack aberrometer: a light 
detector, monochromatic light source, and a wavefront sensor consisting of a 
micro-lens array and a CCD detector. A narrow beam of collimated light 
radiation projects a spot onto the retina and a part of this light is scattered 
back from the retina. The wavefront exiting the eye is captured by the micro-
lens array and is broken into multiple small beams. Each micro-lens forms a 
spot of the wavefront or light on the camera. The micro-lens array is 
conjugate with the pupil and its focal plane is at the detector. For a perfect 
eye, the wavefront at the sensor would be a plane wave. The transverse ray 
aberration (slope of the wavefront) associated with each micro-lens can be 
determined in terms of vectors by subtracting the positions of reference (X, 
Y) centroids from that of aberrated centroids (Xa, Ya) of the image spots 
(Figure 3:4).  
  
Hartmann-Shack aberrometers are more popular than most other types of 
aberrometers because they are faster and are less affected by scattering of 
light (Dai, 2008). They have been extensively used for measuring aberrations 
because they are reliable and accurate (Cheng, Himebaugh, Kollbaum, & 
Thibos, 2003; Thibos & Hong, 1999). It is difficult to measure aberrations 
accurately with subjective techniques because of the dependence on 
subjective judgement.  
 
In this study, a COAS-HD (Complete Ophthalmic Analysis System – High 
Definition, Wavefront Sciences) Hartmann-Shack aberrometer was used to 
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determine refraction, measure ocular aberrations and its components, and 
measure amplitude of accommodation (section 3.5.3.1). The COAS-HD uses 
an 840 nm super luminescent diode source and a charged-coupled device 
camera (CCD) camera. It contains a micro-lens array with 83 × 62 lenslets. 
Each lenslet has a 2.48 mm focal length and is 0.108 mm in diameter, and 
transverse aberrations are sampled at 0.159 µm across the pupil (Mathur, 
2009). A 4.5 mm diameter pupil was used in this study, corresponding to 
approximately 490 positions. 
 
 
Figure 3:4 Hartmann-Shack principle. Left: Side view shows an aberrated wavefront 
focused on the CCD camera by the micro-lens array. The micro-lens array is conjugate 
with the pupil of the eye. Right: distorted lattice of spots produced by an aberrated 
wavefront on the CCD camera. [Adapted from Atchison (2005)]. 
 
3.5.2.1 Aberration Terminology   
Ocular aberrations were determined according to the OSA/ISO system that 
uses Zernike aberration polynomials (ISO, 2008). It uses a two index system 
with polynomials written as   
  where index n indicates the radial order of 
the polynomial in the pupil and index m indicates the angular dependence of 
the polynomial in the pupil. Co-efficients of the polynomials are written as 
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 . An alternative to the above is to write polynomials and co-efficients as 
Z(n, m) and C(n, m). 
 
Co-efficients were determined to the 6th order for 4.5 mm pupils. The major 
terms of interest were spherical aberration (  
  co-efficient), vertical coma 
(  
   co-efficient), and horizontal coma (  
  co-efficient), as well as the root-
mean-square higher-order aberration (HO RMS) determined from the 3rd to 
6th aberration orders. These terms were selected because their co-efficients are 
usually greater than co-efficients of other higher-order aberrations.  
 
As recommended by the standard, to allow for mirror symmetry when 
combining right and left eye data, signs were changed for left eye co-
efficients of Zernike polynomials with positive, odd m indices (e.g.   
 ) or 
with negative, even m indices (e.g.   
  ). 
 
3.5.2.2 Component Aberrations 
Ocular higher-order axial aberrations increase with age. In young eyes, the 
anterior corneal and internal ocular aberration components usually 
compensate each other, but this balance is gradually lost with increasing age 
(Atchison & Markwell, 2008; Berrio, Tabernero, & Artal, 2010; Kelly, Mihashi, 
& Howland, 2004). Berrio et al. (2010) quantified the extent to which internal 
aberrations balance the corneal aberrations as: 
Compensation factor (CF) = 1 – (|Ci-internal|/|Ci-corneal|)..... (3.2) 
where Ci represents any Zernike coefficient. Compensation factor = 1 
indicates perfect compensation and compensation factor = 0 indicates no 
compensation. 
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Internal ocular aberrations (posterior cornea and lens aberrations) can be 
estimated by subtracting the anterior corneal aberrations, estimated from 
videokeratoscope data, from the total ocular aberrations measured with the 
aberrometer. However, these two instruments work under different 
illumination conditions and have different origins of the aberrations 
measurements. In the videokeratoscope, corneal aberrations are measured 
under photopic conditions due to high luminance of the Placido ring target 
near the eye and the reference of corneal aberration is the corneal topography 
centre, while in the aberrometer the ocular aberrations are usually measured 
under mesopic conditions (room lighting is kept low) and the reference of 
total aberration is the entrance pupil centre.  
 
This problem is overcome by referencing the corneal topography to the 
entrance pupil under the wave aberration measurements conditions. This 
requires finding the positions of the corneal topography centre and pupil 
centre of the wave aberration relative to the limbus centre (Figure 3:5a). This 
was done in a Matlab program. The program has components to deal with 
topographer and aberrometer information. One component reads the 
topographer .mxf files and iris image files (.ptd) and the other reads the 
aberrometer’s iris image file (.IX). The mean corneal radius of curvature R, 
the average of the flattest and steepest meridians, is determined from the 
.mxf file. The keratometric centre is automatically identified as the centre of 
the smallest placido ring of the .ptd image file and the limbus centre was 
obtained by fitting a draggable ellipse to the limbus. This gives the corneal 
topographic centre relative to the limbus centre in the plane of the entrance 
pupil. For a second component, the IX images from the COAS-HD 
aberrometer are manually fitted with two draggable ellipses, one for 
obtaining the limbus centre and one for obtaining the pupil centre. This gives 
the aberrometer pupil centre relative to the limbus centre in the plane of the 
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entrance pupil. The corneal topographic centre relative to the aberration 
pupil centre TCPC (x, y) is given by (Figure 3:5a): 
TCPC (x, y) = [corneal topographic centre (x, y) – limbus centre (x, y)] – 
[aberrometry pupil centre(x, y) – limbus centre (x, y)] …..(3.3) 
Positive x and positive y correspond to the topographic centre being to the 
right and above the aberrometry pupil centre from the reference of an 
observer looking at the front of an eye. The anterior chamber depth ACD 
measured by the Lenstar is entered by the user and TCPC (x, y), R and ACD 
are saved into a .dat file. 
 
 
Figure 3:5 Re-referencing the cornea. a) TCPC determination from aberrometry and 
corneal topography [adapted from Tabernero et al. (2009)]; b) Horizontal components of 
corneal decentration and tilt (x, θx) [adapted from Mathur et al. (2012)].  
 
Using into-the-eye ray-tracing, anterior corneal aberrations at 555 nm up to 
sixth order were estimated with Zemax optical design software (Radiant 
Zemax, Redmond, USA). A macro program was written in Zemax 
programming language to read the .mxf files incorporating the anterior 
height data (section 3.4.5.1) and to convert them to 8 mm diameter “grid sag” 
surfaces. This macro read the .dat file mentioned above in order to estimate 
the position of the entrance pupil EP relative to the cornea, tilt about the 
horizontal and vertical axes (x, y), and the anterior corneal decentration (x, 
y) (Mathur, et al., 2012). The equations required are (Figure 3:5b): 
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where n is the refractive index of the cornea and is taken as 1.3375, and WD is 
working distance of the corneal topographer (60 mm)(Mathur, et al., 2012). 
Positive x and positive y correspond to the inferior and right sides of the 
participant’s cornea moving away from an observer looking at the front of 
the eye.  
 
Under the control of the macro, the corneal system consisted of a distant 
object, a stop to coincide with the entrance pupil, the anterior cornea surface 
at –EP from the stop with decentration and tilt relative to the line-of-sight, 
and an image plane. The stop diameter was 4.5 mm. The refractive index 
inside the anterior corneal surface was taken as 1.3375, rather than a more 
realistic index of 1.376, to compensate for the lack of a posterior corneal 
surface. The image plane was placed to minimise RMS wavefront error.  
 
The macro created anterior corneal aberration co-efficients as .txt files. These 
were imported into an Excel program, and internal aberration co-efficients 
were determined by subtracting the corneal aberration coefficients from 
ocular aberration co-efficients. To allow for mirror symmetry between right 
and left eyes, signs of some co-efficients of left eyes were changed (section 
3.5.2.1). 
 
A pilot study was performed on five participants to determine the 
repeatability of the corneal decentration and tilt procedure. Measurements 
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were performed on two different occasions for each participant, and two 
images were analysed on each occasion. The standard deviations for 
decentration along horizontal and vertical axes were similar at ± 0.11 mm 
and ± 0.12 mm, respectively. The standard deviations for tilts about the 
horizontal and vertical axes were ± 0.47° and ± 0.45°, respectively.  
 
3.5.3 Calibration of Aberrometer for Amplitude of Accommodation 
Objective amplitude of accommodation was determined with the COAS-HD 
aberrometer (section 3.5.2).  
 
The COAS-HD slider position was calibrated for different accommodation 
stimuli. An observer (the author) focused a distance telescope at infinity by 
adjusting its eye piece. The telescope was placed in front of the COAS-HD 
and the instrument was moved so that front of the telescope objective was 
focused by the pupil camera of the instrument and thus was at the correct 
eye position. Ophthalmic trial lenses (–6 D to +8 D in 1 D intervals) were 
placed against the objective lens of the telescope. The observer looked 
through the telescope at the fixation target with lights turned off in the room 
and moved the slider until the fixation target was in focus for each trial lens. 
Powers of the trial lenses were verified with a vertometer. 
 
Three readings of slider position were taken for each trial lens and averaged. 
Trial lens power sign was reversed to give the refraction and a quadratic 
regression was calculated for the slider position (Figure 3:6): 
4696.10085.10165.0 2  rry    …… (3.7) 
where y indicates COAS slider position and   indicates refraction. To 
calculate the slider position for different accommodative stimuli, “r” was 
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replaced by “r ‒ a” in equation (3.7), where r is base line refraction and a is 
accommodative stimulus: 
4696.1)(*0085.1)(*0165.0 2  arary  ….. (3.8) 
 
 
Figure 3:6 Slider positions for different refractions and the quadratic regression fit. 
 
3.5.3.1 Procedure to Determine Amplitude of Accommodation 
Room lights were turned off. The brightness of the COAS internal target was 
set to a setting of 0.1 in the control software (see next section for explanation 
of selecting this setting). A participant placed his or her chin on the chin rest 
with the non-tested eye patched. The COAS was moved so that the pupil of 
the tested eye was in focus and aligned according to the image of the pupil 
camera. The participant was instructed to relax the eyes while looking at the 
target. Three readings were taken with “auto-acquire mode”, using 2nd and 
4th order Zernike polynomial coefficients for a 4 mm pupil. The average 
spherical equivalent was calculated from these readings and referred to as 
the baseline spherical equivalent.  
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The slider control was changed in the software to “acquire (single) mode” so 
that the slider did not move in response to a refraction/accommodation 
combination. The slider position was adjusted using the computer mouse so 
1 D stimulus was provided as calculated from equation (3.8). The participant 
was instructed to keep the target in focus as well as possible and the average 
spherical equivalent was calculated from three measurements. The same 
procedure was adapted for other accommodation stimuli until it was clear 
that a maximum accommodation response had been achieved. 
Accommodative response was calculated by subtracting the average 
spherical equivalent from the baseline spherical equivalent: 
Accommodative response = baseline spherical equivalent – spherical equivalent..…. (3.9)  
Figure 3:7 shows an accommodative response/stimulus curve for a non-
diabetic participant. The maximum accommodation response is 6.3 D. 
 
 
Figure 3:7 Accommodative response/stimulus curves of a non-diabetic participant. The 
error bars indicate the standard deviations from three measurements. 
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3.5.3.2 Pilot Work 
To determine the effect of COAS internal target brightness on the pupil size 
and accommodative response, four young non-diabetic participants were 
recruited from students of the Queensland University of Technology. Their 
ages ranged from 24 − 34 years. The brightness level of the COAS was set at 
0.1, 1, 5 and 10 in the control software for participants 1 and 2, and an 
additional level of 5 was used for participants 3 and 4. Maximum 
accommodative response was determined at different brightness levels 
according to the procedure described in the previous section. 
 
For participant 1 maximum accommodative response (5.3 ± 1.3 D) was 
observed at the highest brightness level (10), but for the other three 
participants the maximum response occurred at the lowest brightness level 
(0.1). The maximum pupil diameter for all participants occurred at the lowest 
brightness (0.1) and size decreased with increase of accommodative 
response, although the changes were small for participant 3 (Figure 3:8). 
 
As there was generally little influence of brightness level on accommodation 
response and as three out of four participants showed maximum 
accommodative response at the lowest brightness level (0.1), we decided to 
use this level in the main experiments. Measurements on further three 
participants indicate good accommodation response at this level (Figure 3:9).  
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Figure 3:8 Accommodative responses (left) and pupil sizes (right) of four participants. For 
participants 1 and 2, internal target brightness levels were at 0.1, 1 and 10. For participants 
3 and 4 an additional brightness level of 5 was added. The error bars indicate standard 
deviations. Ages of participants were 24 years (1), 25 years (2), 25 years (3) and 34 years (4). 
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Figure 3:9 Three graphs show the accommodative response of participants when the 
luminance of the internal target was 0.1. The error bars indicate the standard deviations. 
Ages of participants were 30 years (5), 27 years (6), and 25 years (7). 
 
3.5.4 Flicker Photometry ‒ Lens Yellowing  
Flicker photometry is a technique first used by Abney and Festing (1886) to 
establish the additivity of luminances. It can be adapted to measure lens 
optical density (Delori & Burns, 1996; Lutze & Bresnick, 1991; Wooten, 
Hammond, & Renzi, 2007; Xu, Pokorny, & Smith, 1997), spectral sensitivity of 
ocular media (Kraft & Werner, 1994) and spectral luminous efficiency of the 
eye (Sagawa & Takahashi, 2001). 
 
In heterochromic flicker photometry, two sources of different colours 
illuminate the same area in the visual field alternatively. The intensity of one 
of these sources is adjusted until the perception of flicker is eliminated or 
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minimised. The lens is relatively non-absorbing for 550 nm light, so an 
elevated threshold for a 420 nm stimulus relative to that of a 550 nm stimulus 
is a measure of 420 nm light absorbed by the lens. The rods are equally 
sensitive to these wavelengths (Lutze & Bresnick, 1991). Therefore, lens 
density could be directly measured by comparing absolute scotopic 
thresholds to rhodopsin curves (Norren & Vos, 1974).  
 
With increasing age, lens absorption increases at short wavelengths, resulting 
in lens yellowing. The objective of this test is to measure and compare lens 
yellowing in people with and without diabetes.  
 
3.5.4.1 Apparatus and General Procedure 
A flicker photometer was enclosed in a 140 cm long x 100 cm wide x 200 cm 
high room covered with a black cloth to allow dark adaptation. The 
photometer  consisted of a 565 nm green LED (60 mcd, 10 mm diffused, 10˚ 
viewing angle, Kingbright L-813GD) and a 430 nm blue LED (60 mcd, 10 mm 
diffused, 10˚ viewing angle, Kingbright RT1017BUW) with 550±10 nm 
(Thorlabs, 25 mm FB420-10) and 420 ± 10 nm (Thorlabs, 25 mm FB550-10) 
narrow band interference filters, respectively (Figure 3:10). The light from the 
two sources was combined through a fifty-fifty 20 mm cube beam splitter 
(Melles-Griot 03BSC007). The light was limited by an 8 mm diameter 
aperture having a diffuser at a distance of 48 cm from the eye and thus 
subtending 1.0°. A 1.2 log unit neutral density filter was placed in front of it. 
The fixation target was a red LED at 7° angle on the temporal side which had 
been dimmed by four pieces of 1.2 log unit neutral density filter. The system 
has the limitation that it was not possible to measure the light output of the 
system, and hence the lens yellowing obtained is a relative measure. 
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Figure 3:10 Flicker photometry system. 
 
The system was controlled by a Delphi software program called “Bg LED”, a 
control box with a microprocessor, control knob and a push button. The 
program sent commands and parameters to the microprocessor control unit. 
It set the flicker frequency (setting the number of pulses) of LEDs, and it set 
the initial setting of pulse width modulation (luminance) of green and blue 
LEDs. It also received the luminance of the blue LED when the participant 
pushed the button. The control knob varied the luminance of the blue LED 
by varying the pulse width modulation between 0 and 255.  
 
To produce 5 Hz frequency (see next section), we set 245 pulses per 100 ms in 
the program (Figure 3:11). 
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Figure 3:11 Flicker generation and pulse width. 
 
At the start of an experiment, each participant was shown the apparatus and 
a brief description of the experiment was given. The non-tested eye was 
covered with an eye-patch. Each participant was dark-adapted for 25 
minutes. The participant put his/her chin on the chin rest with the eye level 
with the light sources, and looked at the red fixating target while observing 
the flickering of the alternating LEDs. The pulse width modulation of both 
the green and blue LEDs was set initially to 10. The participant rotated the 
control knob to alter the luminance (pulse width modulation) of the blue 
LED. To avoid Troxler’s phenomenon, participants were advised to look at 
the roof of the room for short intervals of time during testing.  
 
Participants located the non-flicker range by clicking the push button at the 
middle of the range, when no flickering was observed. Later on the technique 
was changed, with participants determining the upper end of the lower 
flicker range and the lower end of the upper flicker range, and we calculated 
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the middle of the range from the average values of these two readings. Ten 
such readings were taken on each participant, and the average of these 10 
values was taken as the threshold.  
 
3.5.4.2 Pilot Work  
To test the system and choose the best parameters, we conducted several 
pilot experiments. Seven participants, consisting of six myopes and one 
emmetrope aged 28 to 57 years and all with 6/6 visual acuity, took part. The 
participants found the upper and lower end of the non-flicker range by 
rotating the knob, and clicked the push button at the middle to get the 
threshold. Ten such readings were taken for each individual threshold. 
 
Experiment 1 
To show that threshold increases with lens yellowing an experiment was 
conducted with and without a yellow filter (Lee filter, 013-straw tint) on two 
participants. The flicker frequency was set at 5 Hz and 25 pulse width 
modulation change per rotation of the control knob. The mean threshold 
doubled with the yellow filter, slightly less than expected (Figure 3:12).  
 
The expected change in threshold with the filter was calculated by measuring 
the average transmittances of the yellow filter for 400 nm to 440 nm and for 
530 nm to 570 nm by weighting spectral transmittances tλ with their scotopic 
sensitivity factors kλ. The ratio of these average transmittances was given by 

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Figure 3:12 Thresholds of two participants (P1, P2) with and without a yellow filter. Error 
bars are standard deviations. Dashed lines predict thresholds with the filter. 
 
Experiment 2 
To find the most suitable flicker frequency, I performed experiments on two 
participants with 2 Hz and 5 Hz frequencies having 50 pulse width 
modulations per rotation of the control knob. Initially both green and blue 
LEDs were set to 10 pulse width. The thresholds of participant 1 and 
participant 2 were more variable with 5 Hz frequencies having standard 
deviation 8.1 and 5.8, respectively as compared to 2 Hz frequencies with 2.9 
and 4.9 standard deviations, respectively (Figure 3:13). However, the 
participants felt that they had difficulty in detecting the flicker with 2 Hz 
while they felt comfortable with 5 Hz. Hence, 5 Hz was selected as a flicker 
frequency for the study. 
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Figure 3:13 Thresholds of two participants (P1, P2) with 2 Hz and 5 Hz flicker frequencies. 
 
Experiment 3 
To find the most suitable pulse width modulation per rotation of the control 
knob an experiment was conducted in three steps. The initial luminance of 
the green and blue LEDs were set to 10 pulse width modulation.  
 
In the first step, the frequency of the flicker was set to 5 Hz and with 25 pulse 
width modulation change per rotation of control knob. There were three 
participants (1, 2 and 3). Participants had very low mean threshold (Figure 
3:14). Participants experienced difficulty in finding the non-flicker range 
because of the large number of rotations this involved.  
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Figure 3:14 Threshold of three participants (P1, P2, P3) when the pulse width modulation 
of rotating knob was kept at 25, 50 and 100 per rotation. 
 
In the second step, the flicker frequency was set to 5 Hz with 50 pulse width 
modulation change per rotation of the control knob. There were 4 
participants (1, 2, 4 and 5). The mean thresholds and standard deviations 
increased for participants 1 and 2 compared with their results for 25 pulse 
width modulation change per rotation (Figure 3:14). The participants still felt 
difficulty in finding the non-flicker range.  
 
In the third step, the flicker frequency was set to 5 Hz with 100 pulse width 
modulation change per rotation of the control knob. There were 4 
participants (1, 2, 3 and 5) (Figure 3:14). The participants felt more 
comfortable in finding the non-flicker position with 100 pulse width 
modulation change per rotation of the control knob than with lower rates 
because they did not have to turn it as far (fewer rotations) to bring greater 
changes in luminance. Hence, the 100 pulse width modulation per rotation 
was selected for the study. 
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3.5.5 Phakometry 
Purkinje images have been used to assess the properties of cornea and lens 
since their description by Purkinje (Rabbetts & Mallen, 2007b). When an eye 
is illuminated with a light source, four main Purkinje images are formed by 
reflection at anterior (PI) and posterior (PII) corneal surfaces and at anterior 
(PIII) and posterior (PIV) lens surfaces. PIII is approximately twice the size of 
PI in an unaccommodated eye, while PIV is inverted and slightly smaller 
than PI. PI, PII and PIV are formed near the pupil plane while PIII lies in the 
vitreous in the unaccommodated state. In phakometry, the sizes of PIII and 
PIV relative to that of PI are used to determine lens surface radii of curvature 
and equivalent index. 
 
3.5.5.1 Phakometer  
A phakometer was built on a 450 mm x 300 mm movable optical breadboard 
over a base with a forehead and chin rest for easy alignment (Figure 3:15). It 
contained a semicircular ring of thirteen 890 nm LEDs (Osram, SFH 487) 
angled 20° inwards. The ring arrangement was used rather than single 
sources to make images more easily distinguishable (PIII and PIV are 
inverted with each other) and locatable when they are partially obscured by 
the pupil.  
 
An OLED (viewing area 12.78 mm x 9 mm, dimensions 19.8 mm x 15.2 mm x 
5.1mm, pixel pitch 15 µm) controlled by computer, presented a fixation 
target across ±2.68˚ horizontal and ±1.99˚ vertical range at nine positions. A 
beam splitter reflected the target to the participant. Images were captured by 
an IR-enhanced CCD camera (PixeLINK) provided with a 55 mm focal length 
telecentric lens (Edmund optics) focused at a distance of 260 mm. The Badal 
lens (100 mm focal length) presented the target displayed on the OLED. Its 
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anterior focal point coincided with the camera’s focus point. It corrected 
spherical refraction from −8 to +3 D and could be used to provide 
accommodative stimuli.  
 
 
Figure 3:15 Phakometer. Purkinje images are formed of the illumination ring source. The 
OLED displays the fixation targets through the beam splitter. During accommodation 
calibration the cross-hair fixation target, illuminated uniformly by a white LED through a 
diffuser, is collimated by a focusing lens (100 mm) for the left eye while the 
photorefractor LEDs illuminate the right eye. 
 
The photorefractor consisted of fourteen 890 nm LEDs mounted in a custom-
built knife-edge pattern in front of the lower half of the camera. Its intensity 
was controlled manually by a custom built electronic box. The focusing lens 
and the fixation target were placed on a translation stage for adjustment of 
inter-pupillary distance.  
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The optical axis of the camera-lens was aligned to the central target (5th) on 
the OLED screen. Participants were aligned when they fixated the central 
fixation target of the OLED and the pupil of the eye was imaged in the centre 
of the camera as seen on the computer screen. PI was clearly visible at each 
focussing plane and PIII was more difficult to see clearly than PIV. The 
camera was first focused at PIII and images of the eye were taken after the 
best possible combination of PI, PIII and PIV was obtained.   
 
All measurements were taken with the room light turned off. Custom built 
software in Matlab (MathWorks Inc., Natick, MA, version R2011) was written 
with three modes of fitting ellipses, a merit function to calculate lens radii of 
curvature, and photorefraction to measure refraction. The fitting ellipse 
mode fitted ellipses to Purkinje images PI, PIII, PIV, the pupil and the 
limbus. It included an option to take the log of the image to enhance PIII 
detection (see Appendix B). The fittings give the sizes and centres of the 
Purkinje images, pupil diameter, and limbus diameter (Figure 3:16). The 
Purkinje image positions can be referred to the pupil centre or to the cornea 
limbus centre. One millimetre on the image taken by the camera corresponds 
to 66.2 pixels on the CCD camera.  
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Figure 3:16 Ellipse fitting mode of the software. 
 
3.5.5.2 Photorefraction Calibration 
Photorefraction was used to measure accommodative responses. The 
participant was asked to view the cross-hair fixation target through his/her 
left eye while the ophthalmic trial lens (+6 to −6 in 2 D steps) was placed in 
front of the right eye in a trial frame along with an infrared pass filter (Kodak 
Wratten 89B, low cut-off 700 nm). This filter prevented the right eye from 
looking at the left eye cross-hair fixation target during refraction. The back 
vertex distance of the trial lens was also measured.  
 
To measure photorefraction for different accommodative stimuli, the OLED 
was moved along the dioptre scale. The photorefraction images of the right 
eye were taken when it was looking at the central fixation target (5th) of the 
OLED and the left eye was patched. The infrared filter was placed between 
the beam splitter and the camera. 
Pupil centration with respect to instrument was ensured through the pupil 
camera displayed on the computer monitor. Pupillary images with vertical 
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luminance gradient were taken and analysed using photorefraction mode of 
the software written in Matlab. The photorefraction slope generated by the 
trial lens was compensated for the back vertex distance, and the induced 
refraction generated was plotted against pupil luminance profile (as shown 
in figure below).  
 
 
Figure 3:17 PR calibration curve of a participant. 
 
3.5.5.3 Angle Kappa, Lens Tilt and Decentration  
Purkinje image locations (PI, PIII and PIV), with respect to pupil centre, can 
be used to estimate angle kappa, lens tilt, and lens decentration through 
rotating the eye with respect to a source. Measurements were taken but not 
used in the study because of lack of time to process all the images, but the 
process is given for completeness of the Phakometry procedure. I assume a 
linear relationship between rotation angle and its factors (Tabernero, Benito, 
Nourrit, & Artal, 2006) to obtain:  
declenstiltlensrotationglobalalign PIVandPIII   ...... (3.11) 
align PIII and PIV is the eye rotation required to align PIII and PIV, global rotation is a 
global rotation of the eye due to angle kappa () which is obtained by 
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aligning the PI image with the entrance pupil centre, lens dec is the rotation 
required to align PIII and PIV that compensates for the lens decentration 
with respect to the pupil, and lens tilt compensates for the tilt of the lens. 
Tabernero et al. showed that the equation was equivalent to  
DecATiltAKPIVandPIIIalign 21   .......... (3.12) 
where Tilt is the lens tilt, dec is the lens decentration, and A1 and A2 are 
constants determined by ray tracing with model eyes to be A1 = –1.1 and A2 = 
2.0 deg/mm. 
 
Procedure 
After longitudinal and transverse alignment was made to give the best 
possible combination of PI, PIII and PIV images along the line of sight for the 
central target (5th), the participant was asked to fixate at the nine targets in 
turn. Horizontally the targets were 5.80 mm apart and vertically they were 
4.30 mm apart, making angles of approximately ± 2.68˚ and ± 1.99˚ at the 
eye’s centre-of-rotation, respectively.  
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Figure 3:18 Target position and angle relative to the centre-of-rotation of the eye. The 
target 5.80 mm from the central fixation point on the OLED screen made 2.68° and 3.32° 
angles at the pupillary plane, respectively. Similarly, the 4.30 mm target made 1.99° and 
2.58° angles . 
 
The position of each Purkinje image with respect to the pupil centre was 
plotted against horizontal and vertical components of eye rotation, and 
regression fits were made (Figure 3:19). 
 
 
Figure 3:19 Data and linear fits of Purkinje images positions, with respect to pupil centre, 
versus vertical and horizontal components of eye rotations.  
 
The linear regression fits for the horizontal eye rotation components are  
11 hhh bxaPI   33 hhh bxaPIII   44 hhh bxaPIv   (3.13a-c) 
 
and the regression fits for the vertical eye rotation components are  
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11 vvv bxaPI    33 vvv bxaPIII   44 vvv bxaPIV  ...... (3.14a-c) 
 
Angle kappa components are where PI fits cross the x-axes: 
11 / hhh abK   ...... (3.15a) 
11 / vvv abK  ...... (3.15b) 
 
PIII and PIV overlap at (Xh, Yh) for the horizontal eye rotation component 
and at (Xv, Yv) for the vertical eye rotation component. Xh and Xv are the 
estimates of the rotation angle components at which this occurs and Yh and 
Yv are the estimates of the components of lens decentration at which this 
occurs. The (Xh, Yh) co-ordinates of the PIII and PIV vertical components of 
the overlap point are 
)/()( 4343 ahahhhh ahabbX  .......... (3.16a) 
33 hhahh bXaY   ........ (3.16b) 
Similarly the (Xv, Yv) co-ordinates of the PIII and PIV vertical components of 
the overlap point are   
)/()( 4343 avavvvv avabbX  ......... (3.17a) 
333 vvvv bXaY  ....... (3.17b) 
Lens tilt components are obtained by rearranging the second of Tabernero et 
al.’s equations: 
1.1/)0.2( hhhh YkXTilt  ....... (3.18a) 
1.1/)0.2( vvvv YkXTilt  .......... (3.18a) 
The setup was designed so that the camera was imaged at the pupil and 
hence was close to the image PI. In order to get good PIII and PIV images, 
particularly the former, sometimes it was necessary to move the camera 
slightly closer to the eye. The error Rx associated with the refraction 
stimulus Rx for such a positioning error x is shown in Appendix A to be 
)1/(2 xRxxRxRx  ........ (3.19) 
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Errors are shown in Figure 3:20 for positioning errors of 5 mm and 10mm. In 
practice, I expect that the positioning error would not be greater than (–) 5 
mm, which is likely to result in errors of refraction or accommodation no 
greater than 0.5 D.  
 
 
Figure 3:20 Refraction error, as a function of refraction given on Optometer scale on the 
phakometer, caused by the phakometer being too close to the eye by (–)5 mm and (–)10 
mm. 
 
The centre-of-rotation is behind the entrance pupil by about 12 mm, which 
means that the angles of rotation are not those subtended at the entrance 
pupil by a stationary eye. As given in Appendix A, the angle of rotation    
was related to the angle Rxu'  subtended by the entrance pupil, through a 
separation x by 
xRx
u
u
Rx
1
'
' ........... (3.20) 
This is shown in Figure 3:21 for x = +12 mm used throughout. 
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Figure 3:21 Ratio of eye rotation angle to the angle subtended by image at entrance pupil 
of eye, when the centre-of-rotation is 12 mm behind the entrance pupil. 
 
This ratio is considerably different from 1.0 for large refractions, and thus the 
eye rotation angle was determined according to  
)1(' xRxFhu  = ............ (3.21) 
where x is 12 mm,    is the height on the display stimulus and F is the lens 
power (+10 D) (see Appendix A). Of course, positioning errors will affect the 
eye rotation angle up to an estimated 4 %. 
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3.5.5.4 Lens Radii of Curvature and Equivalent Refractive Index 
A merit function was used to calculate lens radii of curvature and equivalent 
refractive index from Purkinje image heights together with the refraction 
determined from the optometer setting, corneal radii of curvatures obtained 
from Pentacam, and corneal thickness, anterior chamber depth, lens 
thickness, vitreous and axial length obtained from Lenstar.  
 
Heights of PI, PIII and PIV were estimated from the image which was taken 
when the participant was looking at the central (5th) fixation target. These 
heights were the averages of horizontal and vertical components of the 
ellipse fitted to the Purkinje images. Three images were analysed for each 
participant and the heights were averaged.  
 
Corneal radii of curvatures were obtained from Pentacam, and corneal 
thickness, anterior chamber depth, lens thickness and axial length were 
obtained from Lenstar. Three readings were taken for each parameter and 
The merit function was set to terminate when further improvement was not 
possible or after a specified number of cycles; 2000 cycles was set as the 
number of cycles and ensured that the function was not terminated without 
reaching its optimum value. 
 
Two types of algorithms have been used to estimate the lens radii of 
curvature from the Purkinje image sizes: the equivalent mirror theorem and 
the merit function. The merit function is more accurate than the equivalent 
mirror theorem because the latter overestimates the posterior radius of 
curvature (Rosales, Dubbelman, Marcos, & Van der Heijde, 2006). For this 
study I used the merit function (Atchison, et al., 2008), but here I provide an 
explanation of both algorithms.  
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3.5.5.4.1 The Equivalent Mirror Theorem 
The equivalent mirror theorem states that an optical system comprising one 
or more refracting surfaces followed by a plane or spherical mirror can be 
replaced by an “equivalent” spherical mirror. The vertex and centre of 
curvature of the equivalent mirror are the images of the vertex and centre of 
curvature of the mirror as formed by the refracting elements.  
 
For the posterior cornea the refracting surface is the anterior cornea. As the 
posterior cornea image is usually not visible we usually ignore it and a three 
Purkinje image eye model is used. For the anterior lens surface, the refracting 
element is the cornea. For the posterior lens surface, the refracting elements 
are the cornea and the anterior lens surface. 
 
Lens Anterior Surface  
The radius of curvature er 2' of the equivalent mirror for the anterior lens 
surface is given by 
                                                            )'/'(' 1312 hhrr e  ........... (3.22) 
where 1'h  and 3'h  are the heights of first and third Purkinje images, and 1r  is 
the radius of curvature of the anterior cornea. 
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Figure 3:22 Equivalent mirror method for determining anterior radius of curvature of lens. 
  
In Figure 3:22, 
eA2  is the vertex and eC 2  is the centre of curvature of the 
anterior surface of equivalent mirror, 2A  is the vertex and 2C  is the centre 
of curvature of anterior lens surface, 
ad1  is the apparent anterior chamber 
depth, 1d  is the real anterior chamber depth, er2  is the radius of curvature of 
the equivalent mirror, 2r  is the radius of curvature of the anterior lens 
surface, and n1 and n2 are the refractive indices of air and aqueous humour.  
Now  
2121 rdCA  and eae rdCA 2121  .....(3.23, 3.24) 
Since 2C  and eC 2  are conjugate by refraction at the cornea 
)/(1)/(' 21212 ea rdrdnLL   ......... (3.25) 
The only unknown, 2r  can be determined. 
 
Lens Posterior Surface 
The radius of curvature of the equivalent mirror corresponding to the 
posterior surface is given by 
)'/'(' 1413 hhrr e  .......... (3.26) 
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where 1'h  and 4'h  are the heights of first and fourth Purkinje images, and 1r  is 
the radius of curvature of the cornea. The method described for the anterior 
lens surface can be modified for the posterior lens surface (Figure 3:23). 
 
 
Figure 3:23 Determining posterior radius of curvature of lens. 
 
Alternatively, if the ocular refraction K, the intraocular lengths, the corneal 
and anterior lens surface radii of curvature are known, ray-tracing can be 
done from the far point (l = 1/K) to the posterior lens surface. The image 
reduced vergence 
3'L  and posterior lens surface power 3F  are given by 
343 /'' dnL   and 333 ' LLF  ............(3.27), (3.28) 
and the posterior lens surface radius of curvature is given by  
34
3
3
nn
F
r

 ................ (3.29) 
 
3.5.5.4.2 Merit Function 
Several studies have used merit functions to calculate lens radii of curvature 
(Atchison, et al., 2008; Garner, 1997; Rosales, Wendt, Marcos, & Glasser, 
2008). The merit function used here is a recursive technique which is a 
combination of three components. One component (MF1) is the square of the 
difference between actual and predicted vitreous length obtained from ray 
tracing into the eye to the retina. Two other components (MF2 & MF3) are the 
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squares of the difference between measured and predicted Purkinje image 
separations obtained from ray tracing into- and then out-of-the-eye after 
reflection from the lens front or back surfaces. MF can be expressed as 
2
exp44
2
exp33
2
exp321 )()()( hhhhVVMFMFMFMF thethethe  .... (3.30) 
The input values Vexp, h3exp and h4exp are the experimental vitreous length and 
the experimental heights of PIII and PIV, respectively. Vthe, h3the and h4the are 
the vitreous length and the theoretical heights of PIII and PIV, respectively, 
which are obtained recursively by ray tracing. Lens radii of curvature and 
equivalent refractive index are estimated by varying them to minimise the 
merit function. The anterior radius of curvature affects all components of the 
merit function, and the posterior radius of curvature and equivalent 
refractive index affect the first and third components. Vthe is determined by 
ray tracing into the eye to the retina after refraction at the cornea and lens.  
 
The paraxial ray tracing involved with determining MF2 will be described. 
While four surface eye models are used in this study, to simplify the 
explanation a three surface eye model omitting the posterior cornea will be 
assumed. An image formed by refraction at a surface is given by: 
)'(
'
'
nnlrn
lrn
l

 ...... (3.31)  
where n and 'n  are the refractive indices in the object and image spaces, 
respectively, and l  and 'l  are the object space and image space distances, 
respectively. By putting 'n  = − n , we can get the reflected image position in a 
surface:  
rl
lr
l


2
' ...... (3.32) 
 
The transverse magnification is given by:  
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lr
r
l
l
M
2
'

 ...... (3.33) 
 
Figure 3:24 Three-surface schematic eye for paraxial ray tracing. 
 
In Figure 3:24, 1r  is corneal radius of curvature, 2r  is anterior lens radii of 
curvature, 3r  is posterior lens radius of curvature, 1d  is anterior chamber 
depth, 2d  is lens thickness, and 1n , 2n , 3n  and 4n are the refractive indices of 
air, aqueous humour, lens and vitreous, respectively. 
 
PI height:  
The position of PI relative to the cornea is given by (Figure 3:25): 
110
110
11
2 rl
rl
l

 ...... (3.34) 
where 10l  and 11l  are the distances of the object and PI from the cornea, 
respectively, and 1r  is the corneal radius of curvature. Magnification is given 
by:  
10
11
1
l
l
M  ...... (3.35) 
The height of PI is given by: 
111' hMh  ...... (3.36) 
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where 1h is the object height and h’1 is the first Purkinje image height.  
 
 
Figure 3:25 Parameters involved in determining height of PI. 
 
PIII height:  
Ray tracing is performed. In figure 3:26, 3h is the object height and 3'h  is PIII 
image height, 30l  is the object position from cornea, 31l  is the image distance 
from cornea, 32l  is the object position from lens, 33l  is the image position 
with respect to lens, 34l  is the object position from cornea and 35l  is the 
image position with respect to cornea. 
 
\ 
Figure 3:26 Parameters involved in determining height of PIII 
 
  
     93 | P a g e |  
Chapter 3: Methodology 
Refraction at the lens: 
 
 
)( 123011
2130
31
nnlnr
nrl
l

 ...... (3.37) 
Referred to the anterior lens surface: 
 13132 dll   ...... (3.38) 
where 1d  is the anterior chamber depth and 32l  is the object distance referred 
to the lens. Reflection at the anterior lens surface gives 
 
232
232
33
2 rl
rl
l

 ...... (3.39) 
where 2r is one of the variables evaluated by the merit function. 
 
Referred to the cornea: 
 
 13334 dll  ...... (3.40) 
where 35l is the object position with respect to cornea. 
 
Refraction at the cornea: 
 
)( 213421
1134
35
nnlnr
nrl
l

 ...... (3.41) 
where 35l is the image position after refracting from the cornea. PIII 
magnification is  
33234
313335
3
lll
lll
M  ...... (3.42) 
Heights of PIII and PI are 
111' Mhh   313' Mhh   ...... (3.43) 
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1
3
1
3
'
'
M
M
h
h
 ...... (3.44) 
 
Determining MF3: 
 
To evaluate the MF3 component of the merit function in equation 3.30 
involving the height of PIV, a similar procedure is followed as for the MF2 
component involving the height of PIII, considering the refraction in the 
anterior lens and reflection in the posterior lens surface.  
 
Modelling for phakometry: 
 
For the Phakometry procedure, a four refracting surface model eye was used. 
The Badal setting for the phakometer provided the refraction. The Lenstar 
was used to determine intraocular ocular distances (see next paragraph for 
an explanation of how vitreous depth was obtained). The averages of 
anterior and posterior principal meridians radii of curvature of the cornea 
were obtained from the Pentacam. Refractive indices of the cornea, aqueous 
and vitreous at 555 nm were taken as those of the Gullstrand number 1 eye: 
1.376, 1.336 and 1.336, respectively. Refractive indices for the source of 
wavelength 890 nm were determined from the dispersion equations 
provided by Atchison & Smith (2005) (their Table 5): 1.36822, 1.32829 and 
1.32855, respectively. Atchison & Smith also provided a correction to the 
refraction (their equation (5a)): 
Rx890 = Rx555 + 0.839 ….. (3.45) 
After the lens radii of curvature and lens equivalent index were determined, 
an estimate of lens refractive index at 555 nm was made. From the equations 
for the different media given by Atchison & Smith, a linear relationship 
between the lens indices at the two wavelengths is 
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nL555 = 1.0262nL890 – 0.0273 …. (3.46) 
Lens equivalent power Fe at 555 nm was calculated from 
Fe = FL1 + FL2 – (tL/nL)FL1FL2 ….(3.47) 
where nL is lens refractive index at 555 nm, tL is lens thickness, and FL1 and FL2 
are the front and front surface powers determined from  
FL1 = (nL – na)/rL1, FL2 = (nv – nL)/rL2 ….(3.48a, 3.48b) 
with na and nv being refractive indices of aqueous and vitreous at 555 nm, 
and rL1, and rL2 being radii of curvature of the lens front and back surfaces. 
 
A note is added here about determining vitreous length. The Lenstar 
determines the position of the retinal epithelium, and its default axial length 
is determined by subtracting 200 m assumed to be the distance from the 
retinal pigment epithelium to the internal limiting membrane. For the 
purpose of phakometry only, I have reinstated the 200 m because the 
position of the photoreceptors, rather than the internal limiting membrane, is 
relevant for refraction. The vitreous length, which is not given by the Lenstar, 
was calculated by subtracting the sum of the corneal thickness, anterior 
chamber depth and lens thickness from the axial length. 
 
3.5.6 Magnetic Resonance Imaging 
Magnetic resonance imaging (MRI) visualises detailed internal structure and 
soft tissues of the body with great contrast. It is a non-optical and non-
invasive technique that can take images of the whole eye in vivo with 
multiple slices of any desired plane or planes. 
 
MRI is based on the principles of nuclear magnetic resonance (NMR). It uses 
a powerful magnetic field to align the nuclear magnetisation of hydrogen 
nuclei in the body and radio frequency (RF) fields to systematically alter the 
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alignment of the magnetization. This causes the nuclei to produce a rotating 
magnetic field detectable by the scanner. To gather enough information to 
construct an image, this signal is manipulated to encode spatial information 
by the application of magnetic field gradients (Novelline & Squire, 2004).  
 
Procedures 
MRI was used to measure the lens refractive index distribution and lens 
diameter using a 3 Tesla (Siemens Trio) whole body scanner in the Centre for 
Advanced Imaging at the University of Queensland. 
 
Participants with and without diabetes were sub-divided into young (18 – 30 
years) and older (47 – 60 years) age groups. As well as the selection criteria 
given in section 3.1 and clinical MRI scanning criteria, participants with 
diabetes in the young group had at least 2 D of amplitude accommodation 
(section 3.5.3.1), and participants in the older group had at least ten years of 
diabetes duration. Female participants were advised not to use eye makeup 
(including mascara) on the day of experiment to avoid artefacts that arise 
from the high magnetic susceptibility properties of mascara.  
 
Special considerations were taken for the participants with diabetes. After 
they gave written consent, their insulin pumps were removed from their 
bodies. Blood glucose levels were measured, and participants with high 
blood levels were advised to inject insulin before scans and were rested for at 
least 15 minutes.  
 
During the MRI procedure, participants were positioned supine on the table 
and heads were stabilised with appropriate padding. An adjustable mirror 
able to move vertically was mounted at approximately 45° angle to the 
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vertical in the magnetic bore. Participants were asked to focus (through the 
mirror) on a white Maltese cross fixation target on a black background 
presented on a translucent screen at the end of the magnet bore at 
approximately 0.93 m from the eye (Figure 3:27). 
  
A standard 4.0 cm (Siemens) receiver coil was taped over the examined eye 
so that the target was visible through the coil hole. A thin spacer made from 
self-adhesive felt glued to the surface of the coil body was used to minimise 
skin contact with the coil, in order to protect against localised RF heating. 
The non-examined eye was occluded using a patch. Participants were 
instructed to focus and fixate on the target, and minimize blinking during 
data acquisition. They were advised to blink and/or close their eyes between 
data acquisitions to avoid eye dryness.  
 
For the young participants, measurements were performed with and without 
accommodation stimulation, whereas for the older participants 
measurements were performed only without accommodation stimulation. 
All images were taken with best corrected refraction in place by attaching a 
suitable lens to the 20 mm thick surface coil on the opposite side from the 
participant’s eye. In the young diabetic group 4 D of accommodation was 
stimulated, while in the young non-diabetic group 5 D of accommodation 
was stimulated with negative lenses. The maximum amplitude of 
accommodation was measured in each participant before the MRI procedure 
(section 3.5.3.1). Participants were advised to focus on the target without 
excessive effort and to avoid any head movement. 
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Figure 3:27 Schematic diagram of fixation target during MR imaging procedure 
 
Imaging protocol 
MRI has relatively slow acquisition rates, limited signal-to-noise ratio (S/N), 
is prone to artefacts and has limited resolution. Several factors influence the 
signal-to-noise ratio (Table 3:2). 
Pilot experiments were performed to test the effects of different parameters 
on the image quality, in order to minimise image artefacts and to optimise 
the Signal-to-Noise ratio (Table 3:2). High resolution images were obtained 
with the 4.0 cm surface coil and were compared with a 32-channel phased-
array head coil. The surface coil showed superior results in respect of signal-
to-noise ratio and image resolution, although the latter had the advantage of 
imaging both eyes together.  
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Table 3:2 Different parameters affecting the Signal to Noise Ratio in MR images 
Parameter SNR Resolution Scan time 
Increasing slice thickness Increases Decreases Decreases 
Increasing FOV Increases Decreases Increases 
Increasing matrix size Increases Increases Increases 
Increasing TR Increases  Increases 
Increasing TE Increases  Increases 
Increasing NEX Increases  Increases 
Increasing magnetic field strength Increases   
Employing local coils Increases   
 
The imaging protocol is given in Table 3:3. The first scan was a localiser scan 
to locate the position of the eye in the centre of the field of view (FOV). 
Multi-slice fast spin echo (FSE) images (64 mm FOV; 256 x 256 matrix; 2 mm 
slice thickness (no gaps); TR = 4000; TE=16; echo train length 12, imaging 
time 128 s) were obtained in both axial and sagittal planes. A T2-weighted 
half-Fourier acquisition single shot turbo spin echo sequence (HASTE) 
generated 3 D isotropic images of the eye with 0.5 mm cubic voxels (128 x 
128 x 64 matrix; TR = 2500; TE = 56; imaging time 4 min.). A single slice multi-
echo spin (MSE) sequence (64 mm FOV; 256 x 256 matrix; 2 mm slice 
thickness; TR = 2000; 4 echos: TE = 12.5 / 25 / 37.5 / 50; imaging time 4.5 mins.) 
was used to acquire data for calculating the refractive index distribution 
through the lens. For this purpose, a single slice was placed through the 
symmetry axis of the lens, using the centre slice from the sagittal FSE image 
to identify this axis. For young participants, after placing negative lenses 
over the eye to stimulate accommodation, the protocol was repeated except 
for the FSE axial and HASTE 3 D imaging. Images in the table having serial 
numbers “6” and “9” were used to calculate lens refractive index 
distribution.  
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The transverse or spin-spin relaxation time (T2) is inversely proportional to 
the concentration of macro-molecules (notably crystallin proteins), which in 
the crystalline lens is related to refractive index (Jones & Pope, 2004). 
Consequently, a multi-spin echo (MSE) sequence can be used to obtain a map 
of the T2-distribution through the lens, which is then converted to a 
refractive index map using a calibration equation (see below). Lens refractive 
index distribution can be determined (Jones, et al., 2005; Jones & Pope, 2004; 
Kasthurirangan, et al., 2008) using the decay of pixel signal intensity S fitted 
to the single exponential decay equation: 
ETRExpSS 20
 ...... (3.49) 
where TE is the delay between 180 pulses known as the echo time, S0 is the 
pixel intensity extrapolated to TE = 0 (the signal corresponding to the 
equilibrium or steady state magnetisation), and R2 is the inverse of T2 and is 
the relaxation rate for the lens location (voxel) corresponding to the pixel.  
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Table 3:3 Protocol for the MR imaging. 
 
             
Series 
No 
Type Orient’n
. 
Slice 
Thick 
No. 
Slices 
Slice 
Space 
FOV Matrix TR TE FAT 
SAT 
No. 
Avgs 
Image 
Time 
Non-accommodated images 
1 & 2 Localisers            
3 FSE (ETL=12) Axial 2 mm 15 Nil 64 
mm 
256x256 4000 16 Y 1 2min 8s 
4 FSE (ETL=12) Sagittal 2 mm 15 Nil 64 
mm 
256x256 4000 16 Y 1 2min 8s 
5 3D HASTE Axial 0.5 mm 64 Nil 64 
mm 
128x128 2500 56 Y 2 4min 2s 
6 MSE Axial 2 mm 1 N/A 64 
mm 
256x256 2000 12.5/25/37.5/50 
ms 
Y 1 4min 32s 
Accommodated images 
7 Localiser            
8 FSE (ETL=12) Sagittal 2 mm 15 Nil 64 
mm 
256x256 4000 16 y 1 2min 8s 
9 MSE Axial 2 mm 1 N/A 64 
mm 
256x256 2000 12.5/25/37.5/50 
ms 
Y 1 4min 32s 
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The transverse relaxation rate R2 was determined for each lens pixel using 
equation (3.49). The R2 map was transformed to a refractive index map at 589 
nm wavelength of light using Jones et al.’s (2005) calibration equation: 
2
26
2 1034.6001549.03554.1 RxRn
 ...... (3.50) 
where n is refractive index. 
 
A normalised refractive index distribution can be defined along the axis and 
equator of the crystalline lens according to (Jones, et al., 2005; 
Kasthurirangan, et al., 2008; Smith, Atchison, & Pierscionek, 1992): 
  pprccrn  0 ...... (3.51) 
where r is the normalised distance from the lens centre (r = 0 at the centre 
and r = 1 at the periphery), C0 is the index at the lens centre, Cp is the 
difference in refractive index between the lens centre and periphery, and the 
exponent p characterises the GRIN rate of change. Along the optical axis, the 
normalised optical path [OP] from the lens centre to the surface is 
  )1/()1/()()(][ 1
0
1
1
0
1
0
   pccprcrcdrrccdrrnOP po
p
po
p
po
...... (3.52) 
which is the average index nav since the normalised true path is 1.0. 
 
If uncertainties are known in the individual parameters, such as might be 
given by standard errors when fitting to equation (3.51), the uncertaintly in 
nav is given by 
20 )1(1 





p
pC
p
C
Cn
pp
av ....... (3.53) 
 
Data Processing 
Imaging analysis was performed using custom built software written in 
Matlab to measure refractive index distribution. There were four steps 
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involved in analysis of the image to measure refractive index a) rotation of 
the image to a common axis for image analysis purposes for all participants, 
b) segmentation of the lens from the whole MSE image, c) extracting the 
whole lens refractive index map, and d) selecting axial and equatorial lens 
refractive index profiles. 
 
For rotation, a straight line was drawn by the user from the left edge to the 
right edge of the lens using the mouse (Figure 3:28b). The software calculates 
the angle of line between the line drawn by the user relative to the horizontal 
and the image is rotated according to the angle. After rotation a visual check 
is performed to confirm that appropriate rotation has been obtained to align 
the symmetry axis of the lens with the vertical; otherwise the user repeats the 
process until a satisfactory result is obtained. 
 
Next, the user draws (with a mouse) a rectangular box around the lens which 
defines the region of interest. The analysis software identifies the pixel 
intensity from each of the four MSE images and computes the refractive 
index value for each pixel using the procedure outlined in the previous 
section (Figure 3:29a). The software then automatically segments out the lens 
from the rest of the image using a threshholding algorithm (Figure 3:29b). 
Although the iris touched the anterior lens (Figure 3:28a), this did not affect 
the process because the signal from the iris decayed much more slowly in the 
later echo images. Pixels corresponding to the aqueous and vitreous 
humours were artificially assigned a refractive index of 1.336 
(Kasthurirangan, et al., 2008). 
 
Due to motion and blinking artefacts in some participants, MSE images and 
hence refractive index maps suffered from noise. Therefore, and in order to 
make comparisons between different subject groups, lens refractive index 
     104 | P a g e |  
Chapter 3: Methodology 
profiles were computed using the line of pixels closest to the lens axis or 
equatorial diameter, and also from a 3-pixel-wide band centred on these axes 
(Figure 3:29c). For this purpose, the segmented lens was used, and the rows 
and columns of data in the refractive index maps that corresponded most 
closely to the equator and axis of the lens respectively were identified. For 
example, in Figure 3:29c equatorial profiles were computed from the centre 
row and by averaging the three pixel wide band of refractive indices 
perpendicular to the equatorial direction. As MSE images had in-plane 
resolution of 0.25 mm and slice thickness of 2 mm, this gave an effective 
voxel size of 0.375 mm3 (3 * 0.25 * 0.25 * 2). The central refractive index was 
calculated as the mean refractive index over nine pixels at the lens centre. 
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Figure 3:28 Right eye MSE image of a 28 years old non diabetes participant at different 
stages of eye rotation procedure for analysis. a) First stage, before applying the rotation 
algorithm, b) second stage, when a line was drawn through the equatorial diameter line of 
the lens c) and finally when the desired eye rotation was achieved.  
 
  
a b 
c 
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Figure 3:29 Schematic representation of the refractive index extraction procedure from the 
MSE images and schematic diagram of lens dimensions measurement. (a) Customised 
software identified pixels within the image and generated  a refractive index distribution 
map of the lens (b) A segmentation algorithm segmented the lens from the rest of the 
refractive index map. The vertical and horizontal axes of the figure represent pixels. (c) 
Profiles of refractive index over a central single pixel row and averaged over 3 rows of 
pixels, plotted against pixel number: Left) in the equatorial direction closest to the 
equator, with pixels from left to right indicating nasal to temporal refractive index data; 
Right) in the axial direction closest to the lens axis, with pixels from left to right 
indicating anterior to posterior refractive index data. Each pixel represents 0.25 mm. 
 
The first MSE image (TE = 12.5 ms) with the best S/N and contrast was 
selected to determine lens diameter and axial thickness manually using 
ImageJ software (developed by Wayne Rasband, National Institutes of 
Health, available in public domain at http://rsbweb.nih.gov/ij/index.html). 
The equatorial diameter was measured along the equatorial diameter line 
between nasal and temporal edges of the lens and the axial thickness was 
measured along the optical axis between the anterior and posterior edges of 
the lens. An anterior axial thickness was measured from the anterior edge of 
the lens to the centre of the equatorial diameter line. Similarly, a posterior 
a b 
c 
     107 | P a g e |  
Chapter 3: Methodology 
axial thickness was measured from the posterior edge to the centre of the 
equatorial diameter line. 
 
To analyse refractive index data, lens dimensions were normalised for each 
person. For the equatorial diameter line, the normalised dimension extended 
from –1 to +1. The data were folded about the optical axis to give a 
normalised dimension 0 to +1, and group data were fitted according to 
equation (3.51). 
 
The optical axis dimension was normalised in two different approaches. In 
the first approach, normalisation extended from –1 to +1 relative to the 
midpoint between the anterior and posterior vertices of the lens for each 
person. The data were folded about the midpoint (red dot in Figure 3:30) to 
give a normalised dimension 0 to +1, and group data were fitted according to 
equation (3.51). In the second approach, separate analyses were done for the 
portions anterior and posterior to the equatorial diameter line (blue dot 
Figure 3:30) with normalised dimension for each portion of 0 to +1.  
 
The normalisation and fitting were similar to those used by Kasthurirangan 
et al. (2008), except that they normalised each person’s dimensions to the 
average equatorial diameter or axial thickness of the relevant group and they 
did not use the second normalisation approach for the axial data. 
 
Figure 3:30 Lens dimensions for refractive index profiles 
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Chapter 4:  Results 
This chapter presents all results except for the pilot data of Chapter 3. It has 
eight main sections. Section 4.1 covers general characteristics of participants 
in the study and reasons why some participants did not do particular tests. 
Section 4.2 contains ocular biometry results of spherical equivalent refraction, 
anterior corneal radius of curvature, anterior corneal asphericity, corneal 
central thickness, posterior corneal radius of curvature, anterior chamber 
depth, pupil diameter, pupil decentration, anterior lens radius of curvature, 
posterior lens radius of curvature, lens central thickness, lens equivalent 
refractive index and lens equivalent power. Sections 4.3, 4.4, 4.5, 4.6 and 4.7 
cover straylight, amplitude of accommodation, ocular aberration and its 
components, lens yellowing, and lens dimensions and refractive index 
distribution, respectively. A summary section 4.8 lists the significant multiple 
regression equations found in previous sections.  
 
For each parameter in sections 4.2 to 4.6, simple regression correlations are 
given with the systemic and ocular factors of age, diabetes duration, HBA1c 
level, spherical equivalent refraction, axial length and gender. This is 
followed by multiple regressions, both to the whole group of participants 
(with duration for the participants without diabetes given as zero) and to 
only the diabetes group, to investigate the importance of age and duration of 
diabetes to the parameter. Where factors of gender or axial length were 
significant according to the simple regressions (spherical equivalent 
refraction), these were included in the multiple regression i.e. the analyses 
were “adjusted” for the influence of these factors.  
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T-test results comparing the groups are for the mean of the non-diabetes 
group subtracted from the diabetes group, together with 95% confidence 
intervals. 
 
Figures show dependence of parameters on age for both diabetes and non-
diabetes groups, and ANCOVA analysis is presented determining the 
significance of the group differences in rate of change with age. For lens 
dimensions and refractive index (section 4.7), ANOVAs and unpaired t-tests 
are shown that consider the influence of age group and diabetes status. For 
each parameter in sections 4.2 - 4.7, there is a discussion of results with reference to 
previous studies. 
 
4.1 Characteristics of Participants  
There were 138 participants, consisting of 74 people with diabetes and 64 
people without diabetes. As mentioned at the end of section 3.1, twenty 
people had already been excluded in the analyses because HbA1c assays were 
not able to be performed. Different numbers of participants were available 
for different tests. Reasons included limited time available with the 
participants, the C-Quant instrument for straylight analysis not being 
available from the start of experimentation, eligibility of participants for 
particular tests e.g. amplitude of accommodation was measured only in 
participants less than 47 years of age, and limited funds available for 
magnetic resonance imaging (Table 4:1).  
 
Participant groups were well balanced for age. The mean age and standard 
deviation of the group with diabetes were 42 ± 13 years (range 19 – 63 years), 
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with a duration of diabetes of 20 ± 11 years (3 – 52 years). The mean age and 
standard deviation of the group without diabetes were 41 ± 13 years (20 – 62 
years .  
 
There was a significant gender difference between the two groups, with 
fewer females than males in the diabetes group (30/44) and fewer females 
than males in the non-diabetes group (44/20). Many more females than males 
without diabetes volunteered in response to advertisements, while more 
males than females already in the LANDMark study agreed to take part. 
Normality testing found that only straylight and corneal and total ocular 
spherical aberration coefficients were not normally distributed. However, the 
residuals of the straylight were normal distributed. Transformations were 
tried unsuccessfully to normalise the data, and it was decided to ignore this 
deficiency and treat these parameters as if the data were normally 
distributed.  
 
There was no significant difference in visual acuity between the groups with 
and without diabetes, but log contrast sensitivity was significantly higher in 
the non-diabetes group (1.89 ± 0.10) than in the diabetes group (1.81 ± 0.14). 
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Table 4:1 Participants recruited for different tests and numbers after exclusion 
 People with 
diabetes 
People 
without 
diabetes 
Reasons for not participating, except for lack of 
time availability, and exclusion 
Total participants 74 64  
Anterior corneal radius of 
curvature and asphericity 
(Medmont) 
50/47 49/47 Five participants’ images were too poor for 
analysis 
Phakometry 72/67 62 In 5 participants, PIII quality was poor 
Pupil decentration 50/47 49/47 As for corneal r-o-c, five participants’ images 
were too poor for analysis 
Straylight (C-Quant) 63 57 Instrument not available at start of study 
Amplitude of 
accommodation 
42 32 Limited to people < 47 years 
Aberrations 50/46 49/47 As for corneal r-o-c, five participants’ corneal 
images were too poor for analysis and one 
participant with pupil diameter less than 4.5 
mm was excluded from the diabetes group 
Flicker photometry – lens 
yellowing 
38/30 45/41 Eight participants in diabetes group and four 
participants in non-diabetes group were not 
able to perform the test 
MRI 
young group 
(18 – 30 years)  
older group 
(47 – 60 years) 
 
7 
 
10 
 
13 
 
10 
Expense. One participant blinked excessively 
and image quality was poor, and another was 
not completed because of claustrophobia. 
 
 
Figure 4:1 Relationships between age and diabetes duration. Regression fit is Y = 
+0.385(±0.097)Age + 3.74(±4.24), R2 0.18, p < 0.001. Values in brackets are standard errors. 
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Figure 4:1 compares diabetes duration with age. While there was a 
significant linear relationship, the correlation was low. Some of the older 
participants had diabetes for only a short time e.g. see the cluster of 3 people 
with ages 58 - 62 years and durations less than 5 years.  
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4.2 Ocular Biometry  
Table 4:2 shows the characteristics of the subject who took part in the ocular 
biometry tests. 
Table 4:2 Characteristics of participants  
 People with diabetes People without 
diabetes 
P-values 
Number of participants 74 64 0.48 
Age (mean ± SD, age range), years 40 ± 12, 19 − 63 43 ± 12, 20 − 62 0.77 
Number of eyes (R/L) 48/26 54/10 < 0.01* 
Gender (F/M) 30/44 44/20 0.001* 
Visual acuity (Log-MAR) −0.02 ± 0.21 −0.04 ± 0.20 0.55 
Log contrast sensitivity 1.81 ± 0.14 1.89 ± 0.10 < 0.001* 
Spherical equivalent refraction (D), aberrometer −0.58 ± 1.13 −0.44 ± 0.94 0.44 
Anterior corneal radius of curvature (mm), 
Pentacam 
+7.76 ± 0.22 +7.82 ± 0.27 0.15 
Anterior corneal radius of curvature (mm), 
Medmont 
+7.73 ± 0.20 +7.78 ± 0.23 0.24 
Anterior corneal asphericity Q −0.06 ± 0.13 −0.07 ± 0.12 0.86 
Corneal centre thickness (mm), Pentacam 0.545 ± 0.032 0.537 ± 0.043 0.26 
Corneal centre thickness (mm), Lenstar 0.542 ± 0.031 0.537 ± 0.037 0.37 
Posterior corneal radius of curvature (mm) +6.36 ± 0.24 +6.43 ± 0.26 0.07 
Anterior chamber depth (mm), Pentacam 2.75 ± 0.40 2.86 ± 0.36 0.09 
Anterior chamber depth (mm), Lenstar 2.74 ± 0.40 2.89 ± 0.34 0.03* 
Pupil diameter (mm) 5.96 ± 0.90 6.22 ± 0.84 0.08 
Pupil decentration along x-axis (mm) +0.17 ± 0.50 +0.30 ± 0.42 0.19 
Pupil decentration along y-axis (mm) +0.11 ± 0.33 +0.16 ± 0.32 0.43 
Anterior lens radius of curvature (mm) +9.53 ± 1.08 +10.62 ± 1.14 < 0.001* 
Posterior lens radius of curvature (mm) −5.89 ± 0.72 −6.32 ± 0.74 < 0.01* 
Lens equivalent refractive index, 555nm 1.426 ± 0.011 1.431 ± 0.012 < 0.01* 
Lens central thickness, Lenstar 4.31 ± 0.49 4.01 ± 0.36 < 0.001* 
Lens equivalent power (D), 555 nm 25.06 ± 3.27 24.28 ± 2.33 0.13 
HbA1c (m mol) 7.80 ± 1.11 5.03 ± 0.31 < 0.001* 
Blood glucose level (m mol) 9.30 ± 3.55 – – 
Diabetes duration (years) 19 ± 9 – – 
* indicates significant difference between groups. Data are expressed as the mean ± standard deviation 
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4.2.1 Spherical Equivalent Refraction 
Spherical equivalent refraction was calculated in all participants using the 
aberrometer (section 3.5.3.1). Table 4:3 shows the Pearson correlations of 
spherical equivalent refraction with various ocular and systemic factors for 
the whole group. Spherical equivalent refraction was correlated significantly 
only with age, lens thickness and axial length.  
 
Table 4:3 Pearson correlations of spherical equivalent refraction with different ocular and 
systemic factors 
 
 
Age Diabetes 
duration 
HbA1c Lens 
thickness 
Axial 
length  
Gender 
Correlation 
co-efficient 
p 
0.19 
 
0.03* 
0.03 
 
0.76 
−0.06 
 
0.50 
0.18 
 
0.03* 
−0.43 
 
< 0.001* 
−0.02 
 
0.78 
* indicates significance 
 
Multiple regression analysis was performed with age and diabetes duration 
as predictors using the whole group after adjustment for axial length AL. Age 
and axial length contributed significantly to the fit: 
y = +0.020(±0.007)Age − 0.538(±0.090)AL + 11.45(±2.14), R2 = 0.24  
When the multiple regression analysis was restricted to the diabetes group, 
again age and axial length contributed significantly to the fit: 
y = +0.025(±0.010)Age − 0.660(±0.134)AL + 14.11(±3.14), R2 = 0.29  
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Figure 4:2 Relationships between age and spherical equivalent refraction for people with 
and without diabetes. Fit for diabetes group: Y = +0.016(±0.010)Age – 1.23(±0.45), R2 0.03, p 
0.14; fit for non-diabetes group: Y = +0.016(±0.009)Age – 1.10(±0.40), R2 0.05, p 0.10. Values 
in brackets are standard errors. 
 
Figure 4:2 shows the mean spherical equivalent refraction as a function of 
age for the two groups. ANCOVA did not find a significant difference in 
regression slopes between the groups (F1, 133 = 0.00, p 0.99). The difference in 
refraction between the groups was –0.16 ± 0.49 D (mean ± 95% CI, p 0.44). 
 
Discussion 
The multiple regression analyses show significant association of age and 
axial length, but not of diabetes, with spherical equivalent refraction. It is 
well known that axial length is the major determinant of spherical refraction 
e.g. Atchison et al. (2008) and that refraction in adults moves in the 
hyperopic direction as age increases e.g. Atchison and Smith (2000a). The 
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simple linear fits in Figure 4:2 do not confirm the age trend with spherical 
refraction, but taking the analyses together indicates that the participant 
group is reasonably representative of the general population. I note that 
Wiemer et al.’s (2008d) study including 114 DM1 participants and 74 non-
diabetes participants did not find a significant difference between groups. 
 
To conclude, diabetes does not appear to have influenced spherical 
equivalent refraction. 
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4.2.2 Anterior Corneal Radius of Curvature 
Table 4:4 shows the Pearson correlations of anterior corneal radius of 
curvature with various ocular and systemic factors for the whole group for 
both Pentacam and Medmont instruments. In the case of the Pentacam, 
anterior radius of curvature was correlated significantly with axial length 
and gender, while in the case of the Medmont measurement anterior radius 
of curvature was only correlated significantly with axial length.  
 
Table 4:4 Pearson correlations of anterior corneal radius of curvature (Pentacam, 
Medmont) with different ocular and systemic factors 
 Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Axial 
length 
Gender 
Correlation 
co-efficient 
(Pentacam) 
p 
 
 
−0.07 
 
0.42 
 
−0.13 
 
0.14 
 
−0.11 
 
0.23 
 
−0.10 
 
0.26 
 
−0.07 
 
0.40 
 
0.65 
 
< 0.001* 
 
0.19 
 
0.02* 
Correlation 
co-efficient 
(Medmont) 
p 
 
 
0.02 
 
0.89 
 
−0.10 
 
0.32 
 
−0.14 
 
0.20 
 
−0.04 
 
0.69 
 
0.04 
 
0.71 
 
0.46 
 
< 0.001* 
 
0.01 
 
0.91 
* indicates significance 
 
For both Pentacam and Medmont, multiple regression analysis was 
performed with age and diabetes duration as predictors after adjusting for 
gender and axial length using the whole subject group. For the whole group 
or for the diabetes group, neither factor contributed significantly to the fit. 
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Figure 4:3 Relationships between age and anterior corneal radius of curvature (using 
Pentacam) for people with and without diabetes. Fit for diabetes group: Y = 
−0.001(±0.002)Age + 7.78(±0.09), R2 0.00, p 0.77; fit for non-diabetes group: Y = 
−0.002(±0.003)Age + 7.90(±0.12), R2 0.01, p 0.45. Values in brackets are standard errors. 
 
Figure 4:4 Relationships between age and anterior corneal radius of curvature (using 
Medmont) for people with and without diabetes. Fit for diabetes group: Y = −0.001 (± 
0.002)Age + 7.70 (±0.11), R2 0.00, p 0.75; fit for non-diabetes group: Y = −0.001(±0.003)Age + 
7.81(±0.13), R2 0.00, p 0.81. Values in brackets are standard errors. 
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Figure 4:3 and Figure 4:4 show corneal anterior radius of curvature as a 
function of age for the two groups. There was no significant age trend in 
either group. The mean differences between the groups measured with 
Pentacam and Medmont of −0.06 ± 0.09 mm (mean ± 95% CI, p 0.15) and 
−0.05 ± 0.09 mm (mean ± 95% CI, p 0.24), respectively, were not statistically 
significant. ANCOVA did not find significant difference in regression slopes 
between the groups for either Pentacam or Medmont (F1, 133 = 0.20, p 0.66 and 
F1, 90 = 0.01, p 0.94, respectively). 
 
Discussion 
The analyses show significant associations of axial length and gender (at least 
for the Pentacam) with anterior corneal radii of curvature as has been found 
previously (Atchison, 2006; Atchison, et al., 2008), but not of diabetes, with 
spherical equivalent refraction. The Pentacam and Medmont instrument 
gave similar results. I note that Wiemer et al. (2007) also did not find any 
significant difference in the anterior corneal  radius of curvature between 
DM1 and non-diabetes groups.  
 
To conclude, neither diabetes nor age appears to have influenced anterior 
corneal radius of curvature. 
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4.2.3 Anterior Corneal Asphericity 
Table 4:5 shows the Pearson correlations of anterior corneal asphericity with 
various ocular and systemic factors for the whole group. Anterior corneal 
asphericity was correlated significantly only with age and axial length. 
 
Table 4:5 Pearson correlations of anterior corneal asphericity with different ocular and 
systemic factors 
 Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Axial 
length 
Gender 
Correlation 
co-efficient 
p 
0.21 
 
0.04* 
 
0.07 
 
0.49 
−0.01 
 
0.95 
0.12 
 
0.26 
−0.10 
 
0.37 
0.34 
 
0.001* 
0.03 
 
0.80 
* indicates significance 
 
Multiple regression analysis was performed with age and diabetes duration 
as predictors using the whole group after adjusting for axial length. Neither 
age nor diabetes contributed significantly to the fit. When the multiple 
regression analysis was restricted to the diabetes group, age alone 
contributed significantly to the fit: 
y = +0.004(±0.002)Age − 0.68(±0.55), R2 = 0.15 
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Figure 4:5 Relationships between age and anterior corneal asphericity for people with and 
without diabetes. Fit for diabetes group: Y = +0.004(±0.001)Age – 0.22(±0.06), R2 0.14, p 0.010; 
fit for non-diabetes group: Y = 0.000(±0.001)Age – 0.08(±0.07), R2 0.00, p 0.85. Values in 
brackets are standard errors. 
 
Figure 4:5 shows the anterior corneal asphericity as a function of age for the 
two groups. The mean difference of 0.01 ± 0.01 mm (mean ± 95% CI) between 
the groups was not statistically significant. ANCOVA did not find a 
significant difference in regression slopes between the groups (F1, 90 = 3.20, p 
0.08). 
 
Discussion 
The simple linear regression analyses showed significant associations of age 
and axial length with anterior corneal asphericity; the former does not match 
a previous study for 101 emmetropes without diabetes using the Medmont 
instrument (Atchison, et al., 2008) which found no effect of age. In the 
subsequent multiple regression analysis, only age was a significant predictor 
and then only for the diabetes group. The mean differences between the 
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groups were not significantly different, as found previously by Wiemer et al. 
(2007).  
 
To conclude, diabetes does not appear to have influenced anterior corneal 
asphericity. 
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4.2.4 Corneal Central Thickness 
Table 4:6 shows the Pearson correlations of corneal central thickness with 
various ocular and systemic factors for the whole group for both Pentacam 
and Lenstar instruments. Corneal central thickness was not correlated 
significantly with any factor in either case.  
 
Table 4:6 Pearson correlations of corneal central thickness (Pentacam, Lenstar) with 
different ocular and systemic factors 
 
 
Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Axial 
length 
Gender 
Correlation 
co-efficient 
(Pentacam) 
P 
 
−0.10 
 
0.29 
 
0.16 
 
0.07 
 
0.03 
 
0.76 
 
0.10 
 
0.27 
 
0.01 
 
0.90 
 
−0.04 
 
0.62 
 
−0.01 
 
0.87 
Correlation 
co-efficient 
(Lenstar) 
p 
 
−0.05 
 
0.58 
 
0.12 
 
0.16 
 
0.01 
 
0.91 
 
0.07 
 
0.41 
 
0.00 
 
1.00 
 
0.02 
 
0.84 
 
−0.03 
 
0.74 
* indicates significance 
 
For the Pentacam, multiple regression analysis was performed with age and 
diabetes duration as predictors using the whole group. Only diabetes 
duration contributed significantly to the fit: 
y = 0.0005(± 0.0003)DiaDur + 0.552(± 0.011), R2 = 0.04 
When the multiple regression analysis was restricted to the diabetes group, 
neither factor contributed significantly to the fit. 
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For the Lenstar, multiple regression analysis was performed with age and 
diabetes duration as predictors using the whole subject group and then only 
the diabetes group. Neither predictor had significant influence in either case. 
 
 
Figure 4:6 Relationships between age and corneal central thickness (Pentacam) for people 
with and without diabetes. Fit for diabetes group: Y = 0.0000(±0.0003)Age + 0.545(±0.013), R2 
0.00, p 0.97; fit for non-diabetes group: Y = –0.0006(±0.0004)Age + 0.560(±0.018), R2 0.03, p 
0.19. Values in brackets are standard errors. 
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Figure 4:7 Relationships between age and corneal central thickness (Lenstar) for people 
with and without diabetes. Fit for diabetes group: Y = 0.0003(± 0.0003)Age + 0.530(±0.013), 
R2 0.01, p 0.35; fit for non-diabetes group: Y = –0.0005(±0.0004)Age + 0.561(±0.016), R2 0.04, p 
0.11. Values in brackets are standard errors. 
 
Figure 4:6 and Figure 4:7 show corneal central thickness as a function of age 
for the two instruments. There were no significant age trends in either age 
group. The differences between groups with Pentacam and Lenstar were not 
significant (mean ± 95% CI 0.008 ± 0.012 mm Pentacam and 0.005 ± 0.013 mm 
Lenstar). ANCOVA did not find significant difference in regression slopes 
between the groups for either Pentacam or Lenstar (F1,132 = 1.20, p 0.28 and 
F1,132 = 3.54, p 0.07), respectively. 
 
Discussion 
The multiple regression analysis for the whole group with the Pentacam 
found that central corneal thickness increases with diabetes duration at a rate 
of 0.5 m/year. However, none of the other analyses showed an association 
of diabetes with thickness. Age did not predict thickness, in agreement with 
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other studies e.g. Atchison et al. (2008). The Pentacam and Lenstar 
instruments gave similar estimates of thickness. 
 
As mentioned in section 2.3.1, several previous studies have reported greater 
corneal thickness in people with than in people without diabetes. As an 
example, Lee et al. (2005) found a mean difference of 20 m between DM1 
and non-diabetes groups as compared with the non-significant differences in 
this study of 5 - 8 m, and Lee et al. also found an increase in thickness with 
duration. However as for this study, Wiemer et al. (2007) did not find 
difference in corneal central thickness between the two groups. 
 
In conclusion, age did not influence central corneal thickness and the balance 
of analysis did not find influence of diabetes on corneal thickness, although 
the latter is not supported by most of the literature. 
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4.2.5 Posterior Corneal Radius of Curvature 
Table 4:7 shows the Pearson correlations of posterior corneal radius of 
curvature with various ocular and systemic factors for the whole group. 
Posterior corneal radius of curvature was correlated significantly with 
diabetes duration, axial length and gender.  
 
Table 4:7 Pearson correlations of posterior corneal radius of curvature with different 
ocular and systemic factors 
 Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Axial 
length 
Gender 
Correlation 
co-efficient 
(Pentacam) 
p 
0.11 
 
 
0.22 
−0.20 
 
 
0.02* 
−0.11 
 
 
0.22 
−0.06 
 
 
0.48 
0.04 
 
 
0.65 
0.55 
 
 
< 0.001* 
0.23 
 
 
< 0.01* 
* indicates significance 
Multiple regression analysis was performed with age and diabetes duration 
as predictors after adjusting for gender and axial length using the whole 
subject group and then only the diabetes group. In neither case did age or 
diabetes duration contribute significantly to the fit. 
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Figure 4:8 Relationships between age and posterior corneal radius of curvature for people 
with and without diabetes. Fit for diabetes group: Y = +0.003(±0.002)Age + 6.22(±0.10), R2 
0.03, p 0.14; fit for non-diabetes group: Y = +0.001(±0.003)Age + 6.40(±0.11), R2 0.00, p 0.74. 
Values in brackets are standard errors. 
 
Figure 4:8 shows posterior corneal radius of curvature as a function of age 
for the two groups. The difference of −0.08 ± 0.08 (mean ± 95% CI, p 0.07) mm 
between the groups was not statistically significant. There was no significant 
age trend in either group. ANCOVA did not find significant difference in 
regression slopes between the groups (F1, 133 = 0.52, p 0.47). 
 
Discussion 
As for the anterior cornea, the simple linear regressions found that the 
posterior cornea’s radius of curvature was associated significantly with axial 
length and gender, but it was also associated significantly with diabetes 
duration (in the negative direction). This was not supported by multiple 
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regressions, but the mean difference of −0.08 mm between groups was close 
to being significant (p 0.07). Wiemer et al. (2007) found significantly smaller 
radius of curvature in their DM1 group than in their control group  (mean 
difference ± 95% CI –0.14 ± 0.08 mm, p < 0.05). A power analysis on our 
results (G*power 3.1.7,  0.05, power 0.8) indicates that 159 participants per 
group would be needed to show significance.  
 
There are several differences between this study and that of Wiemer et al. 
(2007, 2008d) which may account for differences in results for posterior 
radius of curvature and for other parameters in section 4.2. The techniques 
were different, with Wiemer et al. using Scheimpflug imaging for all of their 
parameters. Importantly, Wiemer at al. included participants with advanced 
stage retinopathy and had a large range of refractions for both diabetes and 
non-diabetes groups (−10 to +6 D), whereas this study included participants 
with no more than minimal diabetic retinopathy and had a restricted range 
of refraction for both diabetes and non-diabetes groups (− 3 to +2 D). 
 
In conclusion, age does not appear to have influenced posterior corneal 
radius of curvature, but there is some indication that diabetes affected it. 
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4.2.6 Anterior Chamber Depth 
Pearson correlation was performed on combined data of people with and 
without diabetes for the whole group for both Pentacam and Lenstar 
instruments (Table 4:8). In case of Pentacam, anterior chamber depth was 
correlated significantly with all factors except for HbA1c, while in case of the 
Lenstar measurements anterior chamber depth was correlated significantly 
with all factors except HbA1c and gender. 
 
Table 4:8 Pearson correlations of anterior chamber depth with different ocular and 
systemic factors 
 Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Axial 
length 
Gender 
Correlation co-
efficient, Pentacam 
p 
−0.36* 
 
< 0.001* 
−0.42* 
 
< 0.001* 
−0.13 
 
0.19 
−0.63* 
 
< 0.001* 
−0.42 
 
< 0.001* 
0.42 
 
< 0.001* 
0.20 
 
0.02* 
Correlation co-
efficient, Lenstar 
p 
−0.40* 
 
< 0.001* 
−0.44* 
 
< 0.001* 
−0.16 
 
0.11 
−0.71* 
 
< 0.001* 
−0.22 
 
0.01* 
0.46 
 
< 0.001* 
0.15 
 
0.09 
* indicates significance 
 
For Pentacam, multiple regression analysis was performed with age and 
diabetes duration as predictors using the whole group after adjusting for 
gender and axial length. Diabetes duration, age and axial length contributed 
significantly to the fit:  
y = −0.009(±0.002)DiaDur − 0.010(±0.002)Age + 0.147(±0.056)AL − 0.21 (±0.72), R2 = 0.43 
When the multiple regression analysis was restricted to the diabetes group, 
again diabetes duration, age and axial length contributed significantly to the 
fit:  
y = −0.016(±0.003)DiaDur − 0.007(±0.003)Age + 0.146 (±0.041)AL – 0.12(±0.94), R2 = 0.54 
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For Lenstar, multiple regression analysis was performed with age and 
diabetes duration as predictors using the whole group after adjusting for 
axial length. Diabetes duration, age and axial length contributed significantly 
to the fit: 
y = −0.008(±0.002)DiaDur − 0.011(±0.002)Age + 0.179(±0.027)AL − 0.87(±0.64) , R2 = 0.46 
When the multiple regression analysis was restricted to the diabetes group, 
again diabetes duration, age and axial length factors contributed significantly 
to the fit:  
y = −0.013(±0.003)DiaDur − 0.010(±0.003)Age + 0.187(±0.037)AL – 1.00(±0.87) , R2 = 0.56 
 
 
Figure 4:9 Relationships between age and anterior chamber depth (using Pentacam) for 
people with and without diabetes. Fit for diabetes group: Y = –0.012(±0.003)Age + 
3.24(±0.15), R2 0.13, p 0.001; fit for non-diabetes group: Y = – 0.010(±0.003)Age + 3.27(±0.15), 
R2 0.13, p < 0.01. Values in brackets are standard errors. 
 
Figure 4:9 shows anterior chamber depth as a function of age with the 
Pentacam. There was significant decrease of 0.012 mm/year and 0.010 
mm/year in people with and without diabetes, respectively. ANCOVA did 
not find significant difference in regression slopes between the groups (F1, 133 
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= 0.10, p 0.76). People with diabetes had non significantly shallower anterior 
chamber depths than people without diabetes (mean ± 95% CI –0.11 ± 0.14 
mm, p 0.09). 
 
Figure 4:10 Relationships between age and anterior chamber depth (using Lenstar) for 
people with and without diabetes. Fit for diabetes group: Y = –0.013(±0.003)Age + 
3.29(±0.15), R2 0.118, p < 0.001; fit for non-diabetes group: Y = –0.010(±0.003)Age + 
3.30(±0.14), R2 0.14, p < 0.01. Values in brackets are standard errors. 
 
Figure 4:10 shows anterior chamber depth as a function of age with the 
Lenstar. There was a significant decrease of 0.013 mm/year and 0.010 
mm/year in people with and without diabetes, respectively. ANCOVA did 
not find significant difference in regression slopes between the groups (F1, 133 
= 0.37, p 0.55). People with diabetes had significantly shallower anterior 
chamber depth than people without diabetes (mean ± 95% CI –0.14 ± 0.13 
mm, p 0.03). 
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Discussion 
All the multiple regression analyses showed that increases in both age and 
diabetes duration and decrease  in axial length were associated with 
decreased anterior chamber depth. However, the ANCOVA did not find 
difference in slopes between the diabetes and non-diabetes group for the 
plots of age against anterior chamber depth. While the Pentacam and Lenstar 
instruments gave similar results, the difference between groups was 
significant only for the latter. 
 
The results support other studies in finding decreases in anterior chamber 
depth with age and with diabetes duration (section 2.3.4). The mean 
differences in anterior chamber depth between the diabetes and non-diabetes 
groups were similar to that reported by Wiemer et al. (2008d): mean ± 95% CI 
0.13 ± 0.11 mm. Contributions of diabetes duration to the multiple 
regressions were similar to those of previous studies for the diabetes group 
(–0.008 mm/year and –0.013 mm/year for the two instruments here as 
compared with –0.012 mm/year and –0.014 mm/year reported by Wiemer et 
al. (2008d) and Sparrow et al. (1990), respectively. However, unlike the other 
two studies, the differences in rate of anterior chamber depth changes with 
age between the groups were small and were not significant: –0.002 mm/year 
and –0.003 mm/year here compared with –0.009 and –0.007 mm/year for the 
Wiemer et al. and Sparrow et al. studies, respectively.) 
 
In conclusion, anterior chamber depth decreases with age as reported in 
several previous studies. Diabetes appears to accelerate this process, but not 
to the same extent as in other studies. 
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4.2.7 Pupil Diameter 
Pearson correlation was performed on combined data of people with and 
without diabetes (Table 4:9). Pupil diameter was correlated significantly with 
all factors except for lens thickness, spherical equivalent refraction and 
gender. 
 
Table 4:9 Pearson correlations of pupil diameter with different ocular and systemic factors 
Pupil 
diameter 
Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Axial 
length 
Gender 
Correlation 
co-efficient 
p 
−0.40 
 
< 0.001* 
−0.25 
 
0.01* 
−0.17 
 
0.04* 
−0.16 
 
0.07 
−0.07 
 
0.38 
0.29 
 
< 0.01* 
−0.04 
 
0.65 
 
Multiple regression analysis was performed with age and diabetes duration 
as predictors using the whole group after adjusting for axial length. Age and 
axial length contributed significantly to the fit: 
y = −0.029(±0.005)Age + 0.280(±0.072)AL + 0.76(±1.71), R2 = 0.29 
When multiple regression analysis was restricted to the diabetes group, 
again age and axial length contributed significantly to the fit: 
y = −0.025(±0.008)Age + 0.305(±0.108)AL − 0.07(±2.54), R2 = 0.24 
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Figure 4:11 Relationships between age and pupil diameter for people with and without 
diabetes. Fit for diabetes group: Y = −0.024(±0.008)Age + 6.99(±0.33), R2 = 0.12, p < 0.01; fit for 
non-diabetes group: Y = −0.029(±0.007)Age + 7.43(±0.31), R2 = 0.21, p < 0.001. Values in 
brackets are standard errors. 
 
Figure 4:11 shows the relationship of pupil diameter to age. People with and 
without diabetes had a non-significant difference of −0.26 ± 0.30 mm (mean ± 
95% CI, p 0.08). There were significant decreases of −0.024 mm/year and 
−0.029 mm/year in pupil diameter in people with and without diabetes, 
respectively. ANCOVA did not find significant difference in regression 
slopes between the groups (F1, 133 = 0.64, p 0.42). 
 
Discussion 
Diabetes duration had a significant association with pupil diameter 
according to the simple linear regression analysis, but disappeared as a 
significant factor in multiple regression analyses which showed that 
increases in age and axial length decreased and increased pupil size, 
respectively. Also, the mean pupil sizes were not significantly different in 
diabetes and non-diabetes groups, contrary to previous findings (section 
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2.3.3). The age effect is well known (Atchison & Smith, 2000a; Watson & 
Yellott, 2012). A power analysis (G*Power,  0.05, power 0.8) indicates that 
100 participants would be needed to show significance of the mean 
differences between diabetes and non-diabetes groups. 
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4.2.8 Pupil Decentration 
Table 4:10 shows the Pearson correlations of pupil decentration along the 
horizontal axis (Dx) and pupil decentration along the vertical axis (Dy) with 
various ocular and systemic factors for the whole group. Pupil decentration 
components were not correlated significantly with any factor. 
 
Table 4:10 Pearson correlations of pupil decentration with different ocular and systemic 
factors 
 Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Axial 
length 
Gender 
Dx 
correlation 
co-efficient 
p 
 
−1.66 
 
0.11 
 
−0.09 
 
0.40 
 
−0.13 
 
0.20 
 
−0.07 
 
0.48 
 
−0.12 
 
0.28 
 
−0.02 
 
0.79 
 
0.02 
 
0.86 
Dy 
correlation 
co-efficient 
p 
 
0.03 
 
0.76 
 
−0.08 
 
0.47 
 
−0.15 
 
0.20 
 
−0.07 
 
0.50 
 
0.05 
 
0.66 
 
0.07 
 
0.51 
 
−0.02 
 
0.87 
* indicates significance 
 
Multiple regression analysis was performed with age and diabetes duration 
as predictors using the whole subject group and only the diabetes group. 
Neither factor had significant influence in either case, for either the vertical 
or the horizontal axis. 
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Figure 4:12 Relationships between age and pupil decentrations along horizontal and 
vertical axes for people with and without diabetes. Linear fits for pupil decentration along 
horizontal axis in people with and without diabetes were Y = −0.003 (±0.006)Age + 
0.32(±0.27), R2 = 0.01, p 0.64 and Y = −0.011(±0.006)Age + 0.74(±0.26), R2 = 0.08, p 0.05, 
respectively. Linear fits for pupil decentration along vertical axis in people with and 
without diabetes were Y = 0.000(±0.004)Age − 0.11(±0.17), R2 = 0.00, p 0.99 and Y = 
+0.002(±0.004)Age + 0.07(±0.20), R2 = 0.00, p 0.71, respectively.  
 
Figure 4:12 shows pupil decentration along horizontal and vertical axes as a 
function of age for the two groups. ANCOVA did not find significant 
difference in regression slopes between the groups for either horizontal or 
vertical decentrations (F1, 90 = 0.87, p 0.35 and F1, 90 = 0.50, p 0.48, respectively). 
The differences in pupil decentrations between the groups were DX: –0.13 ± 
0.19 mm (mean ± 95% CI, p 0.19); DY: –0.05 ± 0.13 mm (mean ± 95% CI, p 
0.43). 
 
Discussion 
As pupils become smaller, at least due to the effects of luminance, they move 
nasally e.g. Mathur et al. (2014). Because pupils become smaller with age e.g. 
Atchison and Smith (2000a), I considered that pupil centre shifts at least in 
the horizontal direction might occur as a function of age and be accentuated 
by the presence of diabetes. Such shifts could be correlated with aberration 
differences between diabetes and non-diabetes groups (section 4.5). 
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However, the linear and multiple regression analyses showed no significant 
association of any factor with pupil decentration.  
 
To conclude, neither diabetes nor age influenced pupil decentration. 
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4.2.9 Anterior Lens Radius of Curvature 
The characteristics of the sub-groups for anterior lens radius of curvature, 
posterior lens radius of curvature and equivalent refractive index are 
summarised in Table 4:11. There were 67 participants with diabetes and 62 
age-matched participants without diabetes.  
Table 4:11 Characteristics of participants for lens anterior radius of curvature, posterior 
radius of curvature, and equivalent refractive index 
 People with 
diabetes 
People 
without 
diabetes 
P-values 
Number of participants 67 62 0.46 
Age (mean ± SD, age range), 
years 
41 ± 13, 19 − 63 42 ± 13, 20 − 62 0.78 
Number of eyes (R/L) 44/23 52/10  0.02* 
Gender (F/M) 24/43 41/21 0.001* 
Visual acuity (Log-MAR) −0.04 ± 0.18 −0.06 ± 0.15 0.48 
Log contrast sensitivity 1.81 ± 0.14 1.90 ± 0.10 0.001* 
Spherical equivalent 
refraction (dioptres) 
−0.64 ± 1.01 −0.38 ± 0.95 0.15 
Anterior chamber depth 
(mm) 
2.78 ± 0.36 2.89 ± 0.35 0.11 
Lens thickness (mm) 4.30 ± 0.49 4.01 ± 0.35 0.001* 
Axial length (mm) 23.59 ± 0.92 23.73 ± 0.90 0.36 
Anterior lens radius of 
curvature (mm) 
+9.53 ± 1.08 +10.62 ± 1.14 < 0.001* 
Posterior lens radius of 
curvature (mm) 
−5.89 ± 0.72 −6.32 ± 0.74 < 0.01* 
Equivalent refractive index 
(555 nm) 
1.426 ± 0.011 1.431 ± 0.012 < 0.01* 
HbA1c (m mol) 7.83 ± 1.11 5.05 ± 0.32 < 0.001* 
Lens equivalent power (D), 
(555 nm) 
25.06 ± 3.27 24.28 ± 2.33 0.13 
Diabetes duration (years) 19 ± 11 –  
* significant difference between groups 
 
Table 4:12 shows the Pearson correlations of anterior lens radii of curvature 
with various ocular and systemic factors for the whole group. Anterior lens 
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radius of curvature was correlated significantly with all parameters except 
for spherical equivalent refraction and gender. 
 
 Table 4:12 Pearson correlations of anterior radius of curvature with different ocular and 
systemic parameters 
Anterior lens radii 
of curvature 
 
Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Gender Axial 
length 
Correlation co-
efficient 
p 
−0.33 
 
< 0.001* 
−0.56 
 
< 0.001* 
−0.41 
 
0.001* 
−0.61 
 
< 0.001* 
− 0.17 
 
0.06 
0.05 
 
0.57 
0.39 
 
< 0.001* 
* indicates significance 
 
Multiple regression analysis was performed, with age and diabetes duration 
as predictors using the whole subject group after adjusting for axial length. 
Age, duration of diabetes and axial length contributed significantly to the fit 
significant: 
y = −0.045(±0.007)DiaDur − 0.026(±0.007)Age + 0.460(±0.090)AL + 0.72(±2.12), R2 = 0.47 
When the multiple regression analysis was restricted to the diabetes group, 
diabetes duration and axial length were the only factors contributing 
significantly to the fit: 
y = −0.040(±0.012)DiaDur + 0.418(±0.123)AL + 0.98(±2.87), R2 = 0.40 
The fits for this group indicates that age does not contribute to the variation 
in the anterior lens radius of curvature beyond that explained by diabetes 
duration. 
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Figure 4:13 Relationships between age and anterior lens radius of curvature for people 
with and without diabetes. Fit for diabetes group: Y = −0.024(±0.010)Age + 10.52(±0.44), R2 
0.08, p 0.02; fit for non-diabetes group: Y = −0.043(±0.010)Age + 12.39(±0.44), R2 0.23, p < 
0.001. Values in brackets are standard errors.  
 
Figure 4:13 shows anterior lens radius of curvature as a function of age for 
the two groups. People with diabetes had a significantly smaller radii of 
curvature than people without diabetes, with a difference of −1.09 ± 0.40 mm 
(mean ± 95% CI) between the two groups. There were significant decreases of 
0.024 mm/year and 0.043 mm/year in people with and without diabetes, 
respectively. ANCOVA did not find significant difference in regression 
slopes between the groups (F1, 125 = 1.63, p 0.20). 
 
Discussion 
There was a marked difference in the mean anterior radius of curvature for 
the two groups, and diabetes duration contributed to variation in the 
diabetes group. These results were similar to those of Wiemer et al. (2008d), 
who had a mean difference of 1.11 mm between groups and a diabetes 
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duration slope of −0.056 mm/year. As age increased, radii of curvature 
decreased significantly in both studies. However, the slopes were not 
significantly different between groups in this study, while the slope was 
greater for the diabetes group than for the non-diabetes group in Wiemer et 
al.’s study (mean difference ± 95% CI –0.037 ± 0.027 mm/year) (see Figure 
4:14).  
 
In conclusion, the diabetes group had smaller radii of curvatures than the 
non-diabetes group, but the reductions with increase in age were not 
significantly different. 
 
 
Figure 4:14 Anterior lens radius of curvature as a function of age from Wiemer et al. 
(2008d). 
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4.2.10 Posterior Lens Radius of Curvature 
Pearson correlation was performed on combined data of people with and 
without diabetes general characteristics given in Table 4:13. Posterior lens 
radius of curvature was correlated significantly with all parameters except 
gender. 
 
Table 4:13 Pearson correlations of posterior lens radius with different ocular and systemic 
parameters 
 Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Gender Axial 
length 
Correlation 
co-efficient 
(Pentacam) 
p 
 
0.22 
 
0.01* 
 
 
0.36 
 
< 0.001* 
 
0.25 
 
0.01* 
 
0.43 
 
< 0.001* 
 
0.21 
 
0.02* 
 
−0.10 
 
0.27 
 
−0.35 
 
< 0.001* 
* indicates significance 
 
Multiple regression analysis was performed, with age and diabetes duration 
as predictors using the whole subject group after adjusting for axial length. 
Age, diabetes duration and axial length contributed significantly to the fit:  
y = +0.017(±0.005)DiaDur + 0.012(±0.005)Age − 0.270(±0.066)AL − 0.35(±1.55), R2 = 0.25 
When multiple regression analysis was restricted to the diabetes group, 
neither diabetes duration nor age contributed significantly to the fit. 
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Figure 4:15 Relationships between age and posterior lens radius of curvature for people 
with and without diabetes. Fit for diabetes group: Y = +0.005(±0.007)Age − 6.08(±0.30), R2 = 
0.01, p 0.50; fit for non-diabetes group: Y = +0.023(±0.007)Age – 7.26(±0.30), R2 = 0.15, p < 0.01. 
Values in brackets are standard errors. 
 
Figure 4:15 shows lens posterior radius of curvature as a function of age for 
the two groups. People with diabetes had significantly smaller radii of 
curvature than people without diabetes, with a difference of 0.43 ± 0.26 mm 
(mean ± 95% CI) between the two groups. There were absolute decreases of 
0.005 mm/year and 0.023 mm/year in people with and without diabetes, 
respectively but this was only significant in the latter. ANCOVA did not find 
significant difference in regression slopes between the groups (F1, 125 = 3.36, p 
0.07). 
 
Discussion 
There was a marked difference in the mean posterior radius of curvature for 
the two groups, and both diabetes duration and age contributed to variation 
in the whole group. These results were similar to those of Wiemer et al. 
(2008d), who had a mean difference of 0.37 mm between groups and a 
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diabetes duration slope of −0.031 mm/year. As age increased, radii of 
curvature decreased in both studies. However, in this study the slope for the 
diabetes group was not significant and the slopes were not significantly 
different between groups, while the slope was greater for the diabetes group 
in Wiemer et al.’s study (mean difference ± 95% CI +0.023 ± 0.021 mm/year).  
 
In conclusion, the diabetes group had smaller radii of curvatures than the 
non-diabetes group, but the reductions with increase in age were not 
significantly different. 
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4.2.11 Lens Central Thickness 
Pearson correlation was performed on combined data of people with and 
without diabetes (Table 4:11). Lens central thickness was correlated 
significantly with all parameters except spherical equivalent refraction and 
gender. 
 
Table 4:14 Pearson correlations of lens central thickness with different ocular and 
systemic parameters 
 
Parameters Age Diabetes 
duration 
HbA1c Spherical 
equivalent 
refraction 
Gender Axial 
length 
Correlation 
co-efficient 
p 
0.68 
 
< 0.001* 
0.62 
 
< 0.001* 
0.33 
 
< 0.001* 
0.14 
 
0.11 
0.07 
 
0.40 
−0.22 
 
0.01* 
* indicates significance 
 
Multiple regression analysis was performed with age and diabetes duration 
as predictors using the whole group after adjustment for axial length. The 
independent effects of diabetes duration, age and axial length were 
significant: 
y = +0.016(±0.002)DiaDur + 0.021(±0.002)Age – 0.091(±0.024)AL + 5.35(±0.56), R2 = 0.73 
When the multiple regression analysis was restricted to the diabetes group, 
again the three factors contributed significantly to the fit:  
y = +0.020(± 0.003)DiaDur + 0.021(±0.003)Age – 0.113(±0.033)AL + 5.69(±0.77), R2 = 0.77  
The fits indicate similar importance of both diabetes duration and age.  
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Figure 4:16 Relationships between age and lens central thickness for people with and 
without diabetes. Fit for diabetes group: Y = +0.027(±0.003)Age + 3.16(±0.14), R2 0.60, p < 
0.001; fit for non-diabetes group: Y = +0.021(±0.002)Age + 3.16(±0.11), R2 0.54, p < 0.001. 
Values in brackets are standard errors. 
 
Figure 4:16 shows lens central thickness as a function of age for the two 
groups. People with diabetes had significantly greater lens thickness than 
people without diabetes, with a difference of +0.29 ± 0.15 mm (mean ± 95% 
CI) between the two groups. There were significant increases of 0.027 
mm/year and 0.021 mm/year in people with diabetes and without diabetes, 
respectively. People with diabetes had thicker lenses than people without 
diabetes with mean difference 0.29 ± 0.08 mm. ANCOVA did not find 
significant difference in regression slopes between the groups (F1, 133 = 2.23, p 
0.11). 
 
Discussion 
Lens thickness was considerable greater in the diabetes group than in the 
non-diabetes group ( mean 0.29 mm), with both age and diabetes duration 
contributing to variation. Lens thickness increased with age more quickly for 
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the diabetes group than for the non-diabetes group, but the difference in rate 
of 0.006 mm/year was not significant. The difference between groups was 
greater than that of Wiemer et al. (2008d) (mean ± 95% CI 0.20 ± 0.04 mm). 
The importance of diabetes duration was similar to those obtained by 
Wiemer et al. of +0.020 ± 0.008 mm/year and by Sparrow et al. (1990) of +0.017 
mm/year, but the rates of change with age were significantly different 
between the groups in these studies e.g. +0.009 ± 0.008 95% CIs in Wiemer et 
al.’s study (Figure 4:17). 
 
In conclusion, lens thickness was considerably greater in the diabetes group 
than in the non-diabetes group, but the greater rate of increase with age in 
the former was not quite significant.  
 
Figure 4:17 Lens thickness as a function of age from Wiemer et al. (2008d). 
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4.2.12 Lens Equivalent Refractive Index 
Pearson correlation was performed on combined data of people with and 
without diabetes general characteristics given in table (Table 4:15). Lens 
equivalent refractive index was correlated significantly with all parameters 
except spherical equivalent refraction. 
 
Table 4:15 Pearson correlations of lens equivalent refractive index with different ocular 
and systemic parameters 
 Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Gender Axial 
length 
Correlation 
co-efficient 
p 
−0.48 
 
< 0.001* 
−0.31 
 
< 0.001* 
−0.21 
 
*0.02 
−0.37 
 
< 0.001* 
−0.13 
 
0.14 
−0.18 
 
0.04* 
−0.26 
 
0.01* 
* indicates significance 
 
Multiple regression analysis was performed with age and diabetes duration 
as predictors using the whole group after adjusting for axial length. Diabetes 
duration, age and axial length contributed significantly to the fit: 
y = −0.0003(±0.0001)DiaDur − 0.0004(±0.0001)Age  − 0.0033(±0.0010)AL + 1.525(±0.024), 
R2 = 0.35 
 When the multiple regression analysis was restricted to the diabetes group, 
diabetes duration and axial length were significant factors: 
y = −0.0003(±0.0001) DiaDur − 0.0041(±0.0015)AL + 1.537(±0.034), R2 = 0.28 
The fits for the group with diabetes indicate that diabetes duration 
contributed to the variation in the equivalent lens refractive index beyond 
that explained by age.  
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Figure 4:18 Relationships between age and lens equivalent refractive index for people 
with and without diabetes. Fit for diabetes group: Y = −0.00033(±0.00010)Age + 
1.439(±0.004), R2 = 0.14, p < 0.001; fit for non-diabetes group: Y = −0.00056(±0.00009)Age + 
1.455(±0.004), R2 = 0.38, p < 0.001. Values in brackets are standard errors.  
 
Figure 4:18 shows lens equivalent refractive index as a function of age. There 
were significant decreases of –0.00033/year and –0.00056/year in people with 
diabetes and without diabetes, respectively. People with diabetes had lower 
refractive index than people without diabetes with a difference −0.006 ± 0.004 
(mean ± 95% CI). ANCOVA did not find significant difference in regression 
slopes between the groups (F1, 125 = 3.07, p 0.08). 
 
Discussion 
Equivalent refractive index was considerably lower in the diabetes group 
than in the non-diabetes group, with only diabetes duration contributing to 
variation in the diabetes group. The index decreased more slowly with age 
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for the diabetes group than for the non-diabetes group, but the difference in 
rate of 0.00023/year was not significant. The difference between groups was 
similar to that of Wiemer et al. (2008d) (mean ± 95% CI –0.004 ± 0.002). 
Diabetes duration was also important to variation in the diabetic group in 
Wiemer et al.’s (2008d) study at –0.00018 ± 0.00017/year (mean ± 95% CI). The 
rate of change of index with age was much higher in Wiemer’s study for the 
diabetes group at –0.0007/year compared with the –0.0003/year found here 
(Figure 4:19), and unlike this study the rate of change in index with age was 
greater for the diabetes than for the non-diabetes group. 
 
In conclusion, equivalent refractive index was considerably lower in the 
diabetes group than in the non-diabetes group, but the rates of decrease with 
age were not quite significantly different.  
 
 
Figure 4:19 Lens equivalent refractive index as a function of age from Wiemer et al. 
(2008d). 
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4.2.13 Lens Equivalent Power 
Table 4:16 shows the Pearson correlations of lens equivalent power with 
various ocular and systemic factors for the whole group. Lens equivalent 
power was calculated using refractive indices at 555 nm. Lens equivalent 
power was correlated significantly with age, axial length and gender. 
Table 4:16 Pearson correlations of lens equivalent power with different ocular and 
systemic parameters 
 
 
Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Axial 
length 
Gender 
Correlation 
co-efficient 
p 
−0.26 
 
< 0.01* 
0.16 
 
0.07 
0.13 
 
0.14 
0.15 
 
0.08 
0.08 
 
0.38 
−0.74 
 
< 0.001* 
−0.30 
 
< 0.01* 
* indicates significance 
 
Multiple regression analysis was performed with age and diabetes duration 
as predictors using the whole group after adjusting for gender and axial 
length. Only age and axial length contributed significantly to the fit: 
y = −0.046(±0.013)Age − 1.997(±0.190)AL + 73.70(±4.44), R2 = 0.59 
When the multiple regression analysis was restricted to the diabetes group, 
neither age nor diabetes duration contributed significantly to the fit. 
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Figure 4:20 Relationships between age and lens equivalent power for people with and 
without diabetes. Fit for diabetes group: Y = −0.056(±0.030)Age + 27.22(±1.27), R2 0.05, p 0.06; 
fit for non-diabetes group: Y = −0.052(±0.021)Age + 26.39(±0.91), R2 0.09, p 0.02. 
 
Figure 4:20 shows lens equivalent power as a function of age. There was a 
significant reduction in power with age for the non-diabetic group (p 0.02), 
but not for the diabetes group (p 0.05). The difference of 0.69 ± 0.94 D (mean ± 
95% CI) between the groups was not statistically significant. ANCOVA did 
not find significant difference in regression slopes between the groups (F1, 125 
= 0.01, p 0.92). 
 
Discussion 
The mean equivalent lens powers of the diabetes and non-diabetes groups 
were not significantly different. Power reduced with age for both groups; it 
was significant for the non-diabetes group and nearly significantly for the 
diabetes group (p 0.05). Wiemer et al. (2008d) did not find effects of age or 
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diabetes on lens power with their Scheimpflug technique. However, 
Atchison et al. (2008) found a significant decrease of 0.033 D/year in a non-
diabetic group using the Phakometry technique, with a similar mean power 
(23.9 ± 0.6 D) (mean ± 95% CI) to that found here (24.3 ± 0.6 D) (mean ± 95% 
CI). 
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4.3 Straylight  
The characteristics of the sub-groups for straylight testing are summarised in 
Table 4:17. There were 63 participants with diabetes and 57 age-matched 
participants without diabetes. Twelve participants with diabetes and seven 
participants without diabetes (12% of total) did not do this test because of 
unavailability of the C-Quant instrument at the beginning of the study. Two 
older participants with straylight higher than 1.60 logs were excluded 
according to the study criteria.  
 
Table 4:17 Characteristics of participants for straylight testing 
 People with 
diabetes 
People 
without 
diabetes 
P-values 
Number of participants 63 57 0.48 
Age (mean ± SD, age range), 
years 
41 ± 12,  
19 − 63 
41 ± 12,  
20 − 62 
0.83 
Number of eyes (R/L) 41/22 50/7 < 0.01* 
Gender (F/M) 26/37 39/18 < 0.01* 
Visual acuity (Log-MAR) −0.03 ± 0.22 −0.04 ± 0.21 0.76 
Log contrast sensitivity  1.82 ± 0.13 1.91 ± 0.09 < 0.01* 
Spherical equivalent 
refraction (dioptres) 
−0.59 ± 1.16 −0.51 ± 0.95 0.72 
Anterior chamber depth (mm) 2.76 ± 0.36 2.88 ± 0.36 0.09 
Lens thickness (mm) 4.25 ± 0.45 4.00 ± 0.34 < 0.01* 
Axial length (mm) 23.59 ± 0.94 23.69 ± 0.91 0.58 
Straylight (log(s)) 0.95 ± 0.19 0.83 ± 0.15 < 0.001* 
HbA1c (m mol) 7.78 ± 1.14 5.03 ± 0.32 < 0.001* 
Diabetes duration (years) 19 ± 11 –  
* significant difference  
 
Table 4:18 shows the Pearson correlations of straylight with various ocular 
and systemic factors for the whole group. Straylight was correlated 
significantly with age, duration of diabetes, HbA1c and lens thickness. The 
correlations were similar  for diabetes duration and age. 
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Table 4:18 Pearson correlations of straylight with different ocular and systemic factors 
 
 
Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Axial 
length 
Gender 
Correlation 
co-efficient 
p 
0.46 
 
< 0.001* 
0.50 
 
<0.001* 
0.29 
 
< 0.01* 
0.49 
 
< 0.001* 
−0.01 
 
0.88 
–0.08 
 
0.36 
–0.08 
 
0.41 
* indicates significance 
 
Multiple regression analysis was performed with age and diabetes duration 
as predictors using the whole group. Both factors contributed significantly to 
the fit: 
y = 0.006 (± 0.001)DiaDur + 0.005 (± 0.001) Age + 0.61 (± 0.05), R2 = 0.38  
When the multiple regression analysis was restricted to the diabetes group, 
again both factors contributed significantly to the fit:  
y = 0.007 (± 0.002)DiaDur + 0.004 (± 0.002)Age + 0.67 (± 0.07), R2 = 0.30  
The fit for the whole group indicates similar importance of the two factors, 
but the fit for the group with diabetes indicated a greater importance of 
duration of diabetes than of age.  
  
     158 | P a g e |  
Chapter 4: Results 
 
Figure 4:21 Relationships between age and strayline for people with and without 
diabetes. Fit for diabetes group: Y = +0.006(± 0.002)Age + 0.70 (± 0.08), R2 0.17, p < 0.01; fit for 
non-diabetes group: Y = +0.007(± 0.001)Age + 0.53 (± 0.06), R2 0.36, p < 0.01. Values in 
brackets are standard errors.  
 
Figure 4:21 shows straylight as a function of age for the two groups. There 
was significant increase of 0.006 mm/year and 0.007 mm/year in people with 
diabetes and without diabetes, respectively. People with diabetes had higher 
straylight than people without diabetes with difference +0.12 ± 0.06 logs 
(mean ± 95% CI). ANCOVA did not find significant difference in regression 
slopes between the groups (F1,116 = 0.67, p 0.41). 
 
Discussion 
Straylight was greater in the diabetes than in the non-diabetes group. It 
increased with both diabetes duration and age according to the multiple 
regressions, but the rates of change with increase in age were similar for both 
groups.  
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4.4 Amplitude of Accommodation 
The characteristics of the sub-group for amplitude of accommodation testing 
are summarised in Table 4:19. There were 43 participants with diabetes and 
32 age-matched participants without diabetes.  
 
Table 4:19 Characteristics of participants for amplitude of accommodation testing 
 People with 
diabetes 
People 
without 
diabetes 
P-values 
Number of participants 43 32  
Age (mean ± SD, age range), 
years 
33 ± 8, 19 − 46 34 ± 8, 20 − 46 0.43 
Number of eyes (R/L) 30/13 29/3 0.03* 
Gender (F/M) 17/26 19/13 0.09 
Visual acuity (Log-MAR) −0.05 ± 0.07 −0.01 ± 0.27 0.41 
Log contrast sensitivity  1.83 ± 0.14 1.91 ± 0.08 < 0.01* 
Spherical equivalent 
refraction (dioptres) 
−0.83 ± 1.04 −0.62 ± 0.83 0.35 
Anterior chamber depth (mm) 2.94 ± 0.29 3.03 ± 0.28 0.18 
Lens thickness (mm) 3.97 ± 0.31 3.86 ± 0.25 < 0.01* 
Axial length (mm) 23.52 ± 0.90 23.79 ± 0.86 0.19 
Objective amplitude of 
accommodation (D) 
2.7 ± 1.6 4.1 ± 2.1 < 0.01* 
Subjective amplitude of 
accommodation (D) 
4.0 ± 1.7 5.6 ± 2.1 < 0.001* 
HbA1c (m mol) 7.96 ± 1.23 5.01 ± 0.36 < 0.01* 
Diabetes duration (years) 16 ± 8 –  
* significant difference between groups 
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Figure 4:22 Bland-Altman plot comparing the objective and subjective methods of 
amplitude of accommodation. The mean difference and the prediction limits are 
represented by the straight lines.  
 
Figure 4:22 is a Bland-Altman plot of agreement between the objective and 
subjective methods for the combined groups. The objective amplitudes were smaller 
than the subjective amplitudes by 1.39 ± 1.21 D (mean ± 95% CI). People with 
diabetes had lower objective (mean ± SD, 2.70 ± 1.59 D) and subjective (mean ± SD, 
3.98 ± 1.72 D) amplitudes of accommodation than people without diabetes 
(objective: mean ± SD 4.07 ± 2.10 D), subjective: mean ± SD 5.60 ± 2.12 D). 
 
Table 4:20 shows the Pearson correlations of objective amplitude of 
accommodation with various ocular and systemic factors for the whole 
group. Accommodation was correlated significantly with age, duration of 
diabetes, HbA1c, lens thickness and spherical equivalent refraction but not 
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with axial length and gender. The correlation was higher for age than for 
diabetes duration. 
Table 4:20 Pearson correlations of objective amplitude of accommodation with different 
ocular and systemic factors 
 
 
Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Axial 
length 
Gender 
Correlation 
co-efficient 
p  
−0.64 
 
< 0.001* 
−0.48 
 
< 0.001* 
−0.37 
 
< 0.001* 
−0.69 
 
< 0.001* 
0.24 
 
0.04* 
0.14 
 
0.23 
−0.04 
 
0.74 
* indicates significance 
 
Table 4:21 shows the Pearson correlations of subjective amplitude of 
accommodation with various ocular and systemic factors for the whole 
group. Accommodation was correlated significantly with age, duration of 
diabetes, HbA1c, lens thickness but not with spherical equivalent refraction, 
axial length and gender. The correlation was higher for age than for diabetes 
duration. 
 
Table 4:21 Pearson correlations of subjective amplitude of accommodation with different 
ocular and systemic factors 
 
 
Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Axial 
length 
Gender 
Correlation 
co-efficient 
p 
−0.65 
 
< 0.001* 
−0.57 
 
< 0.001* 
−0.42 
 
< 0.001* 
−0.72 
 
< 0.001* 
0.15 
 
0.21 
0.15 
 
0.22 
0.01 
 
0.91 
* indicates significance 
 
Multiple regression analysis was performed with age and diabetes duration 
as predictors using the whole subject group. The independent effects of both 
of these on objective amplitude of accommodation were significant (Table 
4:20), and both factors contributed significantly to the fit: 
y = −0.083(± 0.015)DiaDur − 0.145(±0.018)Age + 8.92(±0.65), R2 = 0.59 
     162 | P a g e |  
Chapter 4: Results 
When the multiple regression analysis was restricted to the diabetes group, 
again both factors contributed significantly to the fit: 
y = −0.076(±0.023)DiaDur − 0.097(±0.022)Age + 7.13(±0.74), R2 = 0.51  
Similarly, the independent effects of diabetes duration and age on subjective 
amplitude of accommodation were both significant (Table 4:21), and both 
factors contributed significantly to the fit: 
y = −0.105(±0.014)DiaDur − 0.154(±0.017)Age + 10.67(±0.61), R2 = 0.68 
When the multiple regression analysis was restricted to the diabetes group, 
again both factors contributed significantly to the fit:  
y = −0.106(±0.022)DiaDur − 0.103(±0.021)Age + 9.08(±0.70), R2 = 0.63 
 
 
Figure 4:23 Relationships between age and objective amplitude of accommodation for 
people with and without diabetes. Fit for diabetes group: Y = −0.117(±0.023)Age + 
6.62(±0.81), R2 0.38, p < 0.01; fit for non-diabetes group: Y = −0.226(±0.027)Age + 11.85(±0.96), 
R2 0.70, p < 0.01. Values in brackets are standard errors.  
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Figure 4:23 shows objective amplitude of accommodation as a function of 
age. There were significant decreases of −0.117 D/year and −0.226 D/year in 
people with diabetes and without diabetes, respectively. ANCOVA showed 
significant differences in regression slopes between the groups (F1,71 = 8.90, p 
< 0.01).  
 
 
Figure 4:24 Relationships between age subjective amplitude of accommodation for people 
with and without diabetes. Fit for diabetes group: Y = −0.131(±0.025)Age + 8.37(±0.85), R2 
0.41, p < 0.01; fit for non-diabetes group: Y = −0.232(±0.026)Age + 13.59(±0.90), R2 0.73, p < 
0.01. Values in brackets are standard errors.  
 
Figure 4:24 shows subjective amplitude of accommodation as a function of 
age. There were significant decreases of −0.131 D/year and −0.232 D/year in 
people with diabetes and without diabetes, respectively. ANCOVA showed 
significant differences in regression slopes between the groups (F1,71 = 7.52, p  
< 0.01).  
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Discussion 
In support of a previous study (Moss, et al., 1987), we have found lowered 
amplitude of accommodation in participants with diabetes when compared 
with age-matched controls. We have estimated the importance of duration of 
diabetes relative to that of age to be 0.6 to 1.0, which overall indicates greater 
importance of age than of diabetes duration. These estimates are a little 
higher than previous estimates using subjective amplitudes of 0.4 to 0.6 
(Braun, et al., 1995; Moss, et al., 1987; Pawelski & Gliem, 1971). 
 
Subjective amplitudes of accommodation were greater than objective 
amplitudes by a mean 1.4 D. The trends for the two measurements were 
similar. All the multiple regressions indicated that both increasing diabetes 
duration and age were associated with reduction in amplitude, with 
estimates of the importance of diabetes duration relative to age varying from 
0.57 to 1.03. Despite this, the rates of change of amplitude loss with age were 
greater in people without diabetes than in people with diabetes; this result 
was unexpected, but may be related to the considerable number of older 
participants who had short diabetes durations (Figure 4:25). 
 
Figure 4:26 shows subjective amplitudes of accommodation from different 
studies (Braun, et al., 1995; Moss, et al., 1987). Comparisons for both diabetic 
and non-diabetic groups are possible only with the study of Moss et al. For 
Moss et al. rates of change with age were similar for groups both with and 
without diabetes (about −0.25 D/year) and were similar for my group 
without diabetes, but considerably higher than for my diabetes group (0.13 
D/year). The results for Moss et al appear high with the trends indicating that 
their group with diabetes would have mean amplitude of more than 3 D at 
the age of 50 years, such that presbyopia would not occur until at least 50 
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years rather than more commonly in the mid-40s. The slope in Braun et al.’s 
study in people with diabetic retinopathy was low at 0.071 D/year.  
 
I believe that the low subjective amplitudes in my study are due to the small 
detail of the target, giving small influence of depth-of-focus on judgements 
and hence giving a critical estimate of amplitude. In the Badal hand 
optometer, the angular size of the target does not change with target 
position.  The acuity of the target is specified as 0.5 (0.3 logMAR), but 
measurements of the targets show that the letter detail is fine relative to the 
size of the letter and the acuity is actually about 0.0 logMAR. 
 
Two of the people with diabetes had zero objective accommodation 
response. This biased the results as it was not known at what age they would 
have ceased to have a response, but we believed it was better to include them 
than bias the results even more by not including them. 
 
Figure 4:25 Relationships between age and diabetes duration for the people who had 
accommodation measurements. Regression fit is Y = +0.272(±0.143)Age + 6.75(±4.93), R2 0.08, 
p = 0.06. Values in brackets are standard errors.  
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Figure 4:26 Comparison of subjective amplitude of accommodation between previous 
studies (Braun, et al., 1995; Moss, et al., 1987) and present study. For the present study, 
only fits have been shown. 
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4.5 Ocular Aberrations and their Components 
The characteristics of the sub-groups for ocular aberrations testing at 4.5 mm 
pupil diameter are summarised in Table 4:22. There were 46 participants 
with diabetes and 47 age-matched participants without diabetes. Five 
participants’ corneal topography images were too poor to perform analysis 
and were excluded. 
Table 4:22 Characteristics of participants for ocular aberrations testing 
 People with 
diabetes 
People 
without 
diabetes 
P-
values 
Number of participants 46 47 0.34 
Age (mean ± SD, age range), years 41 ± 8, 20−63 43 ± 11, 20−62 0.43 
Number of eyes (R/L) 32/14 38/09 0.23 
Gender (F/M) 18/28 29/18 0.04* 
Visual acuity (Log-MAR) −0.03 ± 0.18 −0.05 ± 0.16 0.53 
Log contrast sensitivity 1.81 ± 0.14 1.88 ± 0.10 < 0.01* 
Spherical equivalent refraction (dioptres) −0.70 ± 1.08 −0.35 ± 0.95 0.11 
Anterior chamber depth (mm) 2.74 ± 0.40 2.86 ± 0.34 0.14 
Lens thickness (mm) 4.27 ± 0.50 4.08 ± 0.37 0.04* 
Axial length (mm) 23.51 ± 0.83 23.75 ± 0.86 0.44 
Corneal horizontal coma coeff (µm) −0.104 ± 0.117 −0.113 ± 0.118 0.70 
Corneal vertical coma coeff (µm) −0.070 ± 0.119 −0.031 ± 0.114 0.11 
Corneal spherical aberration coeff (µm) +0.050 ± 0.034 +0.047 ± 0.032 0.59 
Corneal higher order RMS (µm) 0.201 ± 0.123 0.201 ± 0.115 1.00 
Total horizontal coma coeff (µm) −0.022 ± 0.084 +0.017 ± 0.094 0.04* 
Total vertical coma coeff (µm) −0.013 ± 0.086 +0.027 ± 0.058 0.01* 
Total spherical aberration co-eff  (µm) +0.042 ± 0.075 +0.025 ± 0.051 0.21 
Total higher order RMS (µm) 0.180 ± 0.092 0.170 ± 0.072 0.57 
Internal horizontal coma coeff (µm) +0.082 ± 0.145 +0.131 ± 0.158 0.13 
Internal vertical coma coeff (µm) +0.058 ± 0.132 +0.058 ± 0.122 0.98 
Internal spherical aberration coeff (µm) −0.008 ± 0.090 −0.021 ± 0.053 0.39 
Internal higher order RMS (µm) 0.268 ± 0.111 0.274 ± 0.114 0.80 
HbA1c (m mol) 7.97 ± 1.15 5.01 ± 0.31 < 0.001* 
Diabetes duration (years) 19 ± 11 –  
Data are expressed as the mean ± standard deviation 
* Indicates significant difference between groups.  
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Corneal Aberrations 
Table 4:23 shows the Pearson correlations of corneal aberrations components 
with various ocular and systemic factors for the whole group. The only 
significant correlation was found for vertical coma with HbA1c. 
 
Table 4:23 Pearson correlations of corneal aberrations components with different ocular 
and systemic factors 
Corneal 
aberrations 
components  
Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Axial 
length 
Gender 
Horizontal coma 
correlation 
co-efficient 
p 
0.11 
 
 
0.31 
0.06 
 
 
0.59 
0.05 
 
 
0.67 
0.09 
 
 
0.40 
0.08 
 
 
0.43 
−0.09 
 
 
0.40 
−0.18 
 
 
0.08 
Vertical coma 
correlation  
co-efficient 
p 
−0.18 
 
 
0.09 
−0.16 
 
 
0.12 
−0.22 
 
 
0.04* 
−0.11 
 
 
0.32 
−0.17 
 
 
0.10 
0.18 
 
 
0.10 
0.08 
 
 
0.42 
Spherical  
aberration 
correlation 
co-efficient 
p 
−0.03 
 
 
 
0.78 
−0.03 
 
 
 
0.79 
0.07 
 
 
 
0.49 
−0.15 
 
 
 
0.16 
−0.12 
 
 
 
0.25 
0.11 
 
 
 
0.31 
−0.03 
 
 
 
0.77 
HORMS 
co-efficient 
p 
0.17 
 
0.11 
0.01 
 
0.92 
0.06 
 
0.56 
0.04 
 
0.74 
−0.03 
 
0.75 
0.03 
 
0.77 
0.09 
 
0.39 
* indicates significance 
 
For all aberrations components, multiple regression analysis was performed 
with age and diabetes duration as predictors using the whole group and then 
only the diabetes group. For each component, neither factor contributed 
significantly to the fit in either case. 
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Figure 4:27 Relationships between age and corneal aberration components for people with 
and without diabetes. a) Horizontal coma linear fit, diabetes group: Y = +0.001(±0.001)Age − 
0.13(±0.06), R2 0.00, p 0.66; non-diabetes group: Y = +0.001(±0.001)Age − 0.18(± 0.06), R2 0.02, p 
0.31. b) Vertical coma linear fit, diabetes group: Y = −0.003(±0.001)Age + 0.04(±0.06), R2 0.08, 
p 0.06; non-diabetes group: Y = −0.001(±0.001)Age + 0.01(±0.06), R2 0.01, p 0.46. c) Spherical 
aberration linear fit: diabetes group: Y = +0.000(±0.000)Age + 0.04(± 0.02), R2 0.00, p 0.67; 
non-diabetes group: Y = +0.000(±0.000)Age + 0.06(± 0.02), R2 0.01, p 0.44. d) HORMS linear 
fit, diabetes group: Y = +0.001(± 0.002)Age + 0.17(±0.06), R2 0.01, p 0.64; non-diabetes group: 
Y = +0.002(± 0.001)Age + 0.10(±0.06), R2 0.07, p 0.07. Values in brackets are standard errors.  
 
Figure 4:27 shows corneal aberration components as functions of age. There 
was no significant difference between the groups for any aberration 
component. There was no significant rates of change with age for any 
combination of group and aberration component, and ANCOVA did not find 
any significant differences in regression slopes between groups. 
b
b 
a 
c d 
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Total Ocular Aberrations 
Table 4:24 shows the Pearson correlations of total ocular aberrations 
components with various ocular and systemic factors for the whole group. 
Significant correlations were for horizontal coma with diabetes duration and 
HbA1c, for vertical coma with all factors except gender, for spherical 
aberration with diabetes duration, and for HORMS with diabetes duration. 
 
Table 4:24 Pearson correlations of total ocular aberrations components with different 
ocular and systemic factors 
Total Ocular 
aberration 
components 
Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Axial 
length 
Gender 
Horizontal coma 
correlation 
co-efficient 
p 
−0.06 
 
 
0.54 
−0.23 
 
 
0.03* 
−0.24 
 
 
0.02* 
−0.12 
 
 
0.25 
−0.01 
 
 
0.92 
0.12 
 
 
0.28 
0.05 
 
 
0.67 
Vertical coma 
correlation 
co-efficient 
p 
−0.39 
 
 
< 0.01* 
−0.52 
 
 
< 0.001* 
−0.33 
 
 
0.001* 
−0.62 
 
 
< 0.001* 
−0.21 
 
 
0.04* 
0.41 
 
 
< 0.001* 
0.04 
 
 
0.70 
Spherical  
aberration 
correlation 
co-efficient 
p 
−0.02 
 
 
 
0.84 
0.31 
 
 
 
< 0.01* 
0.11 
 
 
 
0.28 
0.19 
 
 
 
0.08 
0.16 
 
 
 
0.13 
−0.20 
 
 
 
0.06 
0.05 
 
 
 
0.66 
HORMS 
co-efficient 
p 
0.04 
 
0.67 
0.27 
 
0.01* 
0.19 
 
0.07 
0.21 
 
0.05 
−0.01 
 
0.94 
−0.20 
 
0.06 
0.01 
 
0.92 
 
For horizontal coma, multiple regression analysis was performed with age 
and diabetes duration as predictors using the whole group. Only diabetes 
duration contributed significantly to the fit: 
y = −0.0017(±0.0008)DiaDur + 0.025(±0.033), R2 = 0.05 
When the multiple regression analysis was restricted to the diabetes group, 
neither factor contributed significantly to the fit. 
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For vertical coma, multiple regression analysis was performed with age and 
diabetes duration as predictors using the combined groups. Both factors 
contributed significantly to the fit:  
y = −0.0030(±0.0005)DiaDur − 0.0021(±0.0005)Age + 0.121(±0.022), R2 = 0.38 
When the multiple regression analysis was restricted to the diabetes group, 
diabetes duration alone contributed significantly to the fit: 
y = −0.0045(±0.0011)DiaDur + 0.123(±0.043), R2 = 0.42 
For spherical aberration, multiple regression analysis was performed with 
age and diabetes duration as predictors using the combined groups. Only 
diabetes duration contributed significantly to the fit: 
y = +0.0017(±0.0005)DiaDur + 0.031(±0.023), R2 = 0.10 
When the multiple regression analysis was restricted to the diabetes group, 
again diabetes duration contributed significantly to the fit: 
y = +0.0036(±0.0011)DiaDur + 0.022(±0.036), R2 = 0.20 
For HORMS, multiple regression analysis was performed with age and 
diabetes duration as predictors using the whole group. Only diabetes 
duration contributed significantly to the fit in either case. 
y = +0.0018(±0.0007)DiaDur + 0.155(±0.030), R2 = 0.07 
When the multiple regression analysis was restricted to the diabetes group, 
again diabetes duration contributed significantly to the fit: 
y = +0.0044(±0.0013)DiaDur + 0.127(±0.044), R2 = 0.22 
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Figure 4:28 Relationships between age and total ocular aberration components for people 
with and without diabetes. a) Horizontal coma linear fit, diabetes group: Y = 
+0.001(±0.001)Age − 0.05(±0.04), R2 0.01, p 0.48; non-diabetes group: Y = −0.002(±0.001)Age + 
0.10(±0.05), R2 0.06, p 0.09. b) Vertical coma linear fit, diabetes group: Y = −0.003(±0.001)Age 
+ 0.11(±0.04), R2 0.18, p < 0.01; non-diabetes group: Y = −0.002(±0.001)Age + 0.12(±0.03), R2 
0.22, p 0.001. c) Spherical aberration linear fit, diabetes group: Y = +0.000(±0.001)Age + 
0.03(±0.04), R2 0.00, p 0.84; non-diabetes group: Y = +0.000(± 0.001)Age + 0.04(±0.03), R2 0.01, p 
0.64. d) HORMS linear fit, diabetes group: Y = +0.001(±0.001)Age + 0.14(±0.05), R2 0.02, p 
0.41; non-diabetes group: HORMS linear fit Y = +0.000(±0.001)Age + 0.18(±0.04), R2 0.00, p 
0.78. Values in brackets are standard errors.  
 
Figure 4:28 shows the total ocular aberration components as functions of age. 
Significant differences between the groups were −0.039 ± 0.037 (mean ± 95% 
CI) µm for horizontal coma and −0.040 ± 0.030 (mean ± 95% CI) µm for 
vertical coma. There were significant decreases of −0.003 µm/year and −0.002 
µm/year for vertical coma in people with and without diabetes, respectively. 
ANCOVA did not find significant differences in regression slopes between 
b a 
c d 
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the groups for horizontal coma, vertical coma, spherical aberration or 
HORMS but it was close to be significant for horizontal coma (F1,89 = 3.04, p 
0.09).  
 
Internal Aberrations 
Table 4:25 shows the Pearson correlations of internal aberration components 
with various ocular and systemic factors for the whole group. The only 
significant correlations were for vertical coma with lens thickness and for 
spherical aberration with diabetes duration and lens thickness. 
 
Table 4:25 Pearson correlations of internal aberrations components with different ocular 
and systemic factors 
Internal 
aberration 
components 
Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Axial 
length 
Gender 
Horizontal 
coma 
correlation 
co-efficient 
p values 
−0.12 
 
 
 
0.26 
−0.18 
 
 
 
0.09 
−0.18 
 
 
 
0.09 
−0.14 
 
 
 
0.18 
−0.07 
 
 
 
0.51 
0.14 
 
 
 
0.20 
0.17 
 
 
 
0.11 
Vertical 
coma 
correlation 
co-efficient 
p values 
−0.07 
 
 
 
0.52 
−0.16 
 
 
 
0.14 
0.04 
 
 
 
0.97 
−0.27 
 
 
 
< 0.01* 
0.03 
 
 
 
0.76 
0.08 
 
 
 
0.45 
0.06 
 
 
 
0.60 
Spherical  
aberration 
correlation 
co-efficient 
p values 
−0.01 
 
 
 
0.96 
0.29 
 
 
 
0.01* 
0.07 
 
 
 
0.52 
0.23 
 
 
 
0.03* 
0.19 
 
 
 
0.07 
−0.22 
 
 
 
0.03 
0.05 
 
 
 
0.61 
HORMS 
correlation 
co-efficient 
p values 
0.13 
 
 
0.22 
0.06 
 
 
0.55 
0.06 
 
 
0.55 
0.12 
 
 
0.25 
−0.08 
 
 
0.47 
0.023 
 
 
0.83 
0.19 
 
 
0.07 
 
For horizontal coma, multiple regression analysis was performed with age 
and diabetes duration as predictors using the whole group and then for only 
the diabetes group. Neither factor contributed significantly to the fit in either 
case. 
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For vertical coma, multiple regression analysis was performed with age and 
diabetes duration as predictors using the whole group. Neither factor 
contributed significantly to the fit. When the multiple regression analysis 
was restricted to the diabetes group, diabetes duration alone contributed 
significantly to the fit: 
y = −0.0052(± 0.0020)DiaDur + 0.084(±0.065), R2 = 0.14 
For spherical aberration, multiple regression analysis was performed with 
age and diabetes duration as predictors using the whole group. Only 
diabetes duration factor contributed significantly to the fit.  
y = +0.0018(± 0.0006)DiaDur − 0.021(±0.038), R2 = 0.08 
When the multiple regression analysis was restricted to the diabetes group, 
again diabetes duration contributed significantly to the fit: 
y = +0.0043(± 0.0013)DiaDur − 0.023(±0.042), R2 = 0.21 
For HORMS, multiple regression analysis was performed with age and 
diabetes duration as predictors using the whole group and then only the 
diabetes group. Neither diabetes duration nor age contributed significantly 
to the fit in either case. 
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Figure 4:29 Relationships between age and internal aberration components for people 
with and without diabetes. a) Horizontal coma linear fit, diabetes group: fit Y = 
+0.000(±0.002)Age + 0.08(±0.08), R2 0.00, p 0.96; non-diabetes group: Y = −0.003(±0.002)Age + 
0.27(±0.08), R2 0.07, p 0.08. b) Vertical coma linear fit, diabetes group: Y = +0.000(±0.002)Age 
+ 0.07 (±0.07), R2 0.00, p 0.89; non-diabetes group: Y = −0.001(±0.001)Age + 0.11(±0.07), R2 0.01, 
p 0.43. c) Spherical aberration linear fit, diabetes group: Y = −0.000(±0.001)Age − 0.01(±0.05), 
R2 0.00, p 0.99; non-diabetes group: Y = +0.000(± 0.001)Age − 0.02(±0.03), R2 0.00, p 0.99. d) 
HORMS linear fit, diabetes group: Y = +0.002(± 0.001)Age + 0.20(±0.06), R2 0.03, p 0.22; non-
diabetes group: Y = +0.001(±0.001)Age + 0.25(±0.06), R2 0.01, p 0.62. Values in brackets are 
standard errors.  
 
 Figure 4:29 shows the internal ocular aberrations as a function of age. There 
was no significant difference between the groups for any aberration 
component. There was no significant rates of change with age for any 
a b 
c 
d 
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combination of group and aberration component, and ANCOVA did not find 
any significant differences in regression slopes between groups. 
 
Discussion 
For only two coefficient/component combinations, total ocular horizontal 
coma and total ocular vertical coma, were there significant differences 
between diabetes and non-diabetes groups (Table 4:22), and there were no 
significant differences of higher-order RMS between the groups.  
 
Across the various aberration component and whole group/diabetes group 
combinations, only a few were associated significantly with diabetes: 
horizontal coma (total), vertical coma (internal, total), spherical aberration 
(internal, total) and HORMS (total). For the diabetes group alone, both 
internal and total ocular vertical coma and spherical aberration changed 
significantly as a function of diabetes duration.  
 
Shahidi et al. (2004) and Valeshabad et al. (2014) reported greater higher-
order RMS aberrations in diabetic groups than in control groups for 6 mm 
and 5 mm pupils, respectively. Diabetic type was not specified, but all had 
diabetic retinopathy. The smaller pupil size of 4.5 mm was used for this 
study as it was large enough to include assessment of all but one participant. 
 
In conclusion, in this study diabetes appears to have had minor effects on 
aberrations.  
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4.6 Lens Yellowing  
The characteristics of the sub-groups for flicker photometry testing are 
summarised in Table 4:26. There were 30 participants with diabetes and 41 
age-matched participants without diabetes. Eight participants in the diabetes 
group and four participants in the non-diabetes group were not able to 
perform the testing. 
 
Table 4:26 Characteristics of participants for lens yellowing 
 People with 
diabetes 
People without 
diabetes 
P-values 
Number of participants 30 41 0.48 
Age (mean ± SD, age range), 
years 
39 ± 12, 19 − 63 40 ± 11, 20 − 62 0.64 
Number of eyes (R/L) 24/6 35/6 0.55 
Gender (F/M) 11/19 29/12 0.01* 
Visual acuity (Log-MAR) −0.05 ± 0.26 −0.03 ± 0.24 0.74 
Log contrast sensitivity  1.84 ± 0.12 1.91 ± 0.08 0.02* 
Spherical equivalent 
refraction (dioptres) 
−0.61 ± 1.17 −0.55 ± 0.83 0.43 
Anterior chamber depth 
(mm) 
2.82 ± 0.35 2.90 ± 0.36 0.39 
Lens thickness (mm) 4.13 ± 0.44 3.98 ± 0.33 0.12 
Axial length (mm) 23.66 ± 0.90 23.66 ± 0.78 0.99 
Log lens yellowing  1.72 ± 0.34 1.49 ± 0.28 < 0.01* 
HbA1c (m mol) 7.77 ± 1.20 5.03 ± 0.35 < 0.001* 
Diabetes duration (years) 18 ± 11 –  
 
Table 4:27 shows the Pearson correlations of lens yellowing with various 
ocular and systemic factors for the whole group. Lens yellowing was 
significantly correlated with age, duration of diabetes, HbA1c and lens 
thickness but not with spherical equivalent refraction, axial length and 
gender. The correlations was higher for age than for diabetes duration. 
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Table 4:27 Pearson correlations of log lens yellowing with different ocular and systemic 
parameters 
 
 
Age Diabetes 
duration 
HbA1c Lens 
thickness 
Spherical 
equivalent 
refraction 
Axial 
length 
Gender 
Correlation 
co-efficient 
p 
0.63 
 
< 0.001* 
0.48 
 
< 0.001* 
0.40 
 
0.001* 
0.62 
 
< 0.001* 
0.11 
 
0.38 
–0.15 
 
0.23 
–0.05 
 
0.68 
* indicates significance 
 
Multiple regression analysis was performed with age and diabetes duration 
as predictors using the whole group. Both factors contributed significantly to 
the fit: 
y = 0.011(±0.002)DiaDur + 0.016(±0.002)Age + 0.87(±0.09), R2 = 0.56  
When the multiple regression analysis was restricted to the diabetes group, 
only age contributed significantly to the lens yellowing fit:  
y = 0.008(±0.004)Age + 0.97(±0.15), R2 = 0.53 
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Figure 4:30 Relationships between age and lens yellowing for people with and without 
diabetes. Fit for diabetes group: Y = +0.019(±0.004)Age + 1.00(±0.15), R2 0.47, p < 0.001; fit for 
non-diabetes group:  Y = +0.018(±0.003)Age + 0.78(±0.12), R2 0.49, p < 0.001. Values in 
brackets are standard errors.  
 
Figure 4:30 shows lens yellowing as a function of age. People with diabetes 
had significantly higher lens yellowing than people without diabetes with 
mean difference 0.23 ± 0.15 logs (mean ± 95% CI). There were significant, 
similar increases of 0.019 log yellowing/year and 0.018 log yellowing/year in 
people with and without diabetes, respectively. 
 
Discussion 
Lens yellowing was higher in the diabetes group than in the non-diabetes 
group, but the rates of change with age were similar.  
 
Figure 4:31 compares my results with those of previous studies (Davies & 
Morland, 2002; Lutze & Bresnick, 1991). When comparing the studies, 
attention can be paid only to the slopes as I have no absolute scale. All 
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studies have greater lens yellowing in the diabetes group. Similar to this 
study, Davies and Morland (2002) found a significant effect of age but not 
diabetes duration on lens yellowing in their diabetes group (10 DM1 and 24 
DM2 participants). However, both studies (Davies & Morland, 2002; Lutze & 
Bresnick, 1991) found greater rates of increase of lens yellowing with age in 
DM1 groups than in non-diabetes groups.  
 
 
Figure 4:31 Comparison of lens yellowing from Lutze & Bresnick (1991) and Davies & 
Morland (2002) with the current study. For clarity the fits only have been shown. 
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4.7 Lens Dimensions and Refractive Index Distribution 
The characteristics of the sub-groups for the MRI investigation are 
summarised in Table 4:28. There were 17 participants with diabetes (7 young, 
10 older) and 23 age-matched participants without diabetes (13 young, 10 
older). Selection of the participants has been described in sections 3.1 and 
3.5.6. 
 
Two-way ANOVAs were performed to consider the effects of diabetes and 
age on each of lens equatorial diameter, axial thickness and centre refractive 
indices. The diabetes group had significantly lower equatorial diameters than 
the non-diabetes group (F1, 36 = 24.5, p < 0.01; diabetes group mean ± 95% CI: 
8.65 ± 0.26 mm; non-diabetes group 9.42 ± 0.18 mm), and significantly greater 
axial thickness than the non-diabetes group (F1, 36 = 11.9, p < 0.01; diabetes 
group mean ± 95% CI : 4.33 ± 0.30 mm; non-diabetes group 3.80 ± 0.14 mm). 
The centre refractive indices of the two groups were not significantly 
different (F1, 36 = 3.0, p = 0.09).  
 
Age group did not affect equatorial diameter significantly (F1, 36 = 0.10, p = 
0.20). The older group had significantly greater axial thickness than the 
young group, as was expected from section 4.2.11 (F1, 36 = 22.4, p < 0.01; older 
group mean ± 95% CI: 4.35 ± 0.26 mm; young group 3.70 ± 0.25 mm) (Figure 
4:32). The older group had significantly lower centre refractive index than the 
young group (F1, 36 = 4.14, p = 0.04; older group mean ± 95% CI: 1.398 ± 0.003; 
younger group 1.401 ± 0.004).  
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Table 4:28 Characteristics of participants for lens dimensions and refractive index 
distribution 
 People with 
diabetes 
People without 
diabetes 
P-values 
Number of young participants 7 13 0.40 
Number of older participants 10 10 1.00 
Young group (mean ± SD, age range), years 23 ± 4, 20 − 30 24 ± 4, 20 − 29 0.32 
Older group (mean ± SD, age range), years 54 ± 4, 48 − 59 55 ± 4, 50 − 61 0.31 
Young group, number of eyes (R/L) 6/1 13/0 0.16 
Older group, number of eyes (R/L) 9/1 9/1 1.00 
Young group, gender (F/M) 2/5 7/6 0.28 
Older group, gender (F/M) 6/4 6/4 1.00 
Young group, visual acuity (Log-MAR) −0.03 ± 0.07 0.00 ± 0.30 0.83 
Older group, visual acuity (Log-MAR) −0.05 ± 0.05 -0.07 ± 0.30 0.23 
Young group, log contrast sensitivity 1.85 ± 0.12 1.91 ± 0.09 0.05* 
Older group, log contrast sensitivity 1.88 ± 0.09 1.87 ± 0.10 0.82 
Young group, spherical equivalent 
refraction (dioptres) 
−0.39 ± 0.84 −0.72 ± 1.07 0.32 
Older group, spherical equivalent  
refraction (dioptres) 
−0.06 ± 1.21 −0.36 ± 1.11 0.62 
Young group, MRI lens equatorial 
diameter (mm) 
8.68 ± 0.51 9.53 ± 0.35 0.00* 
Young group, MRI axial lens thickness 
(mm) 
3.93 ± 0.29 3.58 ± 0.11 0.02* 
Young group, MRI lens centre refractive 
index 
1.400 ± 0.007 1.403 ± 0.008 0.42 
Young group, MRI lens anterior axial 
thickness (mm) 
1.22 ± 0.29 1.13 ± 0.15 0.34 
Young group, MRI lens posterior axial 
thickness (mm) 
2.71 ± 0.12 2.45 ± 0.18 0.00* 
Older group, MRI lens equatorial diameter 
(mm) 
8.63 ± 0.56 9.27 ± 0.47 0.01* 
Older group, MRI lens axial thickness 
(mm) 
4.61 ± 0.65 4.10 ± 0.33 0.04* 
Older group, MRI lens centre refractive 
index 
1.397 ± 0.005 1.398 ± 0.005 0.55 
Older group, MRI lens anterior axial 
thickness (mm) 
1.67 ± 0.27 1.37 ± 0.28 0.03* 
Older group, MRI lens posterior axial 
thickness (mm) 
2.94 ± 0.50 2.72 ± 0.12 0.20 
Young group, HbA1c (m mol) 7.60 ± 0.92 4.95 ± 0.26 < 0.001* 
Older group, HbA1c (m mol) 7.92 ± 0.99 5.10 ± 0.28 < 0.001* 
Young group, diabetes duration (years) 17 ±  4 –  
Older group, diabetes duration (years) 30 ± 12 –  
Data are expressed as the mean ± standard deviation 
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Figure 4:32 Characteristic MSE images from each of the groups: a) 30 year young female 
with 24 year diabetes duration, b) 58 year older male with 35 year diabetes duration, c) 28 
years young male non-diabetes, and d) 52 years older male non-diabetes. These 
demonstrate the main findings in this section of greater axial thickness for older than for 
young lenses (b versus a and d versus c) and smaller equatorial diameter and greater axial 
thickness for diabetes than for non-diabetes lenses (a versus c and b versus d). 
 
The combined normalised refractive index profile data of each group (young 
with DM1, young without DM1, older DM1, older without DM1) were fitted 
by the power equation (3.51) for different dimensions, and the average 
refractive index along the axis of the lens was determined with equation 
(3.52). 
 
Table 4:29 shows fitted refractive index co-efficients for the equatorial 
diameter line, and for the optical axis, together with the average axial 
refractive index. In this table, the first normalisation approach described in 
section 3.5.6 was used for fitting the axial data, in which the profiles are 
folded about the mid-point of the lens axis and no distinction is made 
between the anterior and posterior segments. Table 4:30 shows the fitted 
refractive index co-efficients for the optical axis obtained using the second 
a b 
c d 
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normalisation approach for fitting the axial data described in section 3.5.6, in 
which the anterior and posterior segments are fitted separately, together with 
the corresponding average axial refractive index. Figure 4:33 shows refractive 
index data along the normalised equatorial diameter line and the optical axis 
(first normalisation approach). Figure 4:34 shows the data for the equatorial 
diameter line and optical axis, together with fits according to equation (3.51). 
 
Table 4:29 Co-efficients of fit n(r) = Co + Cprp to refractive index data along equatorial 
diameter line and optical axis of different groups, together with the average refractive 
index along the axial direction. Numbers in brackets are standard errors. * significantly 
different from older group with diabetes; # significantly different from older group 
without diabetes. 
Participant 
group 
Co 
equator 
Cp 
equator 
p 
equator 
Co 
axial 
Cp 
axial 
p 
axial 
nav 
axial 
Young group  
with diabetes 
1.4004* 
(0.0010) 
–0.0309 
(0.0026) 
2.8022*# 
(0.4522) 
1.4016# 
(0.0017) 
−0.0448*# 
(0.0061) 
2.5541 
(0.5621) 
1.3890 
 (0.0054) 
Young group no 
diabetes 
1.4015* 
(0.0006) 
–0.0432 
(0.0040) 
4.4812*# 
(0.5228) 
1.3988 
(0.0012) 
−0.0297 
(0.0027) 
3.6039 
(0.6518) 
1.3923 
 (0.0027) 
Older group 
with diabetes 
1.3974 
(0.0006) 
–0.0318 
(0.0043) 
8.6327 
(1.5302) 
1.3967 
(0.0010) 
−0.0281 
(0.0028) 
3.5286 
(0.6390) 
1.3905 
 (0.0025) 
Older group no 
diabetes 
1.3978 
(0.0006) 
–0.0608 
(0.0123) 
9.5572 
(1.5638) 
1.3961 
(0.0010) 
−0.0235 
(0.0025) 
4.9400 
(1.0944) 
1.3921 
 (0.0021) 
 
Table 4:30 Co-efficients of fit n(r) = Co + Cprp to anterior axial and posterior axial refractive 
index data of different groups using the second approach to normalisation along the 
optical axis. Numbers in brackets are standard errors. # significantly different from older 
group without diabetes. 
Participant group Co 
anterior 
axial 
Cp 
anterior 
axial 
p 
anterior 
axial 
Co 
posterior 
axial 
Cp 
posterior 
axial 
p 
posterior 
axial 
Young group  
with diabetes 
1.3993 
(0.0040) 
−0.0501 
(0.0111) 
2.0717 
(0.8565) 
1.4008# 
(0.0013) 
−0.0391# 
(0.0085) 
5.2397 
(1.5146) 
Young group no 
diabetes 
1.3995 
(0.0030) 
−0.0524 
(0.0095) 
2.3139 
(0.7401) 
1.3991 
(0.0011) 
−0.0219 
(0.0031) 
4.2919 
(1.1320) 
Older group with 
diabetes 
1.3951 
(0.0018) 
−0.0443 
(0.0137) 
4.5203 
(1.6944) 
1.3967 
(0.0010) 
−0.0237 
(0.0026) 
4.3872 
(0.9786) 
Older group no 
diabetes 
1.4014 
(0.0022) 
−0.0498 
(0.0088) 
2.8434 
(0.7970) 
1.3959 
(0.0010) 
−0.0190 
(0.0028) 
5.0866 
(1.4774) 
 
There was considerable variation within groups. The central plateaus 
appeared wider for the older than for the younger groups, particularly along 
the equatorial diameter line.  
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Unpaired t-tests were used to compare groups for each of the directions, in 
which the standard deviations were not assumed to be equal and Bonferroni 
correction was applied as there were 6 pair-wise comparisons per direction. 
There were a few significant differences only (Table 4:29 and Table 4:30). 
These involved the following: both young groups compared with both older 
groups - p equatorially; both young groups compared with the older diabetes 
group - Co equatorially; young diabetes group compared with both older 
groups – Cp axially; young diabetes group compared with older group 
without diabetes - Co axially, Cp posterior axially and p posterior axially. 
There were no significant differences between diabetes and non-diabetes 
groups of the same age.  
 
Discussion 
The interesting finding was the smaller equatorial diameters in the group 
with diabetes than in the control group. The refractive index data within 
groups were highly variable. A few statistically significant differences were 
found between young and older groups, although not between diabetes and 
non-diabetes groups of the same age.  
 
Comparing the non-diabetic lenses in this study with the findings of  
Kasthurirangan et al. (2008) for unaccommodated lenses, there was 
agreement in that there were similar axial thickness changes with age,  there 
was no change in centre refractive index with age, and the rate of decline in 
refractive index from centre to the periphery was greater along the equatorial 
diameter line than along the optical axis. However, there were some 
differences: Kasthurirangan et al.’s mean diameter was 0.23 mm smaller than 
found here, their central indices were about 0.007 higher, differences 
between centre and edge refractive indices were about 0.005 greater, and 
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they found significantly larger lens diameters in the older group than in the 
younger group whereas there was no  difference in the current study. 
 
 
Figure 4:33 Normalised refractive index profiles for diabetes and non-diabetes groups: (a) 
young groups, equatorial diameter line, (b) older groups, equatorial diameter line, (c) 
young groups, axial, and (d) older groups, axial. Positive distances correspond to 
nasal/anterior parts of the lens.  
  
a 
c 
b 
d 
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Figure 4:34 Normalised refractive index profiles for diabetes and non-diabetes groups, 
together with fits: (a) young groups, equatorial diameter line, (b) older groups, equatorial 
diameter line, (c) young groups, axial, (d) older groups, axial, (e) young groups, anterior 
axial, (f) older groups, anterior axial (g) young groups, posterior axial, and (h) older 
groups, posterior axial. 
 
f 
h 
b 
c d 
e 
g 
a 
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4.8 Summary 
Table 4:31 shows multiple regression fits for biometric and other parameters, 
both for the whole group and for the diabetes group. The emphasis is on 
diabetes duration and age as factors, but axial length is included where it has 
significant effects in regression fits that includes diabetes duration and/or 
age; othervwise no factors are shown. These equations have been presented 
in earlier sections, but for simplicity here, standard errors are omitted and 
aberration components are listed only when there are significant effects of 
diabetes duration and/or age. 
 
In the multiple regression fits shown in Table 4:31, duration of diabetes was 
an occasional significant contributor to the variation in a parameter – 
ignoring the aberration parameters for which effects were small, it was 
significant for 11/21 parameters for the whole group and 8/21 parameters for 
the diabetes group. For the whole group, this may because it was nothing 
more than a proxy for having diabetes. To investigate this, diabetes duration 
was replaced by diabetes status in regressions. Diabetes status refers to the 
presence or absence of diabetes status, and values of 1 and 0 were assigned to 
these states, respectively. Table 4:32 shows results, and includes parameters 
from Table 4:31 for which diabetic duration was a significant factor (there 
were no parameters for which diabetes status and not diabetes duration was 
a significant factor).  
 
For six parameters, swapping from diabetes duration to diabetes status 
meant that that diabetes was lost as a significant factor and its contribution 
was replaced to some extent by changes in the age co-efficient. For seven 
parameters, diabetes was retained as a significant factor, but with some 
lowering of the regression fit (i.e. R2 reduced) and compensatory increase in 
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the age co-efficient of up to 40%. These findings indicate that diabetes 
duration provided more information than the presence of diabetes alone, and 
was worthwhile including in regression analyses. 
 
Table 4:31 Multiple regression fits in the whole group and in the diabetes group 
Parameter Group Dur’n (yrs) Age 
(years) 
Axial 
length 
(mm) 
constant 
(D/mm/-
/logs/m) 
R-
squared 
Spherical equivalent 
refraction (D) 
Whole Group  +0.020 −0.538 + 11.45 0.24 
Diabetes group  +0.025 −0.660 + 14.11 0.29 
Anterior corneal radius of 
curvature(mm), Pentacam 
Whole Group      
Diabetes group      
Anterior corneal radius of 
curvature (mm), Medmont 
Whole Group      
Diabetes group      
Anterior corneal 
asphericity Q 
Whole Group      
Diabetes group  + 0.004  −0.68 0.15 
Corneal centre thickness 
(mm), Pentacam 
Whole Group +0.0005   +0.552 0.04 
Diabetes group      
Corneal centre thickness 
(mm), Lenstar 
Whole Group      
Diabetes group      
Posterior corneal  radius of 
curvature (mm) 
Whole Group      
Diabetes group      
Anterior chamber depth 
(mm), Pentacam 
Whole Group −0.009 −0.010 +0.147 −0.21 0.43 
Diabetes group −0.016 −0.007 +0.146 −0.12 0.54 
Anterior chamber depth 
(mm), Lenstar 
Whole Group −0.008 −0.011 +0.179 −0.87 0.46 
Diabetes group −0.013 −0.010 +0.187 −1.00 0.56 
Pupil diameter (mm) Whole Group  −0.029 +0.280 +0.76 0.29 
Diabetes group  −0.025 +0.305 −0.07 0.24 
Pupil decentration along 
x-axis (mm) 
Whole Group      
Diabetes group      
Pupil decentration along 
y-axis (mm) 
Whole Group      
Diabetes group      
Anterior lens radius of 
curvature (mm) 
Whole Group –0.045 –0.026 +0.460 +0.72 0.47 
Diabetes group −0.040  +0.418 +0.98 0.40 
Posterior lens radius of 
curvature (mm) 
Whole Group +0.017 +0.012 −0.270 −0.35 0.25 
Diabetes group      
Lens central thickness, 
Lenstar (mm) 
Whole Group +0.016 +0.021 −0.091 +5.35 0.73 
Diabetes group +0.020 +0.021 −0.113 +5.69 0.77 
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Table 4:31 (cont.) 
Parameter Group Dur’n (yrs) Age (years) Axial 
length 
(mm) 
constant 
(D/mm/-
/logs/m) 
R-
squared 
Lens equivalent 
refractive index 
 
Whole Group −0.0003 −0.0004 −0.0033 +1.525 0.35 
Diabetes group −0.0003  −0.0041 +1.537 0.28 
Lens equivalent power 
(D) 
Whole Group  −0.046 −1.997 73.70 0.59 
Diabetes group      
Straylight (logs) Whole Group +0.006 +0.005  +0.61 0.38 
Diabetes group +0.007 +0.004  +0.67 0.30 
Objective amplitude 
of accommodation (D) 
Whole Group −0.083 −0.145  8.92 0.59 
Diabetes group −0.076 −0.097  7.13 0.51 
Subjective amplitude 
of accommodation (D) 
Whole Group −0.105 −0.154  10.67 0.68 
Diabetes group −0.106 −0.103  9.08 0.63 
Total horizontal coma 
(µm) 
Whole Group −0.0017   +0.025 0.05 
Diabetes group      
Total vertical coma 
(µm) 
Whole Group −0.0030 −0.0021  +0.121 0.38 
Diabetes group −0.0045   +0.123 0.42 
Total spherical 
aberration (µm) 
Whole Group +0.0017   +0.031 0.10 
Diabetes group +0.0036   +0.022 0.20 
Total HORMS( µm) Whole Group +0.0018   +0.155 0.07 
Diabetes group +0.0044   +0.127 0.22 
Internal vertical coma  
(µm) 
Whole Group      
Diabetes group −0.0052 .  +0.084 0.14 
Internal spherical 
aberration (µm) 
Whole Group +0.0018   −0.021 0.08 
Diabetes group +0.0043   −0.023 0.21 
Log lens yellowing Whole Group +0.011 +0.016  +0.87 0.56 
Diabetes group  +0.008  +0.97 0.53 
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Table 4:32 Multiple regression fits in the whole group with either diabetes duration or 
diabetes status as factors, and where diabetes duration was a significant factor.  
Parameter Group Dur’n(yrs)/ 
Diabetes status 
Age (years) Axial 
length 
(mm) 
constant 
(D/mm/-
/logs/m) 
R-
squared 
Corneal centre 
thickness (mm), 
Pentacam 
Diabetes dur’n +0.0005   +0.552 0.04 
Diabetes status      
Anterior chamber 
depth (mm), Pentacam 
Diabetes dur’n −0.009 −0.010 +0.147 −0.21 0.43 
Diabetes status  −0.012 +0.190 −1.14 0.34 
Anterior chamber 
depth (mm), Lenstar 
Diabetes dur’n −0.008 −0.011 +0.179 −0.87 0.46 
Diabetes status  −0.013 +0.200 −1.33 0.41 
Anterior lens radius of 
curvature (mm) 
Diabetes dur’n –0.045 –0.026 +0.460 +0.72 0.47 
Diabetes status –1.031 –0.036 +0.524 −1.01 0.45 
Posterior lens radius of 
curvature (mm) 
Diabetes dur’n +0.017 +0.012 −0.270 −0.35 0.25 
Diabetes status +0.394 +0.015 −0.293 +0.01 0.25 
Lens central thickness, 
Lenstar (mm) 
Diabetes dur’n +0.016 +0.021 −0.091 +5.35 0.73 
Diabetes status +0.249 +0.025 −0.127 +6.01 0.61 
Lens equivalent 
refractive index 
Diabetes dur’n −0.0003 −0.0004 −0.0033 +1.525 0.35 
Diabetes status −0.0063 −0.0004 −0.0031 +1.522 0.35 
Straylight (logs) Diabetes dur’n +0.006 +0.005  +0.61 0.38 
Diabetes status +0.113 +0.007  +0.85 0.30 
Objective amplitude of 
accommodation (D) 
Diabetes dur’n −0.083 −0.145  8.92 0.59 
Diabetes status −1.531 −0.160  9.57 0.56 
Subjective amplitude 
of accommodation (D) 
Diabetes dur’n −0.105 −0.154  10.67 0.68 
Diabetes status −1.783 −0.171  11.47 0.61 
Total horizontal coma 
(µm) 
Diabetes dur’n −0.0017   +0.025 0.05 
Diabetes status −0.0400   +0.043 0.05 
Total vertical coma 
(µm) 
Diabetes dur’n −0.0030 −0.0021  +0.121 0.38 
Diabetes status −0.0451 −0.0026  +0.136 0.24 
Total spherical 
aberration (µm) 
Diabetes dur’n +0.0017   +0.031 0.10 
Diabetes status      
Total HORMS (µm) Diabetes dur’n +0.0018   +0.155 0.07 
Diabetes status      
Internal spherical 
aberration (µm) 
Diabetes dur’n +0.0018   −0.021 0.08 
Diabetes status      
Log lens yellowing Diabetes dur’n +0.011 +0.016  +0.87 0.56 
Diabetes status +0.256 +0.018  +0.76 0.55 
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Chapter 5:  Discussion 
5.1 Summary 
This study follows other studies of optics of diabetic eyes in recent decades, 
most notably that of Wiemer and colleagues (Wiemer, et al., 2008c; Wiemer, 
et al., 2007, 2008d; Wiemer, et al., 2009; Wiemer, et al., 2008a, 2008b). While 
there have been studies that have considered larger numbers of people, this 
is the only comprehensive study of a large range of biometric and optical 
parameters.  
 
The hypothesis of this thesis was that eyes of people with diabetes act as 
older eyes than those of people of the same age without diabetes. An 
associated list of aims was presented in chapter 1; these are addressed below. 
A group of up to 74 people with diabetes type 1 were compared with an age 
matched control group. Based on the results of various biometric and optical 
parameters that have been presented and discussed in Chapter 4, it is easy to 
conclude that the hypothesis has been supported. Relative to the control 
group, the diabetes group demonstrated smaller anterior chamber depths, 
more curved lenses, lower lens equivalent refractive index, greater straylight, 
lower amplitudes of accommodation, greater lens yellowing and different 
coefficients for two total ocular higher-order aberrations. Marginal or no 
significant differences were found between groups for corneal shape, corneal 
thickness, pupil size, pupil decentrations and other higher-order aberrations 
(total, corneal and internal).  
 
Not explicitly stated in the hypothesis, but given as part of the aim about lens 
yellowing (section 5.8), was the expectation that differences between diabetic 
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eyes and non-diabetic eyes would increase with age. Increased differences 
with age had been found previously for central lens thickness (Sparrow, et 
al., 1990; Wiemer, et al., 2008d), for lens yellowing (Davies & Morland, 2002; 
Lutze & Bresnick, 1991) and for the radii of curvature of the lens and 
equivalent lens index (Wiemer, et al., 2008d). In the multiple regression fits, 
duration of diabetes was only an occasional significant contributor to the 
variation in a parameter, and in the case of combining diabetic and non-
diabetic eyes, it was suspected that this may have been only because it was 
really a stand-in for having diabetes; however the analysis in section 4.8 
indicated that diabetes duration gives more information than the presence or 
absence of diabetes. The ANCOVA analyses showed that the slopes of a 
parameter against age were significantly different for the two groups only for 
amplitude of accommodation (section 4.4). They were nearly significant for 
anterior corneal asphericity (4.2.3), central corneal thickness (4.2.4), anterior 
chamber depth (4.2.6), lens thickness (4.2.11), posterior lens radius of 
curvature, lens equivalent refractive index (4.2.10), and total ocular 
horizontal coma co-efficient (4.5), with p values ranging between p 0.07 and 
0.11 suggesting insufficient power of testing. The differences in slope were 
opposite to the expected direction for amplitude of accommodation (4.4, 5.3), 
posterior lens radius of curvature (4.2.10), and lens equivalent refractive 
index (4.2.12).  
 
The conclusion to be drawn is that the changes in this type 1 diabetes group, 
relative to the control group, were small. While this is unfortunate in the 
context of testing my hypothesis and addressing the thesis aims, it indicates 
that people with well-controlled diabetes relative to neuropathy (section 3.1) 
(and who are striving especially hard to remain compliant with 
health/lifestyle/medications given that they were under close scrutiny in the 
LANDMark study) need not have accelerated changes in the optics of the eye 
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with ageing, and presumably the serious consequences of diabetes can be 
slowed. 
 
One very interesting finding of the study is that, in the MRI investigation 
(section 4.8), lens diameters were smaller in the diabetes group than non-
diabetic group. This may affect functions such as accommodation where the 
zonules may be exerting greater pressure on the lens. This has implications 
concerning accommodation restoration with scleral expansion surgery in 
people with diabetes. The numbers for the investigation were small in this 
study (40 across two ages) and further investigation is warranted to study 
changes in the lens diameter, movements of the zonule and ciliary muscle 
during  accommodation.  
 
5.2 Do People with Diabetes have Greater Higher-order Aberrations 
than Age-matched Controls? 
I did not find evidence that ocular aberrations, nor the corneal and internal 
components of these aberrations, were higher in people with diabetes than 
people without diabetes. Two higher-order aberrations, horizontal and 
vertical coma, had significantly different coefficients for the two groups. 
 
It is generally understood that the aberrations of the eye increase with age, 
although such changes were not marked in the few studies in which there 
was control for the refraction distribution (Atchison & Markwell, 2008; 
Plainis & Pallikaris, 2008). Thus, if diabetic eyes behave like older eyes, it 
might be expected that ocular aberrations would be higher in the diabetes 
group than in the control group. In particular, the internal contribution to 
aberrations, which will be determined by the lens, might also increase. 
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Shahidi et al. (2004) and Valeshabad et al. (2014) reported greater higher-
order RMS aberrations in diabetic groups (with diabetic retinopathy) than in 
control groups for 6 mm and 5 mm pupils, respectively. The pupils were 
dilated in these studies. An unresolved question is whether I would have 
obtained significant differences at a larger pupil than the 4.5 mm pupil 
selected because it was large enough to include all but one participant. I did 
not dilate pupils because I thought that there might be interactions between 
natural pupil size, decentration and aberrations. In fact I found that the 
differences in pupil size between the groups were not significant, although 
there was a tendency for diabetic pupils to be smaller (section 4.2.7), and that 
there was no tendency for different pupil decentrations (relative to the 
limbus) in the groups (section 4.2.8).  
 
5.3 Can Loss of Accommodation with Diabetes be Attributed to 
Changes in the Lens Including Refractive Index Distribution? 
Optical and neurological contributions to loss of accommodation were not 
able to be distinguished in this study. While there were biometric differences 
between diabetes and non-diabetes participants – lens surface curvatures, 
lens thickness, equivalent refractive index and amplitude of accommodation 
– no picture emerged of the contribution to loss of accommodation with 
diabetes. Refractive index distributions were different between young people 
and older people equatorially, but there were no significant differences 
between the diabetes and non-diabetes groups of the same age (section 4.7). 
Unfortunately, biometric and optical changes with accommodation were not 
investigated. 
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Previous studies of amplitude of accommodation in diabetes have used 
subjective methods (Braun, et al., 1995; Moss, et al., 1987). These overestimate 
amplitude because of depth-of-focus effects (Hamasaki, Ong, & Marg, 1956; 
Sun et al., 1988). Accordingly they will interact with pupil size, which had 
been expected to be smaller with diabetes. Therefore, I used the aberrometer 
to measure amplitude objectively (section 4.4). While as expected, objective 
amplitudes were smaller than subjective amplitudes, trends and 
dependencies were similar for the two methods.  
 
The Moss et al. (1987) study found that subjective amplitudes were smaller in 
a diabetic group than in a control group by about 1.8 D, but the rates of loss 
with age were similar for both at about 0.25 D/year. This suggests that the 
onset of presbyopia, the loss of adequate near vision focus due to loss of 
accommodation, would occur a few years earlier in people with diabetes.   
 
The current study found that, while people with diabetes had lower 
amplitudes than those without diabetes, the rate of loss for the former with 
increase in age were actually smaller (0.12 vs. 0.23 D/year objectively and 
0.13 vs. 0.23 D/year subjectively). The relative loss of accommodation with 
diabetes appears to be a proportional effect in this group. If the subjective 
amplitude at which presbyopia occurs is taken to be the fitted value for the 
control group at 45 years (3.2 D), presbyopia is predicted to occur at 40 years 
for people with diabetes. Of course, in an individual, this will be affected by 
the age of onset of diabetes.  
 
Surprisingly, I could find nothing in the clinical literature to compare with 
this estimate of presbyopia onset in diabetes patients. Leffler et al. (2008) 
predicted that the preferred reading addition in presbyopes was significantly 
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related to the duration of diabetes (although not the presence of diabetes) at a 
rate of 0.06 D per year. 
 
5.4 Do Diabetic Lenses Become Yellower at Greater Rates with Age 
than Age-matched Normal Lenses? 
Lens yellowing was higher in the diabetes group than in the non-diabetes 
group, but the rates of change with age were similar contrary to previous 
studies (Davies & Morland, 2002; Lutze & Bresnick, 1991). This is possibly 
related to the mild levels of diabetic retinopathy of participants in the current 
study.  
5.5 Is the Refractive Index Distribution of the Diabetic Lens 
Different from that of the Non-diabetic Lens? 
I could not find any evidence that this was the case. 
 
The magnetic resonance imaging component of the study included young (20 
– 29 years) and older (48 – 61 years) diabetes and non-diabetes groups with 
approximately 10 subjects in each. Power fits of refractive index (equation 
(3.51)) were made to the combined data of the participants along the 
equatorial diameter line and optical axis in each of the groups. There were a 
few significant differences involving the young groups compared with the 
older groups, but there were no significant differences within either age 
group for the people with and without diabetes. The age-related effects in 
refractive index distribution support the study by Kasthurirangan et al. 
(2008).  
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Recently 3-D optical coherence tomography has been developed by the 
Marcos group to measure lens parameters including the lens gradient index 
e.g. Siedlecki et al. (2012). With the much higher resolution of OCT than MRI, 
it will be interesting if subtleties in refractive index distribution in different 
conditions such as diabetes can be distinguished, although like our method 
their technique relies on approximations and assumptions. 
5.6 Are Corrections to Assumed Refractive Index Needed in 
Biometric Measurements of Diabetic Eyes? 
The answer is no, as argued below. 
 
As mentioned in section 5.5, the magnetic resonance imaging component of 
the study included young (20 – 29 years) and older (48 – 61 years) diabetes 
and non-diabetes groups. The average axial refractive index had a 0.003 
range between the groups, and the variation within groups (standard 
deviations 0.008 to 0.014) was much greater than the between-group 
variation. While the differences between groups were not significant, let us 
assume that they were. Further, assume that an instrument like the Lenstar is 
calibrated for a lens refractive index nref. The associated optical path length is  
OPL = dLnref 
where dL is the lens central thickness. If this optical path length had been 
determined for another lens with a refractive index n and thickness (dL – dL) 
the relationship would be  
OPL = (dL – dL)nr 
dL, the error in central thickness given by the instrument, can be found by 
equating the right hand sides of the two equations: 
dL = dL(nref/n – 1) 
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If it is assumed that nref is 1.3921 and corresponds to the average axial 
refractive index of the older, non-diabetes group, the average errors for the 
other groups range between –0.0001dLand +dL. If the measured 
thickness was 5.00 mm, errors would range between–0.001 mm and +0.012 
mm. The precision of the Lenstar (although not necessarily the accuracy) is 
0.01 mm, which is similar to the range of these errors. 
 
5.7 Do People with Diabetes have More Straylight than People 
without Diabetes? 
Straylight increased with both diabetes duration and age according to the 
multiple regressions reported in section 4.3, but the rate of change with 
increase in age was not significantly different than those of the control group. 
  
5.8 Limitation of the Study 
The participant group has been described in section 3.1, with a summary in 
section 5.1. The diabetes group may be considered to be “well controlled”. 
This selection was both a strength and a weakness: a strength in that I was 
dealing with a relatively homogenous group, and a weakness in that 
differences between people with and without diabetes were not as marked as 
would have been otherwise expected. Power tests to determine the necessary 
size of groups (section 3.2), particularly as regards rate of change of 
parameters with age, were based on studies including people with more 
severe ocular complications of diabetes than in this study. As discussed in 
some sections in chapter 4, the group sizes were not sufficient for some tests 
and new estimates were given e.g. 159 and 100 participants per group for 
corneal posterior radius of curvature and for pupil size in sections 4.2.5 and 
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4.2.7, respectively. Unfortunately, there were not sufficient resources nor 
time to obtain the additional participants.  
 
5.9 Further Work 
This research relates to long term changes in people with diabetes with 
minimal diabetic retinopathy. It would be interesting to conduct a similar 
study with people having severe diabetic retinopathy using high resolution 
optical coherence tomography to study the lens. It would also be interesting 
use a provocative glucose clamping study to investigate the effect of short 
term fluctuations of blood glucose on biometrical and optical changes in 
diabetes. In particular, determination could be made as to whether short 
term changes mimic the effects of longer term diabetes in regards to changes 
in equivalent index and surfaces, and loss of accommodation. As reported in 
section 2.3.8.2, refraction changes during hyperglycaemia may be in either 
the myopic or hyperopic directions, with Wiemer et al. (2009) suggesting that 
this may depend upon whether increased lens curvature or reduced 
equivalent refractive index is dominant. In such a study, young diabetes 
participants could have blood glucose levels clamped at 5 mmol/l 
(euglycaemic) and 15 mmol/l (hyperglycaemic) for 2 hours each. Tests could 
include uncorrected distance visual acuity, corneal topography and Lenstar 
for the unaccommodated state, and aberrometry and phakometry at a range 
of accommodation levels.  
 
In this study, I was unable to determine likely neural and contributions to the 
loss of amplitude of accommodation in diabetes (section 5.3). Investigating 
changes in lens shape (surface curvatures and diameters) and refractive 
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index distribution during accommodation may provide understanding of 
this. 
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Appendices 
Appendix A: Effect of Phakometer Positioning Errors on Refraction, Eye 
Rotation and Purkinje Image Sizes 
 
The phakometer is designed so that the entrance pupil of the eye is at the 
focal point of the phakometer (Badal) lens and is focused by the camera. 
However, sometimes the phakometer position must be altered to improve 
quality of Purkinje images, particularly that of PIII. Also, the eye rotates at a 
point behind the eye entrance pupil. Furthermore, changes in phakometer 
position will change the size of the Purkinje images. This appendix considers 
errors in refraction, eye rotation and Purkinje image sizes associated with 
positioning errors. 
 
For this investigation, ray tracing is performed using heights and angles with 
refraction and transfer equations having the form 
u’ = u + hF   h+ = h – ud 
where u is incident angle at a surface, u’ is refracted angle at the surface, h is 
height at the surface, F is lens power and d is distance to the next surface for 
which h+ is the ray height. Here anticlockwise angles from a ray to the axis 
are taken as positive and heights above the axis are taken as positive. 
 
Refraction 
 
In Figure A: 1, the display plane passes through O, a (negative) distance l 
from the first principal plane of the Badal lens of power F. The display’s 
image plane passes through O’. The eye entrance pupil at EP is a distance 1/F 
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+ x from the second principal point of the Badal lens, where x is the 
positioning error.  
 
We trace a paraxial marginal ray from O to O’, starting with the marginal ray 
angle u. Transfer to the lens with height hL is given by 
hL = 0 – (–lu) = ul        (A1) 
which can be re-arranged to 
u = hL/l         (A2) 
 
Refraction at the lens gives refracted angle 
u’ = u + hLF         (A3) 
Substituting the right hand side of equation (A2) for u in equation (A3) gives 
u’ = hL/l + hLF = hL[(1 + Fl)/l]       (A4) 
which can be re-arranged to 
hL = u’l/(1 + Fl)        (A5) 
 
The transfer to the pupil with height heye is given by 
heye = hL – u’(1/F + x)        (A6) 
Substituting the right hand side of equation (A5) for hL in equation (A6) gives 
heye = –u’[1 + xF(1 + Fl)]/[F(1 + Fl)]      (A7) 
 
The ray is then transferred to O’ a distance l/Leye from the entrance pupil, and 
for which height is zero, to give 
0 = heye – u’/Leye        (A8) 
from which  
Leye = heye/u’         (A9) 
 
Substituting the right hand side of equation (A7) for heye in equation (A9) 
gives 
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Leye = –F(1 + Fl)/[1 + xF(1 + lF)]      (A10)  
 
In equation (A10), setting x to zero gives the refraction Rx as 
Rx = –F – F2l         (A11) 
Substituting Rx for the right hand side of equation (A11) in equation (A10) 
gives 
Leye = Rx/(1 – xRx)        (A12) 
 
The refraction error Rx associated with positioning error x is given by 
subtracting equation (A11) from equation (A12) to give 
Rx = xRx2/(1 – xRx)        (A13) 
  
Eye Rotation 
The object is a point of height    on the display plane (Figure A: 1). Raytracing 
refraction and transfer equations are performed from this point to the centre 
of the entrance pupil centre using heights and angles. The initial angle of the 
ray is   and the height     of the ray at the lens is given by 
     =    – (–      +          
which can be re-arranged to 
      –   )/l         (A15) 

Refraction at the lens gives  
    =   +    F         
Substituting the right hand side of equation (A15) for   in equation (A16) 
gives 
    = [   (Fl –   )]/l       
which can be re-arranged to 
    = (   l +   )/(1 + Fl        (A18) 
 
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Transfer to the centre of the entrance pupil gives 
0 =      –    (1/F + x)        (A19) 
Substituting the right hand side of equation (A18) for     in equation (A19) 
gives 
    =   F/[ 1 – x(–F – F2l)]       (A20) 
 
Substituting Rx for the right hand side of equation (A11) in equation (A20) 
gives 
    =   F/(1 – xRx)        (A21) 
In equation (A21), setting x to zero gives the angle    RX as 
   RX =   F         (A22) 
Comparing equations (A21) and (A22) gives 
  /   RX = 1 – xRx        (A23) 
 
Figure A: 1 Determining errors with phakometer system. 
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Purkinje Image Sizes 
The design distance for the infrared ring target from the entrance pupil is 75 
mm. Using an appropriate schematic eye, we can determine the changes in 
the ratios of the Purkinje image sizes when this distance is altered. We used 
the four-surface Navarro schematic eye with refractive indices for 890 nm 
determined from the dispersion equations given by Atchison & Smith (2005). 
The equations for ray tracing can be the paraxial refraction equations as 
given at the start of the appendix in which reflections are treated by putting 
n’ = –n and having refractive indices and distances following reflection as 
being negative. Object and image distances in each surface are monitored 
and magnification for the Purkinje images is given using equations similar to 
those given in section 3.5.5.4.2. Alternatively a raytracing procedure may be 
used similar to that given in the section for a three-surface schematic eye. 
  
Results 
Refraction 
The scale for the target display assumes that the Badal condition holds 
according to equation (A11). Should the condition not hold there are errors in 
the refraction given by equation (A13). There are similar errors when the 
accommodation stimulus is changed. Errors in refraction are shown in Figure 
A: 2. when the instrument is brought too close to the eye by 5 and 10 mm 
(positioning errors x = –5 mm and –10 mm, respectively). The refraction error 
is negative for both positive and negative refractions, extending to 
approximately –1.0 D at ±10 D refractions for –10 mm displacements and 
about half this for –5 mm displacement. If the display is moved from a 
position corresponding to a scale reading of 0 D to one corresponding to that 
for –8 D, the accommodation stimulus increases by 7.3 D rather than by 8.0  
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D. We expect positioning errors of the order of 5 mm, and errors in refraction 
and accommodation associated with this do not seem particularly high.  
 
 
Figure A: 2 Refraction error, as a function of refraction given on the Optometer scale, 
caused by the phakometer being too close to the eye by (–) 5 mm and (–)10 mm. 
 
Eye rotation 
If the phakometer is brought closer to the eye (negative values of x), the 
image subtense increases for negative refractions and increases for positive 
refractions. The errors amount to 10 % for 10 mm displacement errors. 
However, the important issue is not the angular subtense, but the rotation of 
the eye. Calculations of the eye rotation for the different target location on 
the display were derived using equation (A21) on the basis of the rotation 
centre being 12 mm behind the entrance pupil (Figure A: 3). Obviously 
angular errors will also be affected by positioning errors, amounting to a 
maximum of about 5% for a 5 mm positioning error. 
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Figure A: 3 Change in image size (%), as a function of refraction given on the Optometer 
scale, caused by the phakometer being too close to the eye by (–) 5 mm and (–) 10 mm. 
 
Purkinje Image Sizes 
For an object distance of –75 mm, Purkinje images PI, PIII and PIV are 3.67 
mm, 10.06 mm and 3.76 mm inside the schematic eye, respectively, and ratios 
PIII/PI and PIV/PI are 1.834 and –0.769, respectively. The ratios, rather than 
the absolute image sizes, are important in phakometry. If the object distance 
changes to –70 mm, changes in these ratios are –0.54% and –0.04%, 
respectively. If the object distance changes to –65 mm, proportional changes 
in these ratios are –1.15 % and –0.09 %, respectively. These seem to be small 
errors. 
 
Other 
Because the camera has a telecentric lens, an incorrect distance from the eye 
because of positioning errors is not important. 
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Appendix B: Manual for using Phakometry Software 
Targets for Fixation 
A slide with black background is created in Microsoft PowerPoint. Nine 
circles (each filled with white colour and having a black number from 1 to 9) 
are created at nine different positions in this slide. One circle is presented in 
the centre while others (eight circles) are represented on the top and bottom, 
and both sides of the slide. The magnification ratio between OLED monitor 
and primary monitor is 1:21.1. On primary monitor, the horizontal inter 
central circles distance is 122.5 while the vertical inter central circles distance 
is 90.0 mm which on OLED monitor results in 5.8 mm horizontal inter central 
circles distance and 4.3 mm vertical inter central circles distance. When a 
participant looks through the beam splitter a mirror image effect is observed. 
To cancel this effect, PowerPoint slides are flipped horizontally on OLED 
monitor. This first slide is used during alignment of the participant. 
 
Nine more slides are created. Each of these slides has one only single circle at 
one of the nine positions on the first slide.  
 
The OLED is connected to the computer through the VGA card (graphic 
card). Every computer has its primary monitor in the form of a window. It 
can detect the OLED monitor, which can be seen when the “display” icon is 
clicked in the control panel. The display interface has the tab “settings” 
which has monitor setting options. The extended monitor option keeps the 
two monitors (one is computer primary monitor and other is OLED monitor) 
side by side.  
 
Whenever another monitor is connected with a computer, the “slide show” 
tab in the PowerPoint is active with “show presentation on” for choosing 
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different monitors. In this way, the OLED monitor is chosen. The slides on it 
can be changed by clicking on the tab “From beginning” and then keep on 
changing by arrow keys on the keyboard. In this way, alternatively the 
circles on the OLED monitor can be changed.  
 
Capturing Images 
To capture images, the following steps are performed 
 The participant’s head is placed on the head rest. He/she looks through the 
Badal lens to the OLED screen. The OLED screen is moved longitudinally 
along the Badal setup to correct refractive error. 
 When the participant looks at the central fixation target (central circle) on the 
OLED screen and he/she can observe all the nine targets and the pupil centre 
is in the centre of the primary monitor, the eye is considered to be aligned 
with the camera.  
 Double click on the “Pixel Link” camera icon to open the camera user 
interface. When the eye is aligned with the camera, Purkinje images PI and 
PIV are easily visible. To get Purkinje image PIII clearly on screen and in 
images, one needs to move the instrument back and forth and manipulate 
the gain, exposure time, and gamma correction in the camera interface. Click 
the “capture button” in the interface to capture an image. This image can be 
saved in the location indicated in the browsing path. 
 
Purkinje Image Heights 
Purkinje images heights are calculated with the Purkinje software using 
Matlab. To open the software, double click on “Purkinje” file. Write 
“Purkinje” in the command window, and press enter key on keyboard. A 
window will open as shown below (without the image).  
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Figure B: 1 A screen capture of the Purkinje software interface. PI, PIII, PIV, Pupil, and 
Lim are the buttons for the calculation of the Purkinje images heights (PI, PIII, PIV), 
pupil diameter and limbus diameter, respectively. The Log button is used to take the log 
of the image to make the Purkinje images clearer and the Edge button is used to perform 
edge detection in the image. 
 
To get an image, click on the “load image” button and one will get the path 
for browsing where images have been saved. Click on the image you want to 
analyse and it will come to the software window (Figure B: 1). One can take 
the log of the image each time before measuring the height of each Purkinje 
image. 
 
To calculate the PI Purkinje image height, push the PI button, stretch the 
cursor anywhere on the image and one will get the ellipse to fit on PI. Double 
click inside the ellipse and software will record the PI height (radius). 
 
To calculate the PIII image height, push the log button again and press the 
PIII button. Stretch the cursor on the image and fit the ellipse over the PIII. 
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Double click inside the ellipse and software will record the PIII height 
(radius). 
 
The same procedure will be used for PIV, Pupil and Limbus in this order. 
When all these parameters are calculated press the “Show PI, PIII, and PIV 
radius” button to see the results and after that press “Save Results”. The 
results are displayed in the command window as well as saved in the Excel 
file “Results” in the current folder of the Matlab window (where Phakometry 
m files are saved). Open the “Results” Excel file with “Open with Matlab” 
option. 
 
Optimization to Determine Lens Parameters 
We have “Phakometry” software which contains a merit function routine to 
estimate lens radii of curvature and lens equivalent refractive index.  
 
Open “PR.m file” in Matlab from the Phakometry software. Write “PR” in 
command window and press the enter key in the keyboard. A dialog box 
“Pixels per millimetre” will appear. In this box, enter the number of pixels 
per millimetre in the images. Click “OK” and the following interface appears 
(Figure B: 2).   
 
Figure B: 2 Interface of the Phakometry software 
 
Press the “calculate radii” button in the interface (Figure B: 2) which gives an 
interface with defaults values (Figure B: 3). Biometry data derived from 
different instruments is entered along with Purkinje image heights. Note that 
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refractive error, radii and image heights are averaged between the principal 
meridians. 
 
Figure B: 3 Biometry and Purkinje height information. 
 
Enter the number of cycles in the “# of cycles” push the “Submit” button. 
2000 cycles is recommended; this is slow but means that the optimisation 
should be complete in nearly all cases. Lens radii of curvature and equivalent 
refractive index results are obtained and saved in a Notepad text file (Figure 
B: 4). The Notepad file can be named according to participant ID by writing 
the participant ID in the “Biometry and Purkinje information window” and 
the ID is displayed on top of the file e.g. AM(96).txt-Notepad (Figure B: 4).  
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Figure B: 4 Snap shot of the optimization result in Notepad. The green rectangle shows 
the equivalent refractive index at 890 nm, while the blue rectangle shows equivalent 
refractive index at 555 nm (correction factor 1.006712214). The red rectangle shows lens 
anterior radius of curvature and the pink rectangle shows lens posterior radius of 
curvature. 
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Changes we can make in Software 
Purkinje 
In “Purkinje.m” file we can change the number of pixels per millimetre at 
line 65 calculated from the image we need to analyse.  
handles.pixel_diameter = 1/62.7; % (mm) from ruler  
 
Means 62.7 pixels per millimetre in a image 
 
Phakometry 
In “subject_read.m” file, we can change refractive indices for different 
wavelength of LEDs at lines 330 to 335. 
 
In “Double_Radii.m” file, we can change the distance of the eye and source 
of light at line 24. In the same file we can change the “radius of the source 
ring” at line 25.  
 
In “PR.m” file, we can change the default value “pixels per millimetre” to 
our own default value at line 7. 
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